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Summary 
 
Responsible for about 700’000 annual deaths worldwide, malaria today is still one of the 
major health problems in developing countries. The most deadly form of human malaria 
called malaria tropica is caused by the apicomplexan parasite Plasmodium falciparum 
that is transmitted by the female Anopheles mosquito. Its pathology is associated with the 
asexual development of the unicellular parasite within the human red blood cell (RBC) 
that is devoid of all internal organelles and any protein trafficking machinery. Therefore, 
intraerythrocytic survival and virulence of P. falciparum strictly depend on extensive host 
cell refurbishments mediated by the export of parasite proteins into the erythrocyte 
cytosol. Although numerous of these proteins have been identified and some extensively 
studied, still surprisingly little is known about their functions and interactions. It could be 
shown that many of these proteins are transported to or via parasite-induced membranous 
structures in the erythrocyte cytosol termed Maurer’s clefts (MCs). While these MCs are 
known to have a crucial role in protein trafficking, probably by acting as secretory 
organelles that concentrate virulence proteins for delivery to the host cell membrane, 
their specific functions have yet to be determined. 
With this study we aimed at bringing new insight into the functions and interactions of 
exported P. falciparum proteins, with intent to create a basis for the extensive interaction 
network of the parasite’s exportome. Therefore we not only performed interaction studies 
using classical approaches like co-immunoprecipitation (Co-IP), but also tried to 
establish the yeast mating-based split-ubiquitin system (mbSUS) as a new in vitro 
interaction platform for P. falciparum membrane proteins on the basis of the integral MC 
protein ‘membrane associated histidine rich protein 1’ (MAHRP1). To contribute to a 
better understanding of protein export we further identified and characterized a new MC 
membrane protein that we termed ‘small exported membrane protein 1’ (SEMP1). 
By Co-IP experiments we identified several potential SEMP1 interaction partners, 
including REX1 and other membrane-associated proteins that were confirmed to co-
localize with SEMP1 at the MCs. Although a number of experiments deemed the quality 
of the generated P. falciparum cDNA library sufficient, we were unsuccessful to identify 
MAHRP1-binding proteins by mbSUS high-throughput screens. However, we could 
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show that even without a functional library the mbSUS provides a useful tool to verify P. 
falciparum membrane protein interactions on a one by one basis by confirming binding 
of SEMP1 to a protein identified as potential interaction partner by Co-IP. A combination 
of Co-IP and mbSUS represents a promising new strategy for the identification and 
confirmation of direct P. falciparum membrane protein interactions.  
We showed by immunofluorescence and solubility assays that SEMP1 is early exported 
into the RBC cytosol upon invasion where it inserts into the MCs before it is at least 
partly translocated to the RBC membrane. Using conventional and conditional loss-of-
function approaches we found that SEMP1 is not essential for parasite survival, 
gametocytogenesis, or export of the major parasite virulence factor ‘P. falciparum 
erythrocyte membrane protein 1’ (PfEMP1) under culture conditions. Transcriptome 
analysis of SEMP1-depleted parasites further showed that expression of a number of 
exported parasite proteins was up-regulated in its absence, including PfEMP3 and a 
‘Plasmodium helical interspersed subtelomeric family’ (PHIST) protein possibly 
indicating a role for SEMP1 in modulation of the erythrocyte membrane skeleton. 
With this thesis we contribute to a better understanding of the export of P. falciparum 
proteins and their interactions within the human RBC. Our findings provide a starting 
point for numerous follow-up studies which in the end should result in a comprehensive 
interaction network. By brining new insight into the complex interactome of exported 
parasite proteins we will hopefully identify new intervention targets to interfere with the 
essential refurbishment of the host cell. 
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Abbreviations 
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INTRODUCTION 
 
Malaria 
 
With over 500 million new yearly infections which cause about 660’000 annual deaths, 
mainly in children under five, malaria still represents one of the world’s most devastating 
human diseases (1). Besides its severe effects on infected individuals, its presence also 
leads to a substantial decrease in the annual Gross Domestic Product (GDP) (2,3). This 
means that in endemic countries malaria affects the uninfected population as well as the 
infected and that the disease is one of the reasons for poverty in developing countries. 
104 countries, mainly in tropical and subtropical regions, were endemic for malaria in 
2010. While with 45 countries the WHO African region is the most affected, the disease 
is also endemic in Asia, Latin America and the Middle East (1). Malaria is caused by a 
single-celled eukaryotic parasite which belongs to the genus Plasmodium and can infect 
humans, primates and rodents. More than 100 species of this protozoan parasite exist, but 
only four of them are able to naturally infect humans: Plasmodium vivax, P. ovale, P. 
malariae and P. falciparum (4). However, increased transmission of non-human malaria 
parasites like P. knowlesi, which usually infects monkeys in restricted parts of South-East 
Asia, is observed (5,6). While P. falciparum is mainly responsible for malaria pathology 
across Sub-Saharan Africa, P. vivax is the most prevalent malaria parasite in most other 
endemic areas like South-East Asia. P.vivax, P.ovale and P.malariae all cause substantial 
morbidity but the most severe form of human malaria called malaria tropica is caused by 
P. falciparum. Since P. falciparum is the only parasite which causes severe malaria, it is 
responsible for the majority of malaria-associated morbidity and nearly all the mortality 
(7). Clinical symptoms of the severe malaria are anaemia, cerebral malaria, 
hypoglycaemia, non-cardiac pulmonary oedema, renal failure and respiratory failure. 
Responsible for most parasite-related disease symptoms is thereby its asexual 
development within the human red blood cell (RBC).  
Malaria control is a difficult task due to the parasite’s extremely complex life cycle and 
its ability to adapt to the resulting heterogeneous environment. Nevertheless during the 
last few years the number of malaria cases could be successfully reduced. This was 
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achieved by control programs which improved access to preventives like insecticide-
treated bed nets (ITNs) and preventive treatment of pregnant women and infants (IPTp 
and IPTi), as well as artemisinin-based combination drug therapy. One of the biggest 
obstacles regarding malaria control is the lack of an effective vaccine. The most advanced 
malaria vaccine RTS,S/AS01 which targets the pre-erythrocytic stage of P. falciparum 
offers only limited protection. Recent phase 3 trials showed 50.4 % efficacy in children 
aged 5 to 17 months (8), and 30.1 % efficacy in infants aged 6 to 12 weeks (9). A new 
vaccine candidate called PfSPZ which is made by isolating attenuated sporozoites from 
the salivary glands of irradiated mosquitoes showed promise in preliminary clinical 
studies: none of six individuals given the highest dose of the vaccine was infected 
following experimental challenge with malaria (10). Another huge problem regarding 
malaria control is emerging drug-resistance in the parasite which calls for new 
antimalarial drugs. However, in order to find new drugs a deeper understanding of the 
parasite and especially of the disease causing asexual blood stage is necessary. 
 
Plasmodium falciparum life cycle 
 
The apicomplexan parasite P. falciparum has a very complex life cycle, which not only 
comprises generation changes of sexual and asexual stages, but also transmission 
between a human host and an insect vector (Fig. 1). The parasite is transmitted by the bite 
of an infected female Anopheles mosquito, which injects sporozoites together with 
anticoagulant-containing saliva into the subcutaneous tissue. The sporozoites then 
migrate to the liver via the human bloodstream, where they invade liver cells. Within the 
hepatocytes they undergo an asexual replication called exo-erythrocytic schizogony, 
during which they develop into polynucleic schizonts. Cell rupture then releases 
thousands of merozoites into the bloodstream where they immediately invade 
erythrocytes. Red blood cell invasion involves the release of several protein factors from 
secretory organelles called rhoptries and micronemes, which enable penetration of the 
erythrocyte membrane and lead to formation of a parasitophorous vacuole. Within the 
infected red blood cell the parasite undergoes an asexual development and matures within 
48 hours from an early ring over a trophozoite to a late schizont stage, which gives rise to 
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16-32 merozoites. The infected erythrocyte then bursts and the merozoites are released 
into the blood stream again, where they immediately invade new red blood cells. The 
symptoms of severe malaria are only associated with this intraerythrocytic asexual cycle. 
In order to evade elimination in the spleen, the parasite mediates adhesion of infected 
RBCs to the host endothelium, which as a side effect causes organ failure and cerebral 
malaria by clogging of blood capillaries and release of pro-inflammatory cytokines (11). 
After several cycles of asexual intraerythrocytic development, eventually some newly 
invaded red blood cells differentiate into sexual forms, male and female gametocytes, 
which represent the transmission stage of the parasite. 
 
Figure 1: Schematic depiction of the P. falciparum life cycle (12). 
 
After uptake by a female Anopheles mosquito upon blood meal, the male gametocytes 
undergo rapid nuclear division and exflagellation to produce microgametes which 
fertilize the female macrogametes within the mosquito midgut. The resulting zygote 
transforms further to an ookinete and traverses the mosquito gut wall, where it encysts as 
an oocyst and produces numerous sporozoites by a process called sporogony. After 
oocyst rupture the sporozoites are released into the mosquito body cavity from where 
they migrate to the salivary gland. 
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Genome of P. falciparum 
 
In 2002 the complete sequence of the 22.8 Mb P. falciparum genome has been published 
(13). Analysis revealed approximately 5400 open reading frames (ORFs) which are 
distributed across 14 chromosomes, a 6 kb linear mitochondrial genome (encoding three 
proteins plus rRNAs) and a 35 kb circular plastid genome with over 60 ORFs (14). It 
could be shown that the parasite’s DNA has a remarkably high A/T content of about 80 
% in coding and even ~ 90 % in non-coding regions. Sequence analysis further revealed a 
large evolutionary distance between P. falciparum and eukaryotic model organisms: 
about 60 % of all parasite ORFs lack homologies to annotated genes, meaning that their 
function is still unknown. Insight into the function and interactions of these proteins will 
provide the basis for the discovery of new drug targets and vaccine development. The 
completion of the P. falciparum genome represented a milestone in malaria research 
allowing for a much more comprehensive investigation of the parasite’s biology by 
performing genome- and proteome-wide experiments. 
 
Erythrocyte modification by P. falciparum 
 
The primary function of human erythrocytes is the transport of oxygen from the lungs to 
the body tissues. To optimize this function, mature red blood cells lost their internal 
organelles in order to generate maximum space for haemoglobin, an iron-containing 
biomolecule which is responsible for oxygen binding. On one hand this characteristic has 
the big advantage for the parasite that its host cell is also devoid of all major 
histocompatibility complex (MHC) molecules which allow to hide from immunological 
detection. On the other hand, since erythrocytes also lack any protein trafficking 
machinery, survival of P. falciparum also strictly depends on extensive structural, 
biochemical and functional host cell modifications which are responsible for the P. 
falciparum associated disease symptoms. Once inside the RBC the parasite therefore 
immediately starts to export hundreds of proteins which cause remarkable structural and 
morphological changes in the infected erythrocyte including increased membrane 
rigidity, permeability and adhesiveness. 
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During the intraerythrocytic part of its life cycle the parasite resides in a parasitophourus 
vacuole (PV) separated from the host cell cytoplasm by the parasitophourus vacuole 
membrane (PVM). Extensions from the PVM to the erythrocyte form the so called 
tubovesicular network (TVN) (15,16). Even though questions remain about the function 
and biogenesis of the TVN, there are indications that it has secretory characteristics 
(16,17) and might be involved in nutrient import (18,19). 
The TVN is not the only parasite derived membranous structure in the RBC cytoplasm. 
The parasite further generates slender tubes with an electron-lucent lumen and an 
electron-dense coat (20–23) called Maurer’s clefts (MCs). As the parasite matures they 
are distributed beneath the erythrocyte surface, where they are anchored to the 
erythrocyte cytoskeleton via tubular structures called tethers (24–29). While some 
questions remain regarding the specific function of the MCs, they are believed to 
constitute a surrogate Golgi which concentrates virulence proteins for further transport to 
the erythrocyte membrane (27,30,31). The basis of this theory is the observation that 
several parasite RBC surface proteins are exported via the MCs. These proteins include 
membrane proteins like the erythrocyte membrane protein1 (PfEMP1) and subtelomeric 
variable open reading frame (STEVOR) as well as soluble proteins like the knob-
associated histidine-rich protein (KAHRP) and PfEMP3 (32–36). Further evidence for a 
Golgi-like function of the MCs comes from the observation that deletion of its proteins 
‘membrane associated histidine rich protein 1’ (MAHRP1) (37), ‚skeleton binding 
protein 1’ (SBP1) (38,39) and ‘ring exported protein 1’ (REX1) (40) prevents PfEMP1 
export to the host cell surface. While questions remain regarding the specific function of 
the MCs, a number of its constituents have been identified by analysis of early 
transcribed genes (41) and proteomic studies (30,42). However, ongoing research steadily 
reveals new candidates, which indicates that the current MC proteome is far from 
complete. In-depth characterization of some of these MC proteins revealed that many of 
them have a predicted hydrophobic domain. While some of them were shown to be 
integral membrane proteins like e.g. MAHRP1 (43), SBP1 (44) and REX2 (45), others 
are rather membrane associated like e.g. REX1 (46). Even though some were shown to be 
essential for PfEMP1 trafficking, the function of most MC proteins remains elusive. One 
reason for the difficulty to identify the function of MC proteins is their inapplicability for 
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yeast-two-hybrid (Y2H) screenings. Due to their hydrophobic nature they are expected to 
insert into yeast membranes upon expression and thereby prevent reconstitution of a 
functional transcription factor in the nucleus, which is a prerequisite for the functionality 
of the system (47). The aim of this study was therefore to establish the yeast mating-
based split-ubiquitin system (mbSUS) as a new in vitro interaction platform for P. 
falciparum membrane proteins. mbSUS would circumvent the problems associated with 
the analysis of membrane proteins using the classical yeast two-hybrid approach and 
provide a very powerful tool not only for the investigation of MC proteins, but also any 
P. falciparum membrane protein of interest. 
 
 
 
Figure 2: Erythrocyte modification by P. falciparum. Survival and virulence of P. falciparum 
critically depend on extensive host cell modifications mediated by the export of numerous 
parasite proteins into the erythrocyte cytoplasm. Extensions from the PVM form the so called 
tubovesicular network (TVN). Other parasite derived membranous structures called Maurer’s 
clefts (MC) are believed to constitute a surrogate Golgi which concentrates virulence proteins 
like the major parasite virulence factor PfEMP1 for further transport to the erythrocyte 
membrane. The MCs are anchored to the erythrocyte cytoskeleton via tubular structures 
called tethers (not shown). The parasite further reshapes the erythrocyte membrane by 
formation of surface protrusions called knobs (K) which anchor PfEMP1. Figure taken from 
(48). 
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Adherence of P. falciparum infected erythrocytes to vascular endothelial cells is 
associated with surface protrusions called knobs which consist of electron-dense 
submembrane cups and the overlying RBC plasma membrane (49). The density of knobs 
on the surface of infected erythrocytes thereby increases with parasite maturity (50). 
Knobs consist of several parasite derived proteins but their main component is the knob-
associated histidine-rich protein 1 (KAHRP) (51,52) which was shown to be essential for 
knob formation (53). There is evidence that KAHRP interacts with several cytoskeletal 
RBC constituents like spectrin, actin, and spectrin-actin band 4.1 complexes (54,55). 
These interactions could be responsible for the structural alterations of infected 
erythrocytes. It was recently shown that interaction of KAHRP with the RBC membrane 
skeleton protein ankyrin R is required for its attachment to the erythrocyte membrane and 
therefore potentially important for promoting the adhesion of malaria-infected red cells to 
endothelial surfaces (56). It is further believed that KAHRP ankers PfEMP1 at the knobs 
by binding to its ATS domain (57–59). However, a recent study was unable to confirm 
this ATS-KAHRP binding under soluble conditions (60). PfEMP1 was shown to bind 
various endothelial host cell receptors in order to mediate adhesion of infected 
erythrocytes to the blood capillaries. While this mechanism enables the parasite to evade 
elimination in the spleen, it also causes organ failure and cerebral malaria by clogging of 
blood capillaries and release of pro-inflammatory cytokines (61). PfEMP1 is therefore the 
major parasite virulence factor. 
Between 12 and 16 hours after invasion, the parasite further establishes so called new 
permeability pathways (NPPs) in the RBC plasma membrane which mediate the uptake 
of nutrients into the infected cell by increasing the membrane permeability (62–64). 
While the origin of the NPP forming components is still debated (65–68), there is 
evidence that exported parasite proteins are involved in their formation (69). It is 
hypothesized that upon infection these parasite proteins activate otherwise silenced 
erythrocyte transporters. Studies thereby suggest that not only one single channel type is 
involved in transport across the RBC membrane (70). However, the nature and number of 
pathways that underlie the NPPs have yet to be identified. 
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Protein export in P. falciparum 
 
In order to survive within the human erythrocyte, a very specialized cell which is devoid 
of all internal organelles and any protein trafficking machinery, P. falciparum needs to 
refurbish its host cell by exporting numerous proteins into the red blood cell cytosol. 
Since the parasite does not reside directly within the erythrocyte cytoplasm but within a 
parasitophorous vacuole (PV), this export is a complicated process which involves 
transport across not only one but several membranes: the parasite membrane, the PV 
membrane (PVM) and for some proteins even the erythrocyte membrane. Although the 
parasite’s Golgi apparatus is highly reduced, homologues for most constituents of the 
classical secretion pathway are present in P. falciparum and most exported proteins 
contain a conserved N-terminal signal peptide. This hydrophobic peptide is recognized by 
the signal recognition particle (SRP) which directs it into the endoplasmic reticulum 
(ER). While this signal sequence is sufficient to direct proteins into the P. falciparum ER 
with default release into the PV, another motif called Plasmodium export element 
(PEXEL) (71) or vacuolar transport signal (VTS) (72) is necessary for further transport 
across the PVM. This Plasmodium-specific export signal is located near the N-terminus, 
usually about 20 amino acids downstream of the signal peptide, and consists of the 
conserved sequence R/KxLxE/Q/D where x is a non-charged amino acid. The PEXEL 
motif was shown to be proteolytically cleaved (73,74) by the ER-resident protease 
Plasmepsin V (75–77) which produces an acetylated –xE/Q/D N-terminus that plays an 
important role in export of the mature protein (78). Because it was observed that PEXEL 
proteins cleaved by other proteases are not exported, even if they produce the same 
mature protein, Plasmepsin V appears to also have a role in guiding the proteins into this 
specific export pathway (76). Recent studies revealed that PEXEL-binding by the 
phosphatidylyinositol-3-phosphate (PI(3)P) may also be involved in the export process 
(79). It was suggested that exported proteins are first guided to an ER export region by 
PI3P before they are cleaved off the membrane by Plasmepsin V (79). However, the 
function of PI3P during protein export remains elusive. The identification of the PEXEL 
motif allowed the prediction of a first P. falciparum exportome which comprised up to 8 
% of all P. falciparum proteins (80). Knock-out studies further revealed that several of 
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these PEXEL-containing proteins are involved in erythrocyte remodelling processes (81). 
Even though many questions remain regarding the transport of PEXEL proteins across 
the PVM, it could be shown that it is an ATP dependant process (82) and that the protein 
needs to be unfolded (83). It was further shown that it probably involves a putative 
translocon termed ‘P. falciparum translocon for exported proteins’ (PTEX). This 
multimeric protein complex whose components are Plasmodium specific was found on 
the inside of the PVM (84). While such a translocon based transport across the PVM does 
make sense for soluble proteins, it seems unsuitable for export of integral membrane 
proteins. One possible explanation could be that these proteins are synthesized as soluble 
proteins which do not insert into membranes before reaching their target membrane. 
However, while some studies support the existence of such a pathway (85), others 
showed that some PVM and MC proteins are already insoluble in the ER (35,86). How 
these proteins are exported is still unclear. 
 
 
 
Figure 3: Model for PEXEL protein export in P. falciparum. After signal-peptide (SP) 
cleavage by the signal peptidase (indicated by black scissors), PI3P (b, hexagon) binding and 
plasmepsin V cleavage (b, blue scissors) guide PEXEL proteins into the export pathway, 
possibly by sorting the mature protein into export competent ER regions. The protein is then 
transported into the PV via a vesicular pathway (c, likely involves the Golgi apparatus), 
where the PVM translocon PTEX mediates its export into the host cell (d) (87). 
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After export across the PVM into the erythrocyte cytosol, most proteins are further 
transported to the MCs and the RBC membrane. It was initially suggested that MCs are 
connected to the PVM and that exported proteins are transported via this network (88), 
but recent studies indicate that they are rather individual unconnected units (89). Another 
theory was that membrane proteins might segregate into nascent MCs when they are 
formed at the PVM (90). However, it was recently shown that the parasite is able to 
transport newly synthesized proteins to MCs already present in the RBC (89). 
 
The identification of the PEXEL / VTS motif represented a break through which 
increased our understanding of P. falciparum protein export tremendously. However, the 
parasite also has a sub-set of proteins called PEXEL-negative exported proteins (PNEPs) 
which is secreted into the host cell despite lacking both a signal peptide and a PEXEL 
sequence. A consensus sequence necessary for PNEP export has not been found, which 
makes it impossible to predict how many PNEPs have yet to be identified. However, 
there is little doubt that the current P. falciparum exportome is far from complete. Most 
PNEPs seem to contain at least one hydrophobic transmembrane (TM) domain (78). 
These TMs were not only shown to be essential for entry into the secretory pathway, the 
observation that they are not interchangeable with TM domains from non-exported 
proteins further indicates an involvement in determining the protein’s target location 
(85,91). While most PNEPs have at least one of these hydrophobic domains, not all of 
them are integral membrane proteins. Some like the ‘membrane-associated histidine rich 
protein 2’ (MAHRP2) and the ‘ring-exported protein 1’ (REX1) were shown to be rather 
membrane associated (29,92). Truncation studies further revealed that for most PNEPs 
not only the TM domain, but also the protein’s N-terminus is essential for export 
(29,37,85,92). However, the length of these essential N-termini varies between different 
PNEPs and no consensus sequence could be identified within them. While the precise 
PNEP export mechanisms remain elusive, ER intermediates of PNEPs indicate export via 
the classical secretory pathway (85,90). Additionally it was shown that the export of 
some PNEPs is brefeldin A sensitive which also points to ER trafficking before the 
export (91). After trafficking across the PVM most PNEPs like e.g. MAHRP1, REX1, 
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REX2 and SBP1 localize to the Maurer’s clefts (43–46,91). But PNEPs can also be found 
at other compartments like e.g. the tethers (29). 
Overall it is still unclear how much PNEP export differs from PEXEL protein trafficking, 
and even different export mechanisms of different PNEPs seems likely. In order to bring 
new insight into the export mechanisms of PNEPs we investigated the sequence 
requirements of the newly identified Maurer’s clefts resident ‘small exported membrane 
protein 1’ (SEMP1) in chapter 4. 
 
Protein-protein interactions 
 
Protein-protein interactions are the building blocks of biological systems and defined as 
the binding between two or more proteins in order to achieve an energetically and 
functionally favourable structure. For two components to be able to interact and achieve 
such a dimeric structure, they need surfaces that are complementary in terms of shape and 
chemistry. The classical classification for dimeric protein associations can either describe 
the binding between two components that are identical (homodimer) or different 
(heterodimer). However, with the number of identified dimeric interactions steadily 
increasing, a more specific classification seemed necessary. Orfan and Rost therefore 
included the longevity of a certain association to define four classes of dimeric 
interactions: 1. homo-obligomer: between permanently interacting identical subunits; 2. 
homo-complex: between transiently interacting identical subunits; 3. hetero-obligomer: 
between permanently interacting different subunits; 4. hetero-complex: between 
transiently interacting different subunits (93) (Fig.4). 
CHAPTER 1: INTRODUCTION 
 
 19 
 
 
Figure 4: Classification of dimeric protein interactions including longevity of the association 
according to Orfan and Rost (93). Homo interactions between identical proteins are illustrated 
by a pair of identical symbols, hetero interactions between non-identical proteins are 
illustrated by a pair of non-identical symbols (94). 
 
Numerous studies investigating specific protein-protein interactions revealed much 
information about the protein components and features, as well as forces important to 
establish the specific bindings. The primary protein structure seems thereby to be crucial: 
the amino acid distribution within a protein not only differs from the interior to the 
exterior (95), also the distribution in a protein-protein interface was shown to be different 
from the rest of the protein surface (96–99). However, there are conflicting reports from 
different studies in terms of specific amino acid preferences at these interaction sites. It 
seems like different classes of protein-protein interactions have different amino acid 
preferences at their binding interfaces which are dependent on energetic properties: 
Transient interaction partners also exist independently of each other. Therefore they can 
not have large hydrophobic patches on their surface which are energetically 
unfavourable. In contrast, obligomer interfaces are permanently shielded from the solvent 
by their binding-partners. Therefore they can contain hydrophobic patches which in that 
case are not energetically unfavourable. Further it seems that there also exist amino acid 
preferences within the protein-protein interface itself which is divided into a core and a 
rim region. The core is thereby the center of high binding energies which contains high 
frequencies of tryptophan and tyrosine residues (93,100,101). 
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The specific properties of residues present at the protein-protein interface generate the 
forces which are responsible for binding of the two protein components. These forces 
include hydrogen bonds, electrostatic forces, salt bridges and hydrophobic forces. Many 
protein-protein interfaces contain water molecules which form hydrogen bonds with both 
components of the association. While the distribution of water molecules within the 
protein-protein interface was shown to be very diverse, it is thought that protein-protein 
bindings involve in general at least as many water mediated contacts as direct ones (102). 
Electrostatic forces caused by charged and polar residues within the protein-protein 
interface vary widely between different complexes (103,104). While in some complexes 
they actually oppose binding, in others they have no or even a positive effect on protein 
associations (105). Additionally electrostatic forces can combine with hydrogen bonds to 
form salt bridges. Another important aspect regarding protein associations is that solvent 
exclusion from the protein-protein interface is an important condition for high affinity 
binding. The so-called O-ring hypothesis suggests that it is achieved by a ring of 
hydrophobic residues located around a central core (106). 
Additionally to the amino acid composition also the secondary structure of a protein was 
shown to be important for its binding ability. It was shown that while turns and loop 
structures are over represented at protein-protein interfaces, the opposite is true for 
helices and sheet structures (100). A possible explanation for this observation is that turns 
and loop structures create a flexible environment that might be beneficial for tight 
packing. 
Upon interaction many proteins undergo conformational changes, which range from 
small side chain conformational changes of core amino acids to changes in orientation of 
whole protein domains. The causes for these conformational changes are the facilitation 
of tight packing, to allow the residues to execute a specific function and the formation of 
hydrogen bonds and salt bridges (107). 
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Protein-protein interactions in Plasmodium falciparum 
 
To completely understand an organism at the molecular level is a big challenge. Cellular 
machineries are highly dynamic and their proteins are involved in complex interactions 
which form a highly sensitive regulation system. While generation of a detailed protein-
protein interaction (PPI) network is never an easy task, P. falciparum has some species 
specific additional difficulties. Because of its large evolutionary distance to eukaryotic 
model organisms, only about 40 % of its proteins have homologues which allowed in 
silico studies to generate computationally modelled PPI networks (108–110). The other 
60 % of the parasite’s genes lack similarity to functionally annotated proteins and could 
therefore only be annotated as hypothetical proteins with unknown function. For these 
proteins high-throughput experiments were needed to establish a starting point for further 
investigations. LaCount et al. used a high-throughput yeast two hybrid (Y2H) system to 
generate a first P. falciparum asexual blood stage PPI network consisting of 1267 
proteins and 2823 interactions which were used to computationally identify clusters of 
functionally related proteins (111). This way several hypothetical proteins were predicted 
to have a role in cell invasion, RNA processing, splicing or to be potentially exported. 
However, its accuracy remains unclear because only a few experimentally proven P. 
falciparum PPIs exist which would allow validation of the generated network, an 
approach used as the gold standard for model organisms. The generated PPI network is a 
good starting point but further experimental validation of its interactions is inevitable. A 
limitation of this first P. falciparum PPI network is the use of a Y2H system which is not 
suited for investigation of membrane proteins. Because of their hydrophobic nature they 
insert into yeast membranes which prevents the attached transcription factor from 
entering the nucleus. Since the majority of exported P. falciparum proteins were shown 
to be membrane proteins, an alternative approach is needed in order to investigate the PPI 
network of the parasite’s exportome. Therefore we tried to establish the ‘mating-based 
split-ubiquitin system’ (mbSUS) as a new in vitro interaction platform for P. falciparum 
membrane proteins (chapter 2). 
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Figure 5: A computationally modeled P. falciparum 3D7 protein–protein interaction 
network. Important groups of annotated proteins are highlighted in different colours: protein 
phosphatases (green), proteins involved in DNA replication (pink), proteins involved in 
translation (red), RNA / DNA helicases (dark blue), protein kinases (black) and heat shock 
proteins (light blue). Insets show a detailed view of some protein clusters which represent a 
specifc cellular or molecular function: DNA replication (a), Phosphatase activity (b), Protein 
translation (c), Heat-shock machinery (d) and Kinase activity (e) (112). 
 
In spite of the described difficulties, several studies successfully identified and 
experimentally confirmed interactions between different P. falciparum proteins. Some of 
them are involved in erythrocyte invasion: the apical membrane antigen 1 (AMA1) was 
shown to interact with the two rhoptry neck proteins RON2 (113) and RON4 (114). Other 
studies revealed the binding between the actin bridging molecule aldolase and 
thrombospondin-related anonymous protein (TRAP), both part of the acto-myosin motor 
responsible for gliding motility (115,116). Another known P. falciparum protein 
interaction between components of this acto-myosin motor is the one between myosin A 
(MyoA) and myosin tail domain interacting protein (MTIP) (117,118). An additional 
detected interaction which was shown to be important for erythrocyte invasion is between 
the reticulocyte binding protein homologue 5 (PfRh5) and the Rh5 interacting protein 
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(RIPR) (119). However, not only invasion related interactions could be identified: pull-
down assays revealed that the leucine rich repeat family member PfLRR1 interacts with 
the protein phosphatase type 1 (PfPP1) to build a complex which is thought to be 
important for regulation of cell cycle progression (120). Hain et al. demonstrated binding 
between the two autophagy-related proteins PfAtg3 and PfAtg8 (121) and the major 
parasite virulence factor PfEMP1 was recently shown to bind with its ATS domain to the 
Plasmodium helical interspersed sub-telomeric (PHIST) protein PF3D7_0936800 (60). 
Further the dynein light chain 1 protein (PfDLC1) was shown to bind to P. falciparum 
myosin A and actin 1 (122) and a recent study revealed an interaction of heat shock 
protein 90 (Hsp90) with activator of Hsp90 ATPase (Aha1) (123). 
 
P. falciparum proteins not only interact with each other, some also bind to erythrocyte 
components. Certain interactions were shown to be involved in RBC invasion of 
merozoites: members of the erythrocyte binding-like (ebl) family called erythrocyte 
binding antigens (EBAs) are thereby responsible for high affinity binding to 
glycoproteins on the erythrocyte surface. EBA-175 was shown to bind to glycophorin A 
(124) and EBA-140 to glycophorin C (125). A second protein family involved in 
erythrocyte invasion by binding to RBC surface receptors are the reticulocyte binding 
protein homologues (PfRh): PfRh4 was demonstrated to bind to the complement receptor 
1 (CR1) (126) and PfRh5 binds to the Ok blood group antigen basigin (127). 
Other studies identified various parasite-erythrocyte protein interactions involved in host 
cell refurbishment: the erythrocyte cytoskeletal protein spectrin was identified as the 
primary attachment site for the ring-infected erythrocyte surface antigen (RESA) (128), 
and also to interact with the major parasite virulence factor PfEMP1 (57) together with 
the knob-associated histidine-rich protein (KAHRP) (54). Spectrin was further shown to 
be a binding site for the erythrocyte membrane protein PfEMP3 (128,129), an interaction 
which was shown to destabilize the RBC skeleton (130). In addition to spectrin also other 
erythrocyte skeleton proteins were shown to interact with parasite proteins: host cell actin 
was demonstrated to interact with PfEMP1 (57) and KAHRP (131), while Protein 4.1 
interacts with the mature parasite-infected erythrocyte surface antigen (MESA) (132,133) 
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and the PHIST protein PF3D7_0402000 (134). KAHRP was further shown to bind the 
adaptor protein Ankyrin (135). 
 
Additionally to erythrocyte components, P. falciparum proteins also interact with other 
host proteins. Binding of parasite ligands on the erythrocyte surface to endothelial host 
cell receptors mediates cytoadherence of infected RBCs and therefore has a key role in 
the pathology of P. falciparum. The best studied and characterized interactions involve 
the parasite-derived RBC surface antigen PfEMP1. Two major subtypes of PfEMP1 
(group B and C) were shown to bind the scavenger receptor CD36 which is expressed on 
endothelial and epithelial cells, macrophages, monocytes, platelets, erythrocyte precursor 
and adipocytes (136–139). A smaller subset of PfEMP1 which contains a pair of DBLβ-
C2 domains is the parasite ligand for ICAM1, a member of the immunoglobulin 
superfamily which is expressed on endothelial cells and leukocytes (140–142). Further it 
could be shown that PfEMP1 binds to the glycoprotein P-selectin found on andothelial 
cells and activated platelets (143) and to the platelet endothelial cell adhesion molecule 1 
PECAM1 (144). PfEMP1 was also demonstrated to bind to the glyosaminoglycan 
heparan sulphate which is believed to be involved in rosette formation and binding of 
infected RBCs to endothelial cells (144–147). Finally a unique PfEMP1 protein termed 
VAR2CSA was shown to bind the chondroitin sulphate A (CSA) receptor in the placenta 
which results in placental malaria (148,149). 
 
While identification of protein-protein interactions is known to be fundamental to 
understand an organism at the molecular level, in case of P. falciparum it has the 
potential to be even more important. Since many proteins are only able to execute their 
function if they are part of a correctly assembled complex, interactions of essential 
proteins are potential new drug targets. Because usually only small protein regions, so 
called binding hotspots, are responsible for the binding with an interaction partner 
(106,150), small molecules can be sufficient to inhibit the interaction if they bind 
specifically (151). Such small molecules and peptides have already been successfully 
used to interfere with crucial protein-protein interactions in viruses (152–155), bacteria 
(156), Trypanosoma brucei (157) and were also identified as potential drugs for cancer 
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treatment (158). For P. falciparum it was shown that synthetic triose phosphate isomerase 
peptides can interfere with formation of the active enzyme (159) and that small synthetic 
peptides of the cysteine protease falcipain-2 (FP2) produced morphological abnormalities 
in the parasite’s food vacuole (160). Recently Hain et al. were further able to prevent the 
interaction between autophagy-related proteins Atg3 and Atg8 with low concentrations of 
the small molecule 1,2,3-trihydroxybenzene (121). The results of these studies indicate 
that protein interaction inhibiting peptides and molecules have an enormous potential as a 
new class of antimalarial drugs. Something that is urgently needed in consideration of the 
increasing spread of drug-resistant parasites. 
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Outline of this thesis 
 
Aim of this thesis was to bring new insight into the interactions and functions of exported 
P. falciparum proteins. Therefore we investigated the two PEXEL-negative exported 
proteins MAHRP1 and ‘small exported membrane protein 1’ (SEMP1). MAHRP1 was 
previously identified as an integral Maurer’s clefts protein, which is essential for export 
of the major parasite virulence factor PfEMP1 (37). Since not only MAHRP1 but most 
PNEPs were shown to be membrane proteins, their interactions can not be investigated by 
classical yeast-two-hybrid assays (Y2H). In chapter 2 we therefore tried to establish the 
‘mating-based split-ubiquitin system’ (mbSUS) (161) as a new in vitro interaction 
platform for P. falciparum membrane proteins on the basis of MAHRP1. The thereby 
generated bait was used to investigate binding of MAHRP1 to its two previously 
identified potential interactors ‘parasite-infected erythrocyte surface protein’ (PIESP2) 
and PF3D7_0501000 by mbSUS pairwise interaction assays (chapter 3). In order to bring 
new insight into the processes of host cell refurbishment we further identified and 
characterized SEMP1. Chapter 4 characterizes SEMP1 which includes the determination 
of its localization by immunofluorescence assays and electron microscopy, its solubility, 
and we investigated its function by knockout studies and transcriptional analysis (also 
chapter 4). Sequence requirements for trafficking of SEMP1 were also analyzed by 
transfection of parasites with plasmids expressing truncated and mutated versions of the 
protein fused to a GFP‐tag. Since the MAHRP1 mbSUS library screenings described in 
chapter 2 were unsuccessful, we performed co-immunoprecipitation experiments to 
identify interaction partners of SEMP1 (also chapter 4). We thereby identified the PNEPs 
PF3D7_0702500 and PF3D7_0601900 which were investigated for direct binding to 
SEMP1 by mbSUS pairwise interaction assays in chapter 5. 
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Introduction 
 
The protozoan parasite Plasmodium falciparum is the causative agent of malaria tropica, 
the most severe form of human malaria responsible for nearly 700’000 annual deaths 
worldwide (1). The pathology of this disease is associated with the asexual development 
of the unicellular parasite within the human red blood cell. During this intraerythrocytic 
part of the life cycle the parasite resides in a parasitophourus vacuole (PV) separated 
from the host cell cytoplasm by the parasitophourus vacuole membrane (PVM). Since 
erythrocytes do not express the major histocompatibility complex (MHC) the parasite can 
hide from immunological detection. On the other hand erythrocytes are highly specialized 
cells, devoid of all internal organelles and any protein-trafficking machinery. Survival 
within the red blood cell and virulence of P. falciparum therefore critically depend on 
extensive host cell modifications. These are mediated through the export of numerous 
parasite proteins into the red blood cell (RBC) cytoplasm, including two parasite induced 
membranous structures: A tubovesicular network (TVN) extending from the PVM (2,3) 
and slender tubes with an electron-lucent lumen and an electron-dense coat called 
Maurer’s clefts (MCs). These MCs seem to have a crucial role in protein trafficking, 
probably by functioning as a secretory organelle that concentrates virulence proteins for 
delivery to the host cell membrane (4,5). One of these proteins exported via the MCs is 
the variable surface antigen called ‘P. falciparum erythrocyte membrane protein 1’ 
(PfEMP1). PfEMP1 mediates adhesion to a variety of endothelial host cell receptors (6–
8) and thus prevents the infected cells from being eliminated in the spleen. PfEMP1 
mediated adherence to vascular endothelial cells constrains blood circulation and triggers 
the release of pro-inflammatory cytokines which leads to damages in various organs like 
the liver, lungs and the brain (9,10) and thus is the major process of malaria pathology.   
 
The example of PfEMP1 demonstrates how the pathology of Malaria is firmly associated 
with exported parasite proteins which therefore are of major interest. Numerous of these 
exported proteins have been identified and some extensively studied. However, still 
surprisingly little is known about their function. Because proteins often work in pairs or 
complexes, one possibility to identify a protein’s function is to identify its interacting 
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partners. Today this is often facilitated by high-throughput in vitro screening methods. 
The most common and easiest high-throughput screen for protein interactions is thereby 
the classical yeast two-hybrid (Y2H) assay (11), which has already been successfully 
used to generate a first P. falciparum blood-stage protein interaction network (12). Y2H 
consists of two components: the DNA-binding domain of a transcription factor (TF) 
fused to the investigated (bait) protein and the transcription activation domain of the TF 
fused to a protein library (prey). When both chimeric proteins are co-expressed in yeast 
and localized to the nucleus, and if the bait and prey protein interact with each other, they 
reconstitute a functional TF that activates the transcription of a marker gene which 
enables growth of the yeast cell on selective medium. However, despite the successful 
application of the classical Y2H to identify a multitude of protein interactions in various 
organisms including P. falciparum, it has one major drawback: Y2H is depleted of 
membrane protein interactions. Since the activation domain of the TF will be retained at 
the membrane when fused to a membrane protein, it is unavailable for reconstitution of 
the functional TF in the yeast nucleus. As a consequence the classical Y2H not only is 
unable to investigate membrane bait proteins in full-length, it is also inappropriate to 
identify interactions with other membrane proteins. Because most of the known exported 
P. falciparum proteins are membrane proteins, an alternative method is therefore required 
to investigate the interactome of the parasite’s exportome. Like the classical Y2H the 
mating-based split-ubiquitin system (mbSUS) is based on yeast as a heterologous system 
and has a similar read out. But mbSUS solves the problem that the TF is non-functional 
when fused to a membrane protein by releasing the TF from the membrane if the 
investigated membrane protein interacts with the prey protein (13–15). Therefore the 
system uses an ubiquitin which is split into an N-terminal (Nub) and a C-terminal (Cub) 
domain (Fig. 1). Ubiquitin is a small conserved protein which serves as a target for 
degradation by the 26S proteasome and is recognized by ubiquitin-specific proteases 
(UBPs) present in all eukaryotic cells (16). When the Cub and Nub domains are co-
expressed, they are able to reconstitute a functional ubiquitin (17). The mbSUS uses the 
circumstance that Nub mutants with an isoleucine (I) to glycine (G) exchange at position 
13 have a reduced affinity to Cub. Hence they are only able to reconstitute the full-length 
ubiquitin when brought into proximity via the interaction of an additional protein pair 
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which is fused to the Nub or the Cub respectively (17). The investigated bait-protein is 
thereby fused to the Cub which further is fused to an artificial TF. This TF consists of the 
bacterial LexA-DNA binding domain and the Herpes simplex VP16 transactivator protein 
(LexA-VP16). In case that the investigated membrane protein interacts with a library 
protein fused to the mutated Nub (soluble and membrane proteins), the Nub and Cub 
moieties are brought together and a functional ubiquitin molecule can be reconstituted 
(Fig. 1). This allows cleavage by endogenous ubiquitin-specific proteases, which releases 
the LexA-VP16 transcription factor from the membrane protein to the cytosol where it 
diffuses into the nucleus and activates transcription of marker genes. In the used NMY51 
yeast reporter strain (18) these marker genes are his3 and ade2 whose activation enables 
the yeast to grow on defined minimal medium lacking histidine and / or adenine (19). 
Two species specific challenges must be considered when using P. falciparum bait 
proteins in the mbSUS: first, many exported parasite proteins do not have a conserved 
eukaryotic export signal. Therefore it is very unlikely that these proteins are efficiently 
secreted and inserted into yeast membranes on their own. A second P. falciparum 
specific challenge regarding mbSUS is the high AT content (80 %) of the parasite’s 
genome (20) which was shown to hinder protein expression in heterologous systems (21). 
To overcome these problems we have the possibility to add different yeast derived 
artificial sequences to the bait’s N-terminus by the use of different bait plasmids: either a 
Saccharomyces cerevisiae signal sequence (SUC2) which ensures proper membrane 
insertion (pBT3-SUC) or a short S. cerevisiae leader sequence (STE2) which optimizes 
expression (pBT3-STE). 
 
We tried to establish mbSUS as a new in vitro interaction platform for P. falciparum 
membrane proteins on the basis of the known integral MC protein ‘membrane-associated 
histidine-rich protein 1’ (MAHRP1). Besides a central transmembrane domain, MAHRP1 
contains an acidic N-terminal and a histidine-rich C-terminal domain which faces the 
erythrocyte cytoplasm (Type I transmembrane protein). This C-terminal domain has a 
histidine content of nearly 30% in 3D7 and contains six tandem repeats of the amino acid 
sequence DHGH, with additional preceding DH repeats (22). Some parasite derived 
histidine-rich proteins were shown to be involved in detoxification by catalyzing the 
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ferriprotoporphyrin (FP) polymerization to haematin and by enhancing its degradation by 
H2O2 (23). Because recombinant MAHRP1 was shown to bind and increase degradation 
of FP in vitro as well (22), it seems likely that it protects the Maurer’s cefts and their 
associated proteins from deleterious effects of FP. MAHRP1 was further shown to have 
an important role in the translocation of PfEMP1, the major parasite virulence factor, 
from the parasite to the host cell membrane: By knocking out the MAHRP1 gene of 3D7 
parasites, Spycher and colleagues (24) demonstrated that PfEMP1 accumulates within the 
confines of the plasma membrane / PVM interface and is not transported to the MCs and 
RBC surface anymore in the absence of MAHRP1. In contrast, the transport of other 
Maurer’s cleft-resident proteins like the skeleton binding protein 1 (SBP1) and transit 
cargo is unaffected by the absence of MAHRP1. Knock-out of MAHRP1 further revealed 
that it is not essential for parasite viability in vitro and MC formation, but in its absence 
MCs become disorganized in permebealized cells (24). Since MAHRP1 contains neither 
an N-terminal ER entry signal nor a PEXEL/VTS motif other regions seem to be 
necessary for its export to the RBC. Localization studies of truncated versions of 
MAHRP1 fused to GFP revealed that the transmembrane domain of the protein is needed 
to enter the endoplasmic reticulum (ER), the first step of the export pathway. It was 
further demonstrated that the second half of the N-terminal domain is needed for transfer 
from the parasite’s ER to the MCs. The first half of the C-terminal domain, while not 
necessary for export, may facilitate delivery to the MCs (25). 
It is still a matter of some debate how cargo proteins like PfEMP1 are trafficked to the 
Maurer’s clefts and further to the host cell membrane. Since MAHRP1 is involved in 
these processes which are the basis for the parasite’s serious pathology, the understanding 
of this protein and its interactions is of major interest. 
 
The aim of this study was to establish the yeast mbSUS as a new in vitro interaction 
platform for P. falciparum membrane proteins. mbSUS would circumvent the problems 
associated with the analysis of membrane proteins using the classical yeast two-hybrid 
approach and would provide a very powerful tool not only for the identification of 
MAHRP1 interaction partners, but also for the investigation of any P. falciparum 
membrane protein of interest. Because many of these proteins are involved in essential 
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biological functions, this would be a crucial step towards a better understanding of P. 
falciparum biology and virulence. 
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Methods 
 
Yeast medium 
 
NMY51 reporter strain (18) was cultured in Yeast Extract - Peptone - Dextrose plus 
Adenine medium (YPAD: 1 % yeast extract (Sigma), 2 % Bacto Peptone (BD), 210 µM 
adenine hemisulfate, 2 % glucose). NMY51 transfected with a bait vector was cultured in 
minimal medium lacking leucine (SD-leu: 38 mM ammonium sulphate, 0.17 % Difco 
yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-arginine, 
230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 108.6 µM adenine hemisulfate, 129 µM L-histidine, 100µM L-tryptophan, 2 % 
glucose). NMY51 co-transfected with bait and prey vectors was cultured in minimal 
medium lacking leucine and tryptophan (SD-trp-leu: 38 mM ammonium sulphate, 0.17 % 
Difco yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-
arginine, 230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 108.6 µM adenine hemisulfate, 129 µM L-histidine, 2 % glucose). mbSUS library 
screenings and functional assays were performed in minimal medium lacking leucine, 
tryptophan and histidine (SD-trp-leu-his: 38 mM ammonium sulphate, 0.17 % Difco 
yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-arginine, 
230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 108.6 µM adenine hemisulfate, 2 % glucose) or minimal medium lacking leucine, 
tryptophan, histidine and adenine (SD-trp-leu-his-ade: 38 mM ammonium sulphate, 0.17 
% Difco yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-
arginine, 230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 2 % glucose). 
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cDNA library construction 
 
mRNA isolation 
 
EasyClone cDNA library construction kit was used for library generation (18). 
Synchronized ring-, trophozoit- and schizont-stage parasite cultures (7 % parasitemia, 90 
ml each) were centrifuged (700g, 5 min), the supernatant removed and each blood pellet 
resuspended in 105 ml 0.15 % Saponin in PBS (ice cold) to isolate the parasites. After 
incubation on ice for 10 min the samples were centrifuged (2600g, 5 min, 4°C) and the 
supernatant removed. Pellet was washed twice with 20 ml ice cold 0.15 % Saponin in 
PBS (2600g, 5 min, 4°C) and once with 10 ml ice cold PBS. The resulting parasite pellet 
was resuspended in 4.5 ml Trizol, vortexed (shortly) and incubated at RT for 10 min. 900 
µl Chloroform were added and the sample gently shaken for 1 min. After incubation at 
RT for 2 min the sample was centrifuged (2600 g, 10 min, 4°C) and the aqueous phase 
transferred to a new tube. 0.8 volumes 2-Propanol were added before the sample was 
vortexed (shortly) and precipitated o/n at -20°C. After centrifugation (20’000 g, 1 h, 4°C) 
the supernatant was discarded and the pellet resuspended in 5.25 ml Trizol. After 
incubation at 37°C for 5 min, 0.2 volumes Chloroform were added. The sample was 
mixed by shaking for 1 min, quickly vortexed and incubated at RT for 2 min. After 
centrifugation (20’000 g, 30 min, 4°C) the upper phase was transferred to a new tube, 0.8 
volumes 2-Propanol were added and the sample precipitated o/n at -20°C. After 
centrifugation (20’000 g, 40 min, 4°C) the supernatant was discarded and the pellet 
washed in 4.9 ml 75 % EtOH (20’000 g, 10 min, 4°C). The pellet was air dried and 
resuspended in 266 µl 5 mM TE buffer. After incubation at 50°C for 3 min, 17.5 µl 100 
mM DTT, 7 µl RNAse inhibitor, 35 µl 10x RQ1 buffer and 24.5 µl RQ1 DNAse 
(Promega) were added. After incubation at 37°C for 30 min, 900 µl Trizol were added 
and incubated at 37°C for additional 5 min. 280 µl Chloroform were added, and after 
shaking for 1 min the sample was incubated at RT for 3 min. After centrifugation 
(12’000g, 60 min, 4°C) the upper phase was transferred to a new tube, 0.8 volumes 2-
Propanol were added and the RNA was precipitated at -20°C o/n. After centrifugation 
(20’000 g, 40 min, 4°C) the supernatant was discarded and the pellet washed in 4.9 ml 
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75% EtOH (20’000 g, 10 min, 4°C). The pellet was air dried and resuspended in 175 µl 5 
mM TE buffer. After incubation at 50°C for 3 min the RNA concentration was measured 
using Nanodrop. 70 µg total RNA from each stage were mixed and messenger RNA 
(mRNA) was isolated using the Poly(A)Purist mRNA purification Kit (Ambion). mRNA 
was eluted with 2x 200 µl “RNA storage solution”. mRNA concentration was determined 
using Nanodrop and the quality analyzed by gel electrophoresis. mRNA was precipitated 
by addition of 1/10 volume 5M Ammonium Acetate, 1 µl Glycogen and 2.5 volumes 100 
% EtOH. After incubation o/n at -20°C mRNA was pelleted at full speed for 40 min at 
4°C, the supernatant discarded and the pellet washed in 1 ml 75 % EtOH (full speed, 10 
min, 4°C). The pellet was air dried and resuspended in “RNA storage solution” (Ambion) 
to receive an mRNA concentration of ~ 450 ng /µl. 
 
First strand cDNA synthesis 
 
2 µl mRNA (450 ng / µl) sample were mixed with 1 µl ddH2O, 1 µl CDS-3M adapter (10 
µM, (18)) and 1 µl PlugOligo-3M adapter (15 µM, (18)). After incubation at 70°C for 2 
min, followed by 42°C for 2 min, 5 µl RT Master mix were added (2 µl 5x first strand 
buffer (18), 1 µl DTT (20 mM), 1 µl 10x dNTPs (10 mM each), 1 µl EasyClone reverse 
transcriptase (18)). After 30 min incubation at 42°C, 5 µl IP solution (18) were added and 
the sample mixed by pipetting. The sample was incubated at 42°C for an additional 90 
min before the tube was placed on ice to stop the reaction. 
 
Double strand cDNA synthesis by PCR amplification 
 
4 µl first strand cDNA were mixed with 160 µl ddH2O, 20 µl 10x EasyClone PCR buffer 
(18), 4 µl 50x dNTP mix (10 mM each), 8 µl PCR primer M1 (10 µM) and 4 µl 50x 
EasyClone Polymerase mix (18). PCR was performed at the following conditions (20 
cycles for steps 2-4): 95°C for 1 min, 95°C for 15 sec, 66°C for 20 sec, 72°C for 3 min, 
66°C for 15 sec, 72°C for 3 min. Double stranded (ds) cDNA was analyzed by gel 
electrophoresis and purified using Nucleospin Extract II kit (Clontech). DNA was eluted 
with 100 µl Elution Buffer (Clontech). 
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SfiI digest and size fractionation of ds cDNA 
 
80 µl ds cDNA were digested with 20 units SfiI enzyme for 20 h at 50 °C. To purify the 
digested ds cDNA and remove fragments < 500 bp, gel extraction was performed using 
Nucleospin Extract II kit (Clontech). After elution with 120 µl Elution Buffer (Clontech), 
ds cDNA was analyzed by gel electrophoresis and concentration measured by Nanodrop. 
Digested cDNA was precipitated o/n at -20°C after adding 1/10 volume 5 M Ammonium 
Acetate, 2.5 volumes 100 % EtOH and 1 µl Glycoblue. After centrifugation (20’000 g, 40 
min, 4°C) the supernatant was discarded and the pellet washed in 1 ml 75 % EtOH 
(20’000 g, 10 min, 4°C). The pellet was air dried and cDNA resuspended in Nuclease 
free ddH2O to a concentration of ~ 130 ng /µl which was used for ligation into the SfiI 
digested prey-vector pPR3-N. 
 
SfiI digest of prey vector pPR3-N 
 
5 µg pPR3-N prey vector (18) was SfiI digested and purified by gel extraction using 
Nucleospin Extract II kit (Clontech). The linearized plasmid was diluted to a 
concentration of 250 ng / µl which was used for ligation. 
 
Ligation of ds cDNA library into pPR3-N prey vector 
 
For ligation of the P. falciparum blood stage ds cDNA library into the prey vector pPR3-
N, the following components were mixed: 2 µl SfiI digested ds cDNA (130 ng / µl), 2 µl 
SfiI digested pPR3-N vector (250 ng / µl), 1 µl 10x T4 buffer (NEB), 1 µl T4 DNA ligase 
(400’000 U/ml, NEB) and 4 µl ddH2O. After incubation at 16°C for 20 h, the volume was 
adjusted to 100 µl with ddH2O and 1/ 10 volume 5 M Ammonium Acetate, 2.5 volumes 
100 % EtOH and 1 µl Glycoblue were added for precipitation. After incubation o/n at -
20°C the ligation was centrifuged (20’000 g, 40 min, 4°C) the supernatant was discarded 
and the pellet washed in 1 ml 75 % EtOH (20’000 g, 10 min, 4°C). The pellet was air 
dried and resuspended in 20 µl Nuclease free ddH2O for Transformation. 
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Large scale cDNA-library amplification 
 
With the 20 µl ligation product, 20 independent transformations were performed (1 µl 
ligation product each) using electrocompetent DH10B E. coli cells (Sigma). 1 µl ligation 
product was transferred into a precooled 1.5 ml tube. Electrocompetent DH10B E. coli 
cells (Sigma) were thawed on wet ice and 20 µl were added to the ligation. The cells / 
ligation mix was transferred to a chilled 1 mm cuvette and electroporated  with 2000 V, 
200 Ω, 25 µF. The cells were resuspended in 1 ml Recovery medium (Sigma, provided 
with the E. coli cells) and transferred to a shaker flask. 5 transformations were pooled in 
one 100 ml shaker flask and 6.5 ml SOC medium (Sigma) were added (one flask 
containing 6.5 ml SOC + 5 x 1 ml cells = 11.5 ml total; 4 Flasks). After incubation at 
37°C (225 rpm) for 1h, 300 µl aliquots were spread on 145 mm LB Agar plates 
containing 100 µg/ml Ampicillin (150 plates total). After incubation o/n at 37°C the 
generated ~4’500’000 independent colonies were collected by adding 2 x 5 ml LB per 
plate with cells scraped into the liquid using a Drigalski spatula and subsequent transfer 
into a sterile bottle. During the cell collection the LB medium and the collection bottle 
were kept on ice to prevent further cell division. The collected cell culture (~1.5 l) was 
distributed into three 1l shaker flasks and incubated at 30°C (225 rpm) for 2.5 h. The 
whole cell culture was pooled and mixed by shaking. 10 ml were removed, centrifuged 
(2600 g, 10 min), the supernatant removed and the pellet was resuspended in 10 ml LB 
containing 25 % Glycerol. 1 ml aliquots were distributed into screw cap cryotubes and 
frozen in liquid nitrogen to generate stabilates (stored at -80°C).  
The remaining cell culture was centrifuged at 3000 g for 5 min to remove the supernatant. 
The resulting pellet was used for DNA isolation using the PowerPrep HP Plasmid 
Maxiprep kit (OriGene). After precipitation each DNA pellet was resuspended in 500 µl 
TE buffer and concentration measured by Nanodrop. 
 
Analysis of the P. falciparum cDNA library quality 
 
To re-transform the amplified cDNA library into E. coli, 50 µl chemocompetent DH5α 
cells were mixed with 5 µl DNA (10 ng / µl), incubated on ice for 5 min and distributed 
CHAPTER 2: MATING-BASED SPLIT-UBIQUITIN SYSTEM FOR P. FALCIPARUM 
 52 
on pre-warmed (37°C) LB Agar plates containing Ampicillin. After incubation o/n at 
37°C, 60 different clones were analyzed by screening PCR using pPR3-N vector primers 
5’-gtcgaaaattcaagacaagg-3’ and 5’-aagcgtgacataactaattac-3’. 20 additional colonies were 
used to inoculate 5 ml LB containing Ampicillin and incubated o/n at 37°C at 225 rpm. 
Library plasmids were isolated using the QIAprep Spin Miniprep kit (Qiagen) and 
sequenced using the pPR3-N vector primers. Additionally the library (10 ng / µl) was 
used as a template for several PCRs with primers of different genes summarized in table 
S1. PCR products were analyzed by gel electrophoresis. 
 
Bait vector construction 
 
Full-length MAHRP1 was PCR amplified from cDNA using primers summarized in table 
S1 and cloned into the bait vector pBT3-C / pBT3-STE / pBT3-SUC / pBT3-N (18) via 
SfiI restriction sites.  
 
Transformation of the bait vector into the NMY51 yeast reporter strain 
 
A single colony from a 3 day old NMY51 streak was inoculated in 20 ml of liquid YPAD 
medium (in a 100 ml Erlenmeyer flask) and incubated o/n on a shaker at 275 rpm and 
30°C. The titer of the culture was determined using a Neubauer chamber and 2.5x108 
cells were added to 50 ml pre-warmed YPAD to give 5x106 cells / ml. The cells were 
incubated at 30°C and 275 rpm till the cell titer was 2x107 (~5 h). Then the cells were 
centrifuged (3000 g, 5 min) and the supernatant removed. After the cells were washed in 
25 ml ddH2O (3000 g, 5 min) they were resuspended in 1 ml dd H2O. Meanwhile the ss 
carrier DNA (2 mg / ml: (18)) was boiled at 95°C for 5 min and chilled on ice. The cell 
suspension was centrifuged (11’000 rpm, 30 sec) and the supernatant discarded. The 
pellet was resuspended in ddH2O to a final volume of 1 ml and vortexed vigorously. 100 
µl aliquots were distributed into new tubes, centrifuged (11’000 rpm, 30 sec) and the 
supernatant removed. 360 µl transformation mix (33 % PEG 3350, 100 mM LiOAc, 0.1 
mg boiled ss carrier DNA, 2.5 µg bait vector) were added and resuspended by vigorously 
vortexing. After incubation at 42°C (water bath) for 40 min the cells were pelleted 
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(11’000 rpm, 30 sec) and the supernatant removed. The cells were resuspended in 200 µl 
ddH2O and 100 µl were spread on pre-warmed (30°C) SD-Leu Agar plates. Plates were 
sealed with parafilm and incubated at 30°C for 3-5 days.  
 
Freezing of yeast strains (Glycerol stocks) 
 
20 ml liquid yeast medium (depending on the strain either YPAD, SD-Leu or SD-Trp) 
were inoculated from a single colony of a 3 day old streak (in a 100 ml Erlenmeyer flask) 
and incubated o/n on a shaker at 275 rpm and 30°C. After centrifugation (2600 g, 5 min), 
the supernatant was removed and the pellet resuspended in 10 ml 2x YPAD containing 25 
% Glycerol. 1 ml aliquots were distributed into screw cap cryotubes and frozen at -80°C. 
 
mbSUS functional assay 
 
A single colony from a 3 day old NMY51 pBT3-SUC-MAHRP1 or pBT3-STE-
MAHRP1 streak was inoculated in 20 ml of liquid YPAD medium (in a 100 ml 
Erlenmeyer flask) and incubated o/n on a shaker at 275 rpm and 30°C. The titer of the 
culture was determined and 2.5 x 108 cells were added to 50 ml pre-warmed YPAD to 
give 5 x 106 cells / ml. The cells were incubated at 30°C and 275 rpm till the cell titer was 
2 x 107. The cells then were centrifuged (3000 g, 5 min) and the supernatant removed. 
The pellet was washed in 25 ml ddH2O (3000 g, 5 min) and resuspended in 1 ml dd H2O. 
Meanwhile the ss carrier DNA (2 mg / ml) was boiled at 95°C for 5 min and chilled on 
ice. The cell suspension was centrifuged (11’000 rpm, 30 sec) and the supernatant 
discarded. The pellet was resuspended in ddH2O to a final volume of 1 ml and vortexed 
vigorously. 200 µl aliquots were distributed into new tubes, centrifuged (11’000 rpm, 30 
sec) and the supernatant removed. 360 µl transformation mix (33 % PEG 3350, 100 mM 
LiOAc, 0.2 mg boiled ss carrier DNA, 2.5 µg pPR3-N (empty library plasmid, negative 
control) / pOst1-NubI (wild type Nub, positive control) plasmid DNA) were added and 
resuspended by vigorously vortexing. After incubation at 42°C (water bath) for 40 min 
the cells were pelleted (11’000 rpm, 30 sec) and the supernatant removed. Each pellet 
was resuspended in 1 ml pre-warmed YPAD and incubated at 30°C for 90 min. After 
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centrifugation (11’000 rpm, 30 sec) the supernatant was removed, each pellet 
resuspended in 180 µl ddH2O (3 ml total) and 80 µl aliquots were spread on pre-warmed 
(30°C) SD-Trp-Leu-His / SD-Trp-Leu-His-Ade Agar plates containing 100 mM 3-AT. 
Additionally a 1:1000 dilution of the transformation was plated on a SD-Trp-Leu plate to 
determine the transformation efficiency. Plates were sealed with parafilm and incubated 
at 30°C for 3 (SD-Trp-Leu) or 5 days (SD-Trp-Leu-His / SD-Trp-Leu-His-Ade) before 
number of colony forming units was determined. 
 
Library Screenings 
 
For one library transformation a total amount of 48 µg P. falciparum blood-stage library 
DNA was used and a transformation-efficiency in the range of 2 x 105 clones / µg DNA 
was yielded. A single colony from a 3 day old NMY51 pBT3-SUC-MAHRP1 streak was 
inoculated in 20 ml of liquid YPAD medium (in a 100 ml Erlenmeyer flask) and 
incubated o/n on a shaker at 275 rpm and 30°C. The titer of the culture was determined 
and 5 x 108 cells were added to 100 ml pre-warmed YPAD to give 5 x 106 cells / ml. The 
cells were incubated at 30°C and 275 rpm till the cell titer was 2 x 107 and split into 2 x 
50 ml. Then the cells were centrifuged (3000 g, 5 min) and the supernatant removed. 
After each pellet was washed in 25 ml ddH2O (3000 g, 5 min) they were resuspended in 1 
ml dd H2O. Meanwhile the ss carrier DNA (2 mg / ml) was boiled at 95°C for 5 min and 
chilled on ice. The cell suspension was centrifuged (11’000 rpm, 30 sec) and the 
supernatant discarded. Both pellets were resuspended in ddH2O to a final volume of 1 ml 
each and vortexed vigorously. 10 x 200 µl aliquots were distributed into new tubes, 
centrifuged (11’000 rpm, 30 sec) and the supernatant removed. 720 µl transformation 
mix (33 % PEG 3350, 100 mM LiOAc, 0.2 mg boiled ss carrier DNA, 4.8 µg cDNA 
library) were added and resuspended by vigorously vortexing. After incubation at 42°C 
(water bath) for 40 min the cells were pelleted (11’000 rpm, 30 sec) and the supernatant 
removed. Each pellet was resuspended in 300 µl ddH2O (3 ml total) and 200 µl aliquots 
were spread on 15 pre-warmed (30°C) SD-Trp-Leu-His-Ade Agar plates containing 100 
mM 3-AT. Additionally a 1:1000 dilution of the library transformation was plated on a 
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SD-Trp-Leu plate to determine the transformation efficiency. Plates were sealed with 
parafilm and incubated at 30°C for 3 (SD-Trp-Leu) or 8 days (SD-Trp-Leu-His-Ade). 
 
Library plasmid recovery and transformation into E. coli for sequencing 
 
For plasmid recovery buffers and spin columns were taken from QIAprep Spin Miniprep 
kit (Qiagen). Colonies expressing potential MAHRP1 binding partners were re-streaked 
on fresh SD-trp-leu-his-ade plates containing 100 mM 3-AT and grown at 30°C for 3 
days. A nicely sized colony was then inoculated in 4 ml of liquid SD-trp-leu and 
incubated o/n on a shaker at 275 rpm and 30°C. Cells were centrifuged (10’000 g, 1 min) 
and the supernatant removed. After resuspension in 250 µl resuspension buffer (Qiagen) 
100µl acid washed glass beads (Sigma) were added and the sample vortexed for 5 min. 
Then 250 µl lysis buffer (Qiagen) were added and after gentle shaking incubated for 4 
min. After Addition of 350 µl neutralization buffer (Qiagen) and gentle shaking the 
sample was centrifuged for 10 min at 14’000 g. The cleared lysate was transferred to a 
spin column (Qiagen) and centrifuged at 6000 g for 1 min. After discarding the flow-
through 500 µl binding buffer (Qiagen) were loaded onto the spin column and 
centrifuged at 6000 g for 1 min. The flow-through was discarded and the sample once 
again washed with 500 µl binding buffer and then with 750 µl wash buffer (6000 g, 1 
min). After discarding the flow-through the sample was centrifuged again for 1 min at 
14’000 g to eliminate remaining wash buffer. 50 µl Elution buffer (Qiagen) were added 
onto the membrane and after incubation for 1 min the DNA was eluted by centrifugation 
(14’000 g, 1 min). The eluted DNA was purified using the Nucleospin Extract II kit 
(Clontech) and eluted with 15 µl Elution buffer (Clontech). 5 µl of the purified plasmid 
DNA were then transformed into chemocompetent DH5α E. coli cells for amplification. 
Therefore 50 µl chemocompetent DH5α E. coli cells were mixed with 5 µl plasmid DNA 
(10 ng / µl), incubated in ice for 5 min and distributed on pre-warmed (37°C) LB Agar 
plates containing Ampicillin. After incubation o/n at 37°C, formed colonies were used to 
inoculate 5 ml LB containing Ampicillin. After incubation at 37°C o/n at 225 rpm, cells 
were pelleted and the library plasmids isolated using the QIAprep Spin Miniprep kit 
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(Qiagen). Plasmids were sequenced using the pPR3-N vector primers 5’-
gtcgaaaattcaagacaagg-3’ and 5’-aagcgtgacataactaattac-3’. 
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Results 
 
P. falciparum cDNA library construction 
 
Messenger RNA (mRNA) was isolated from a mixture containing equal amounts of P. 
falciparum ring-, trophozoite- and schizont-stage total RNA (Fig. 2A). The mRNA then 
was transcribed into double stranded (ds) cDNA (Fig. 2B), PCR amplified and enriched 
for fragments > 500 bp by gel extraction (Fig. 2C). Subsequently the cDNA library was 
ligated into the prey vector pPR3-N (18) which contains the two resistance genes AmpR 
and TRP1. These allow selection by growth on medium containing ampicilin (bacteria) or 
lacking tryptophan (yeast). The prey plasmid pPR3-N adds the coding sequence of an N-
terminal split-ubiquitin (Nub) 5’ to the library gene’s N-terminus. 
 
Identification of the P. falciparum cDNA library quality before amplification 
 
To test the quality of the generated P. falciparum cDNA library an aliquot was 
transformed into E. coli and plasmids of 10 different clones were isolated, SfiI digested 
and run on a gel to see the P. falciparum cDNA inserts. Nine of 10 clones contained a 
cDNA insert which had an average size of ~ 600 bp (Fig. 2D). Since ligation was shown 
to be successful, the library was ready for large scale amplification. 
 
Large scale cDNA library amplification 
 
To amplify the complete P. falciparum cDNA library it was transformed into 
electrocompetent DH10B E. coli cells (Sigma) by electroporation. The cells were 
distributed onto 150 LB Agar plates containing Ampicillin and grown over night at 37°C. 
The resulting ~ 4’500’000 independent colonies were collected and plasmids isolated 
which yielded a total of 4.28 mg P. falciparum blood-stage pPR3-N cDNA library. 
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Analysis of the P. falciparum cDNA library quality 
 
To test the quality of the pPR3-N cDNA library it was retransformed again into 
chemocompetent DH5α E. coli cells. Sixty clones were screened by PCR using pPR3-N 
vector primers that showed that all plasmids contained a DNA insert with an average size 
of ~ 500 bp (Fig. 3A). To further test the representation of P. falciparum genes 20 
different clones were isolated and their inserts sequenced. Twelve clones contained a 
partial P. falciparum gene (Table 1), 7 clones contained P. falciparum ribosomal RNA 
(rRNA) and only 1 clone contained no insert. To test if full-length genes were contained 
in the cDNA library 13 different randomly selected parasite genes were PCR amplified 
using primers spanning the whole ORF: MAHRP1, five “conserved Plasmodium proteins 
with unknown function” (PF3D7_0716300, PF3D7_1012900, PF3D7_1124300, 
PF3D7_1317400 and PF3D7_1468900), a zinc finger protein (PF3D7_1009400), a 
splicing factor (PF3D7_1123900), a fork head domain protein (PF3D7_1307800), a 
bromodomain protein (PF3D7_1033700), a multiprotein bridging factor 
(PF3D7_1128200), a Histone H2A variant (PF3D7_0320900), and a putative vesicle-
associated membrane protein (PF3D7_1439800). Ten of the thirteen full-length genes 
were successfully amplified (Fig. 3B). 
Taken together, 95 % of the blood stage cDNA library plasmids contained a P. 
falciparum insert (60 % a partial gene, 35 % parasite derived rRNA) with an average 
insert size of  ~ 500 bp. While the most of the plasmids seemed to contain only gene 
fragments, we show by PCR that over 10 of 13 randomly selected genes were represented 
as full-length genes. With approximately 4,5 x 106 clones from the large scale 
amplification 60 % or ~ 2.7 x 106 clones should contain a parasite coding sequence. Since 
only 1/6 of them would be expected to be in frame and in the correct orientation the 
library should have an estimate gene-coverage of about 80 fold with an estimate of 5675 
genes. Considering that not all parasite genes are transcribed during the blood stage, the 
coverage is probably even higher. 
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Bait vector construction 
 
To produce a read-out in the nucleus, the bait-Cub and prey-Nub fusion proteins must be 
both present in the cytoplasm. Therefore the topology of the investigated protein has to 
be considered. Because MAHRP1 is a type 1 transmembrane protein, it was ligated into 
the plasmid vector 5’ to the C-terminal half of ubiquitin (Cub) which itself is fused to a 
LexA-VP16 TF. This guarantees that the TF is exposed to the cytoplasm and able to 
diffuse into the yeast nucleus after ubiquitin-cleavage. Two different bait vectors were 
tested for functionality in two independent experiments: pBT3-STE (18) adds the 
Saccharomyces cerevisiae STE2 leader sequence to the N-terminus of the bait protein, 
which serves as a short leader sequence to optimize expression. pBT3-SUC (18) adds a S. 
cerevisiae signal sequence (SUC2) to the bait’s N-terminus, which ensures proper 
insertion into yeast membranes. Additional components of both bait-vectors are the two 
selectable markers KanR and LEU2 which allow selection of plasmid-bearing cells on 
medium containing kanamycin (bacteria) or lacking leucine (yeast). 
 
Functional assay with pBT3-STE-MAHRP1 & pBT3-SUC-MAHRP1 bait vectors 
 
To analyze which bait protein (pBT3-STE-MAHRP1 or pBT3-SUC-MAHRP1) is better 
expressed and inserted into the yeast membranes, both plasmids were co-transformed 
with either of the two control plasmids pOst1-NubI (positive control) and pPR3-N 
(negative control) into the yeast reporter strain NMY51.  
pOst1-NubI contains a wild type N-terminal Ubiquitin (Nub) which has a strong affinity 
for the C-terminal Ubiquitin (Cub) fused to the MAHRP1 bait and therefore enables 
cleavage resulting in cell growth on selective medium (Fig. 4A). 
The empty library vector pPR3-N contains a mutated Nub which lost its affinity for Cub. 
Therefore no ubiquitin cleavage should occur and the TF should be retained at the yeast 
membranes, thereby preventing cell growth on selective medium (Fig. 4A). Figure 4B 
shows that 47 % of the yeast cells co-transformed with pBT3-STE-MAHRP1 and 
pOST1-NubI (positive control) grew on minimal medium lacking histidine and adenine 
(SD-trp-leu-his-ade). On the other hand 19 % of the cells co-transformed with pBT3-
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STE-MAHRP1 and pPR3-N (negative control) could also grow under the same 
conditions. For yeast cells containing the bait vector pBT3-SUC-MAHRP1, 30 % of 
those transformed with pOst1-NubI could grow on minimal medium lacking histidine and 
adenine. In contrast, only 5 % of the cells transformed with the empty library vector 
pPR3-N could grow on the selective medium (Fig. 4B). 
These results show that pBT3-SUC-MAHRP1 bait vector had a significantly reduced 
background growth compared to pBT3-STE-MAHRP1 and was therefore the better 
option for further experiments. 
 
Optimization of the screening stringency 
 
To reduce the number of false positives as much as possible in the subsequent library 
screens, the screening conditions were optimized. A pilot screen which simulated the 
conditions of a large library screen was performed. For this the pBT3-SUC-MAHRP1 
bait-bearing yeast strain was transformed with the empty library vector pPR3-N and 
plated onto SD-trp-leu-his and SD-trp-leu-his-ade agar plates containing different 
concentrations of 3-aminotriazole (3-AT). 3-AT is a competitive inhibitor of the His3 
reporter which enables yeast to grow on selective medium lacking histidine and increased 
concentration of 3-AT should increase the stringency of His3 selection. Since the mutated 
Nub expressed from the empty pPR3-N has no affinity for Cub of the MAHRP1 bait, all 
colonies which grew on selective medium were background. In order to identify the 
optimal 3-AT concentration, the transformed cells were spread on SD-trp-leu-his and SD-
trp-leu-his-ade plates containing 0, 7.5, 10, 20, 50 and 100 mM 3-AT and incubated at 
30°C for 4 days before the number of colonies was determined. Figure 4C shows that 
while a 3-AT concentration of 10 mM already reduced background growth by over 70 %, 
a concentration of 50 mM (SD-trp-leu-his-ade) or even 100 mM (SD-trp-leu-his) was 
needed to completely eliminate background. 
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Functional assay of pBT3-SUC-MAHRP1 with SD-trp-leu-his-ade (100 mM 3-AT) 
 
To test if the pBT3-SUC-MAHRP1 bait is still functional under the determined stringent 
screening conditions, another functional assay was performed. Therefore pBT3-SUC-
MAHRP1 bearing NMY51 yeast cells were transfected with the two control plasmids 
pOst1-NubI (positive control) and pPR3-N (negative control) and plated on SD-trp-leu-
his-ade containing 100 mM 3-AT. After incubation at 30°C for 4 days, the number of 
colonies was determined. Figure 4D shows that approximately 7000 colonies containing 
pOst1-NubI did grow on SD-trp-leu-his-ade containing 100 mM 3-AT whilst not a single 
one was observed with the negative control vector pPR3-N. This not only confirmed that 
the MAHRP1-Cub bait is correctly expressed and functional, but also that the screening 
conditions eliminated background while still allowing growth of true positive clones. 
 
Large scale library screenings with pBT3-SUC-MAHRP1 
 
To identify potential MAHRP1 binding partners, two independent library screens were 
performed. After transformation of the P. falciparum blood-stage cDNA library into the 
NMY51 yeast reporter strain containing the pBT3-SUC-MAHRP1 bait, cells were plated 
onto SD-trp-leu-his-ade plates containing 100 mM 3-AT and grown at 30°C for up to 8 
days. For the two duplicates screens 107 and 5 x 106 colony forming units (cfu)  were 
screened for interacting with the MAHRP1 bait. Considering that ~ 60 % contain a P. 
falciparum gene and only 1/6 are in-frame and in the correct orientation approximately 
1.5 x 106 parasite genes were actually screened. Since the P. falciparum 3D7 strain has a 
total number of 5675 genes, on average every single parasite gene was represented over 
260 times. After four days incubation at 30°C, only 8 colonies were observed, after 5 
days 68 additional colonies appeared, and finally after 7 days over 2700 small colonies 
grew on the 100 mM 3-AT plates. Plasmids of 49 clones were isolated from the yeast 
cells and sequenced. Of the 49 potential MAHRP1 interaction partners (PMIs) 24 
contained a P. falciparum gene (49 %), 18 contained P. falciparum rRNA (37 %), 2 
contained P. falciparum chromosomal non coding DNA (4 %), and 5 plasmids had no 
insert (10 %) (Table 2). Of the 24 clones with parasite genes, only 4 were in frame with 
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the N-terminal ubiquitin (Nub) and therefore potentially functional prey proteins. Two of 
these contained parts of the untranslated region (UTR) which contained a stop codon 
leaving two clones which potentially expressed a P. falciparum gene functional in the 
mbSUS. One was PF3D7_0402200 (surface-associated interspersed (SURFIN) gene 4.1) 
which was annotated as pseudogene (PlasmoDB) and the other potential MAHRP1 
interactor was the putative YL1 nuclear protein (PF3D7_1464000). 
 
In an attempt to counter the large number of false positives produced by the performed 
library screens, the 3-AT concentration of the selective growth-medium was increased 
from 100 to 150 mM to increase stringency. A total of 1.1 x 107 cfu were screened for 
binding with the MAHRP1 bait, which corresponds to ~200 times the whole parasite 
genome when adjusted for library quality, orientation and frame. After 4 days at 30°C 2 
colonies appeared, 25 additional colonies appeared after 5 days and approximately 300 
small cfu after 7 days. The plasmids of 6 colonies were isolated and their insert 
sequenced. Table 2 shows that 2 of the 6 PMIs contained a P. falciparum gene, one 
contained a P. falciparum rRNA, two non-coding P. falciparum DNA / RNA and one 
plasmid had no insert. Only 1 of the two parasite genes, a “conserved Plasmodium 
protein with unknown function” (PF3D7_1451000) was in frame. Since it contained parts 
of the UTR which contained a stop codon, it was not expected to be functionally for the 
mbSUS. 
 
Confirmation of positive PMIs 
 
To eliminate false positives, the isolated libraray plasmids of PMI clones containing a P. 
falciparum insert in frame with the Nub were reintroduced into fresh yeast cells 
expressing the MAHRP1 bait. Neither PMI PF3D7_0402200 and PF3D7_1464000 
(containing only coding sequences for the respective genes), nor PF3D7_1140200 and 
PF3D7_0617800 (containing a part of the UTR which includes a stop codon) were able to 
maintain growth on selective medium. Additionally to these in-frame PMIs, plasmids 
containing the merozoite surface protein 1 (MSP1) were also reintroduced into the 
library. Although never in frame, msp1 was identified to be an insert of 4 different PMI 
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colonies (Table 2). However, also the MSP1 prey was not able to trigger growth of 
MAHRP1 bearing yeast cells on selective medium after retransfection. 
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Discussion 
 
Protein-protein interactions are the building blocks of all biological systems. Because of 
their utmost importance it is not surprising that scores of studies have been undertaken to 
characterize various interactions in model organisms. The identification of binding 
partners of investigated candidate proteins is thereby often facilitated by high-throughput 
in vitro screening methods like the Y2H assay, ribosomal display or phage display.  
Despite their importance, surprisingly little is known about protein-protein interactions in 
P. falciparum. The reasons for this are manifold: the protozoan parasite has a very 
complex life cycle which makes handling and sample generation difficult. Further it is 
generally difficult to recombinantly express P. falciparum proteins. Despite these 
difficulties, LaCount and colleagues successfully established a Y2H assay to generate a 
P. falciparum blood-stage protein interaction network (12). While facing several Y2H-
specific problems like a large number of false positives and bias towards yeast 
homologues, they were able to show the applicability of yeast-based in vitro systems for 
identification of P. falciparum protein interactions. However, the classical Y2H has a 
distinct disadvantage for investigation of membrane bound proteins. Because of their 
hydrophobic nature they insert into yeast membranes and prevent the attached 
transcription factor (TF) from entering the nucleus. Therefore investigation of full-length 
membrane proteins is not possible with Y2H. Since the majority of exported parasite 
proteins, such as MAHRP1 (22) or SBP1 (26) were shown to be membrane proteins, an 
alternative approach was needed to generate an interaction network of exported P. 
falciparum proteins. Here we tried to establish the mating-based split-ubiquitin system 
(mbSUS) (19) as a new in vitro protein interaction platform for P. falciparum membrane 
proteins on the basis of the integral MC protein MAHRP1. 
Since the mbSUS is based on a split ubiquitin whose N-terminal half (Nub) must be fused 
to the prey proteins, preexisting P. falciparum cDNA libraries could not be used and a 
new one had to be generated. Therefore full-length-enriched P. falciparum blood stage 
cDNA was synthesized and cloned into a library vector which adds a Nub to the prey 
protein’s N-terminus. Because of the N-terminal placement of the Nub the library is only 
functional with prey proteins which are either soluble or type II transmembrane proteins, 
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but not with full-length type I prey proteins. However, since the P. falciparum genome is 
very AT rich (~ 80 %) (20), the oligo (dT) adapter used for transcription of full-length 
mRNA into cDNA also annealed within coding sequences. Therefore the library did not 
exclusively contain full-length type I transmembrane (TM) proteins, but also gene 
fragments without a TM domain which are expressed as soluble proteins functional in the 
mbSUS. For RNA isolation from infected RBCs efficient saponin lysis was crucial to 
obtain a library of good quality. Although mature erythrocytes have lost their nucleus 
together with their other organelles, they still appear to contain transcripts of various 
genes (27). In a first attempt to generate a P. falciparum library, over 80 % of inserts 
derived from human haemoglobin mRNA but this contamination could almost 
completely be eliminated by increased saponin lysis. Subsequent analysis of libraries 
showed a high quality with approximately 60% of plasmids containing either full-length 
or partial P. falciparum genes with an average insert size of 500 bp. Accounting for 
random reading frame and orientation of the inserts this would represent an approximate 
80 fold genome coverage. However, this high coverage is a bit misleading in the sense 
that not all parasite genes are represented equally. Since the library was generated from 
cDNA it is expected that due to substantial differences in transcript numbers lowly 
transcribed genes are underrepresented while higly transcribed genes are overrepresented.  
 
During the intra-erythrocytic cycle MAHRP1 is exported early into the RBC where it 
inserts into Maurer’s clefts (MCs) as a type I TM protein (22). Since only the C-terminal 
part of type I TM proteins is exposed to the cytoplasm and amenable for potential binding 
partners in mbSUS, the C-terminal split ubiquitin (Cub) and its adherent TF had to be 
fused C-terminally to the MAHRP1 bait. The MAHRP1 gene has a relatively high AT 
content (64 %), a characteristic which is known to hinder expression of P. falciparum 
proteins in heterologous systems (21). To overcome this potential problem we generated 
a bait plasmid which adds the short Saccharomyces cerevisiae leader sequence STE2 to 
the N-terminus of MAHRP1 which optimizes expression in yeast. Since MAHRP1 is a so 
called PEXEL-negative exported protein which lacks a classical signal peptide (SP), it 
was very unlikely that it is efficiently secreted and inserted into yeast membranes on its 
own. Therefore we further generated a bait plasmid which adds the S. cerevisiae signal 
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sequence SUC2 to the N-terminus of MAHRP1 which ensures proper membrane 
insertion. 
The functionality of both generated baits was tested in functional assays in which growth 
on selective medium of bait-bearing cells transfected with a positive control plasmid 
containing the wild type Nub with high Cub-affinity showed that the TF containing bait 
proteins were both correctly expressed. The reduced growth of bait-bearing cells 
transfected with the empty library vector containing the mutated Nub with reduced Cub-
affinity further showed retention of the TF by membrane insertion of the bait. Although 
both baits were functional in mbSUS it became clear that only SUC-MAHRP1 had an 
acceptable small background under optimized screening conditions. This indicated that 
exported P. falciparum proteins without a classical SP do not insert efficiently into yeast 
membranes and therefore need an artificial yeast signal sequence like SUC2. The 
remaining background could be eliminated by addition of 3-Aminotriazole (3-AT) which 
is a heterocyclic compound and a competitive inhibitor of the his3 marker gene and thus 
increases the stringency of HIS3 selection (28). However, only the highest 3-AT 
concentration of 100 mM completely eliminate background growth and therefore a 
minimal medium lacking histidine and adenine (SD-trp-leu-his-ade) containing at least 
100 mM 3-AT was used for all library screens. 
By screening 2.6 x 107 library plasmids we only identified one single potential MAHRP1 
binding partner, the putative nuclear protein YL1 (PF3D7_1464000). While P. 
falciparum YL1 is still uncharacterized, in mammalian cells this nuclear protein 
presumably plays multiple roles in chromatin modification and remodelling as part of a 
multi-protein complex (29). This makes YL1 extremely unlikely to be a direct interaction 
partner of MAHRP1 which is an exported MC membrane protein. The presumed 
incorrectness of the MAHRP1-YL1 interaction was confirmed by re-transfecting the 
isolated prey plasmid into fresh yeast cells expressing the MAHRP1 bait which did not 
result in growth on selective medium. 
It is difficult to speculate why we were unsuccessful to identify MAHRP1-binding 
proteins using the mbSUS. The system might not be applicable to investigate interactions 
of P. falciparum membrane proteins, because the high AT content of the parasite genome 
(20) hinders protein expression in heterologous systems (21). Although the functional 
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assay indicated that the MAHRP1 bait protein was sufficiently expressed in the yeast 
reporter strain, this by no means allows to conclude that the majority of prey proteins 
would be expressed correctly. To overcome this problem LaCount and colleagues added 
an auxotrophic marker to the C-terminus of their library proteins (12) which allowed 
selection of plasmids encoding expressed P. falciparum proteins for their Y2H 
screenings. This pre-selection has the disadvantage that only 1/3 of all proteins which are 
in frame with the N-terminal Nub fragment are also in frame with this additional marker 
and thus eliminates another large proportion of clones available for the screen. We 
abstained from this selection but in retrospect it could have been beneficial when 
developing this system.   
It is also possible that the quality of the generated library was inadequate. Although a 
number of experiments deemed the quality sufficient it is still possible that certain genes 
including the potential MAHRP1 interaction partners might not be present in the library. 
Sequencing of 55 potential interaction partners revealed that the comparatively long 
untranslated regions (UTRs) of the parasite (30,31) might have caused problems besides 
expected frame shifts. These UTRs by chance often contain a stop codon which causes 
premature termination of transcription of the prey protein sequence after the ubiquitin 
moiety. Three of the five sequenced prey plasmids contained UTRs with a stop codon. In 
a worst case this would mean that over 50 % of the prey proteins in-frame with the Nub 
fragment may still not be expressed for that reason reducing the genome coverage to 
approximately 200 fold than the predicted 450 fold coverage. Nevertheless, such 
coverage should still be sufficient for a mbSUS library screen.  
To prove the applicability of the mbSUS and the generated library a positive control 
would have been necessary. However, at that time hardly any interaction of a membrane 
bound protein was confirmed except the binding of aldolase to the thrombospondin-
related anonymous protein (TRAP) (32,33). Due to the fairly large size of the TM 
containing TRAP (~ 160 kDa), the full-length protein would not have been suitable as 
bait, but since the aldolase binding-site has been shown to be located at the C-terminus in 
relatively close proximity to the TM domain, TRAP fragments probably could have been 
still used as positive control. Recently, interaction of the apical membrane antigen 
(AMA1) and the rhoptry neck protein 2 (RON2) has been shown (34) and the TM 
CHAPTER 2: MATING-BASED SPLIT-UBIQUITIN SYSTEM FOR P. FALCIPARUM 
 68 
containing AMA1 with 72 kDa in size would have been better suited as bait and should 
be seriously considered as a positive control for future experiments. On the other hand, 
the RON2 as interaction partner with a size of 249 kDa is most probably too large to be 
expressed as full-length protein but it would be expected that the library might also 
contains smaller RON2 fragments. 
A last possibility why we failed to identify interaction partners could be the inherent 
problem of the mbSUS or Y2H system with the large number of false positive clones and 
high background (35). In the mbSUS the complete insertion of the bait into the yeast 
membranes is fundamental. Only a small portion of the bait soluble in the cell can trigger 
growth on selective medium on its own. By increasing the 3-AT concentration in the 
selective medium we reduced this growth by increasing the necessary amount of reporter 
gene (his3) transcription. However, the need to use a maximum concentration of 3-AT to 
completely eliminate the background indicated that membrane insertion of the MAHRP1 
bait was far from perfect. In addition, using the maximum 3-AT concentration reduces 
sensitivity of the system which then triggers growth only if bait and prey have a strong 
affinity for each other. It is then possible that binding of MAHRP1 to its interaction 
partner might not be strong enough to overcome these very stringent screening 
conditions. 
 
In summary, we have generated a P. falciparum pPR3-N blood stage cDNA library, 
which had an overall good quality as judged by various measurements. We successfully 
generated and expressed a MAHRP1 bait protein in the yeast reporter NMY51 which was 
shown to insert into yeast membranes and to be functional in the mbSUS with standard 
control plasmids. However, the mbSUS library screens to identify MAHRP1 binding 
proteins remained unsuccessful. Nevertheless, the functionality of our MAHRP1 bait 
with control prey plasmids indicates that mbSUS is applicable for investigation of P. 
falciparum membrane proteins. While the quality and functionality of our library has to 
be further confirmed, e.g. by using AMA1 as positive control, it might still provide a 
powerful tool for identification of new P. falciparum membrane protein interactions. 
Even without a functional library the mbSUS could provide a useful tool to confirm 
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interaction on a one to one basis between a P. falciparum membrane protein and an 
identified specific protein. 
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Tables 
 
Gene ID gene product insert size (bp) full length ratio UTR length (bp) orientation 
PF3D7_1414600 RNA guanylyltransferase 282 0.18 145 3’—5’ 
PF3D7_0719400 conserved Plasmodium protein, unknown function 55 0.01 2 3’—5’ 
PF3D7_1450100 signal recognition particle SRP54, putative 393 0.26 4 5’—3’ 
PF3D7_0930300 merozoite surface protein 1 precursor 797 0.15 4 5’—3’ 
PF3D7_1216400 conserved Plasmodium membrane protein, unknown function 778 0.28 0 5’—3’ 
PF3D7_1029000 unknown function 52 0.02 3 3’—5’ 
PF3D7_1428300 proliferation-associated protein 2g4, putative 82 0.07 2 5’—3’ 
PF3D7_1103800 NOT family protein, putative 119 0.01 4 5’—3’ 
PF3D7_1126700 conserved Plasmodium protein, unknown function 375 0.13 4 5’—3’ 
PF3D7_1430200 plasmepsin IX 130 0.07 4 5’—3’ 
PF3D7_1222300 endoplasmin homolog precursor, putative 694 0.28 8 5’—3’ 
PF3D7_1324900 L-lactate dehydrogenase 216 0.12 6 5’—3’ 
average   331.1 0.13 15.5   
 
Table 1 After large-scale amplification of the blood-stage P. falciparum cDNA library, 20 library plasmids were sequenced to identify their insert. Of those 20, 
12 plasmids contained a partial P. falciparum gene (listed above). On average the library plasmids contained about 13 % of the coding sequence of their 
respective genes and none of the vectors contained a full-length gene. While an untranslated region (UTR) was part of almost every insert, its length was quite 
small. 
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PMI gene gene product size (bp) fragment size 
(bp) 
in frame Clone appeared 
after 
conditions 
1  Chromosome 5, non coding region  229  4 days 100mM 3-AT 
2 PF3D7_0419600 ran binding protein 1 843 545 no 4 days 100mM 3-AT 
3 PF3D7_1132200 TCP-1/cpn60 chaperonin family 1635 770 no 4 days 100mM 3-AT 
4  mal_rna_17:rRNA  218  4 days 100mM 3-AT 
5 PF3D7_0628100 HECT-domain (ubiquitin-transferase) 30864 625 no 4 days 100mM 3-AT 
6 PF3D7_1228600 merozoite surface protein 9 2232 780 no 4 days 100mM 3-AT 
7 PF3D7_1035500 merozoite surface protein 6 1116 500 no 5 days 100mM 3-AT 
8  mal_rna_9:rRNA  90  5 days 100mM 3-AT 
9  empty  0  5 days 100mM 3-AT 
10  empty  0  5 days 100mM 3-AT 
11  mal_rna_19:rRNA  129  5 days 100mM 3-AT 
12  empty  0  5 days 100mM 3-AT 
13 PF3D7_1035300 glutamate-rich protein 3702 400 no 5 days 100mM 3-AT 
14  malmito_rna_RNA5:rRNA  107  5 days 100mM 3-AT 
15  mal_rna_17:rRNA  216  5 days 100mM 3-AT 
16 PF3D7_0402200 surface-associated interspersed gene 4.1, (SURFIN4.1) 6471 820 yes 5 days 100mM 3-AT 
17  empty  0  5 days 100mM 3-AT 
18 PF3D7_0930300 merozoite surface protein 1 5163 850 no 5 days 100mM 3-AT 
19 PF3D7_1229900.1 conserved Plasmodium protein, unknown function 2055 240 no 5 days 100mM 3-AT 
20  Chromosome 10, non coding region  60  5 days 100mM 3-AT 
21  malmito_rna_RNA18:rRNA  46  5 days 100mM 3-AT 
22 PF3D7_0930300 merozoite surface protein 1 5163 870 no 5 days 100mM 3-AT 
23  malmito_rna_LSUG:rRNA  620  5 days 100mM 3-AT 
24  malmito_rna_RNA14:rRNA  69  > 6 days 100mM 3-AT 
25 PF3D7_0723400 conserved Plasmodium protein, unknown function 4269 255 no > 6 days 100mM 3-AT 
26  mal_rna_10:rRNA  108  > 6 days 100mM 3-AT 
27  MAL5_28S  436  > 6 days 100mM 3-AT 
28 PF3D7_0617800 histone H2A 399 396 no > 6 days 100mM 3-AT 
29  malmito_rna_LSUC:rRNA  47  > 6 days 100mM 3-AT 
30 PF3D7_1106200 conserved Plasmodium protein, unknown function 2046 365 no > 6 days 100mM 3-AT 
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PMI gene gene product size (bp) fragment size 
(bp) 
in frame Clone appeared 
after 
conditions 
31 PF3D7_0930300 merozoite surface protein 1 5163 180 no > 6 days 100mM 3-AT 
32  mal_rna_9:rRNA  88  > 6 days 100mM 3-AT 
33  empty  0  > 6 days 100mM 3-AT 
34  malmito_rna_RNA4:rRNA  459  > 6 days 100mM 3-AT 
35 PF3D7_0103400 zinc-carboxypeptidase 4863 365 no > 6 days 100mM 3-AT 
36  malmito_rna_RNA6:rRNA  77  > 6 days 100mM 3-AT 
37 PF3D7_0506900 rhomboid protease ROM4 2280 300 no > 6 days 100mM 3-AT 
38 PF3D7_1140200 conserved Plasmodium protein, unknown function 1344 500 yes (UTR stop) > 6 days 100mM 3-AT 
39  MAL5_18S  816  > 6 days 100mM 3-AT 
40 PF3D7_0113600 surface-associated interspersed gene (SURFIN) 5586 800 no > 6 days 100mM 3-AT 
41 PF3D7_0617800 histone H2A 399 540 yes (UTR stop) > 6 days 100mM 3-AT 
42  mal_rna_10:rRNA  82  > 6 days 100mM 3-AT 
43  malmito_rna_RNA22:rRNA  61  > 6 days 100mM 3-AT 
44 PF3D7_1464000 YL1 nuclear protein, putative 2118 850 yes > 6 days 100mM 3-AT 
45  malmito_rna_1:rRNA  120  > 6 days 100mM 3-AT 
46 PF3D7_1216000 Serine--tRNA ligase, putative 1857 617 no > 6 days 100mM 3-AT 
47 PF3D7_1320700 conserved Plasmodium protein, unknown function 4329 870 no > 6 days 100mM 3-AT 
48 PF3D7_1478900 ncRNA 1044 460 no > 6 days 100mM 3-AT 
49 PF3D7_1411000.1 conserved Plasmodium protein, unknown function 7233 660 no > 6 days 100mM 3-AT 
50   empty   0   4 days 150 mM 3-AT 
51  malmito_rna_RNA11:rRNA  83  4 days 150 mM 3-AT 
52  PF12TR011:ncRNA  126  5 days 150 mM 3-AT 
53  Chromosome 1, non coding region  > 161  5 days 150 mM 3-AT 
54 PF3D7_0930300 merozoite surface protein 1 5163 710 no 5 days 150 mM 3-AT 
55 PF3D7_1451000 conserved Plasmodium protein, unknown function 2415 830 yes (UTR stop) 5 days 150 mM 3-AT 
 
Table 2 Summary of all potential MAHRP1 interactors (PMIs) identified by three independent large-scale P. falciparum blood-stage cDNA library screenings 
with the pBT3-SUC-MAHRP1 bait in the mbSUS. Sequencing of 55 PMI clones revealed that only 26 contained a library plasmid with a (partial) P. falciparum 
coding sequence. Of those 26 only 2 were in frame and potentially expressed.   
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Figure legends 
 
Figure 1 The mating-based split-ubiquitin system. The bait protein is fused to the C-
terminal half (Cub) and the prey to the N-terminal half of a split ubiquitin. If they interact 
a functional ubiquitin protein is reconstituted which gets cleaved by endogenous 
ubiquitin-specific proteases (USP). This allows the artificial transcription factor (TF) 
which was fused to the Cub to enter the nucleus (N) where it starts expression of reporter 
genes (RG). In order to prevent reconstitution of the split ubiquitin without interaction of 
the bait and prey proteins, the Nub contains a mutation. The bait protein which is fused to 
the Cub has to be either an integral transmembrane protein, a peripheral membrane 
protein or attached to the membrane, otherwise it can enter the nucleus and create a report 
without an interaction with the prey protein. The prey protein can be a soluble protein (A) 
as well as a membrane protein (B). 
 
Figure 2 P. falciparum blood stage cDNA library generation. mRNA (A) was isolated 
from P. falciparum blood-stage total RNA and transcribed into ds cDNA (B) which was 
enriched for fragments > 500 bp by gel extraction (C). After ligation of the cDNA into 
the vector pPR3-N, 10 library plasmids were amplified and SfiI digested to determine the 
size of their P. falciparum insert (D) by gel electrophoresis. 
 
Figure 3 Analysis of the pPR3-N P. falciparum cDNA library quality. A: Screening 
PCRs with pPR3-N vector primers of 60 different library clones showed that all analyzed 
plasmids contained a DNA insert which has an average size of ~ 500 bp. B: To analyze if 
the generated library contained full-length genes it was used as a PCR template to 
amplify 13 different randomly selected parasite full-length genes. 10 of the 13 tested 
genes were successfully amplified (*) whereas 3 genes could not be amplified (*). 
 
Figure 4 mbSUS functional assays with the two bait vectors pBT3-SUC-MAHRP1 
and pBT3-STE-MAHRP1. A: Bait-bearing NMY51 yeast cells were transfected with 
either the empty library plasmid pPR3-N (negative control) or the positive control 
plasmid pOst1-NubI. Since pOst1-NubI contains a wild-type N-terminal ubiquitin (NubI) 
CHAPTER 2: MATING-BASED SPLIT-UBIQUITIN SYSTEM FOR P. FALCIPARUM 
 
 77 
with strong Cub-affinity a functional ubiquitin is reconstituted. Cleavage by ubiquitin-
specific proteases enables the transcription factor (TF) to enter the nucleus (N) where it 
starts transcription of reporter genes (RG). pPR3-N contains a mutated Nub with reduced 
Cub-affinity which is not able to reconstitute a functional ubiquitin in absence of bait-
prey binding. The transformed cells were spread on selective medium (SD-trp-leu / SD-
trp-leu-his / SD-trp-leu-his-ade) and after incubation at 30°C for 4 days the number of 
colony forming units was determined (B). The number in brackets indicates the ratio of 
grown cells compared to distributed cells. C: To reduce the number of false positives in 
library screenings as much as possible, a pilot screen with pBT3-SUC-MAHRP1 bearing 
NMY51 yeast cells was performed. After transfection with the empty library vector 
pPR3-N the cells were plated on SD-trp-leu-his(-ade) medium containing different 
concentrations of 3-AT, a competitive inhibitor of the HIS3 reporter. Shown is the 
number of clones grown under the respective conditions after 4 days. Since pPR3-N only 
contains a mutated N-terminal ubiquitin with no affinity for the C-terminal ubiquitin of 
the bait, all observed growth is background. D: mbSUS functional assay with pBT3-
SUC-MAHRP1 bait bearing NMY51 yeast cells transfected with either the negative 
control pPR3-N or the positive control pOst1-NubI. Cells were spread on selective 
medium (SD-terp-leu-his-ade) containing 100 mM 3-AT and after incubation at 30°C for 
4 days the number of colony forming units was determined. 
 
Table 1 60 % of analyzed library plasmids contain a P. falciparum gene fragment. 
After large-scale amplification of the generated blood-stage P. falciparum cDNA library, 
20 library plasmids were sequenced to identify their insert. Of those 20, 12 plasmids 
contained a partial P. falciparum gene. On average the library plasmids contained about 
13 % of the coding sequence of their respective genes and none of the vectors contained a 
full-length gene. While an untranslated region (UTR) was part of almost every insert, its 
length was quite small. 
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Suplementary table 1. Primers used for library generation, quality testing and bait vector construction
Gene primer Sequence RS vector   
CDS-3M adapter   AAGCAGTGGTATCAACGCAGAGTGGCCGAGGCGGCC(T)20VN SfiI   
library generation PlugOligo-3M   AAGCAGTGGTATCAACGCAGAGTGGCCATTACGGCCGGGGG-P SfiI   
PCR Primer M1   AAGCAGTGGTATCAACGCAGAGT     
PF3D7_1033700 
F CAGTGGATCCTGACCAATGATGCTTGAAG BamHI   
library quality 
R CAGTCCATGGATCTTTTTTTGAACTATCCTC NcoI   
PF3D7_1124300 
F CAGTGGATCCAAAATATGGCTGATAATAACCTAG BamHI   
R CAGTCCATGGGTAAGAATCCTTTGATGAATCG NcoI   
PF3D7_1128200 
F CAGTGGATCCTTATCAATGGATCACCAAGATCTG BamHI   
R CAGTCCATGGTTTTTTCTTGGGTGAAGGTAAATTG NcoI   
PF3D7_1317400 
F CAGTGGATCCTTTAATATGGCTAATACATGGAGATG BamHI   
R CAGTCCATGGTGTTTTGTAATTAATTTTTTTTTTTGTAC NcoI   
PF3D7_1468900 
F CAGTGGATCCAAAAAATGAGTTCCCCTACTAATG BamHI   
R CAGTCCATGGTGTATCGTCATAGAAATTTTTGCTC NcoI   
PF3D7_0716300 
F GATCGGATCCTTATGATGAAGGTGTGGGG BamHI   
R GATCCCATGGTGAAAATATTTCTTCATAATTTG NcoI   
PF3D7_1009400 
F GATCGGATCCTACTTATGGGTAGAAAGAAG BamHI   
R GATCGCTAGCTTCACAATTTTGTGTATG NheI   
PF3D7_1123900 
F GATCGGATCCAAAAAATGTCCAATACATTAATTTC BamHI   
R GATCCCATGGTATTAACATCTGTTCAATTAAATC NcoI   
PF3D7_1307800 
F GATCGGATCCTTAAAATGAACACCGAAGAAAAAATTAATAC BamHI   
R GATCCCATGGATCAGCTTGGCAAGTATCG NcoI   
PF3D7_1012900 
F GATCGGATCCAAAATGGTATCATTAAGATTAG BamHI   
R GATCCCATGGATAATCAAAACTGTGTGATG NcoI   
PF3D7_0320900 
F GATCGGATCCAAATGGAAGTTCCAGGAAAAG BamHI   
R GATCCCATGGGTTTTTTTTTGGTTTCTTTTGAG NcoI   
PF3D7_1439800 
F CAGTCTTAAGATGAAACTTTTAAGAGTAACAC AflII   
R CAGTATCGATCCAGTAACCCATATATTTTGTTA ClaI   
MAHRP1 
F ATTAACAAGGCCATTACGGCCGCAGAGCAAGCAGCAGTACA SfiI   
R AACTGATTGGCCGAGGCGGCCCCATTATCTTTTTTTTCTTGTTCTAATTT SfiI   
MAHRP1 
F ATTAACAAGGCCATTACGGCCGCAGAGCAAGCAGCAGTACA SfiI pBT3-SUC / -STE 
bait F ATTAACAAGGCCATTACGGCCAAAAATGGCAGAGCAAGCAGCAGT SfiI pBT3-C 
R AACTGATTGGCCGAGGCGGCCCCATTATCTTTTTTTTCTTGTTCTAATTT SfiI pBT3-C / -SUC / -STE 
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Introduction 
 
With over 500 million new yearly infections which cause about 700’000 annual deaths, 
malaria still represents one of the world’s most devastating human diseases (1). The most 
severe form of human malaria called malaria tropica is caused by the apicomplexan 
parasite Plasmodium falciparum. The symptoms of malaria tropica are strongly 
associated with the asexual development of the unicellular parasite within the human red 
blood cell. Erythrocytes are very specialized cells which are devoid of all internal 
organelles and any protein trafficking machinery in order to accommodate maximum 
space for haemoglobin. Survival and virulence of P. falciparum within RBCs therefore 
critically depend on extensive host cell refurbishments mediated by the export of parasite 
proteins into the erythrocyte cytosol. These include parasite derived membranous 
structures called Maurer’s clefts (MC) which have an important role in protein export 
from the parasite to the erythrocyte membrane. They probably function as a form of a 
surrogate Golgi which concentrates virulence proteins for delivery to the RBC surface 
(2,3). One of these virulence proteins exported via MCs is the variable surface antigen P. 
falciparum erythrocyte membrane protein 1 (PfEMP1). After insertion into the host cell 
membrane it mediates adhesion of the infected RBC to various endothelial host receptors 
to evade elimination in the spleen (4–6). PfEMP1 mediated binding of iRBCs is also 
responsible for damages in various organs like the brain, liver and lungs because it 
hampers blood circulation and induces release of pro-inflammatory cytokines (7,8). 
Because of its pathological effects PfEMP1 is generally regarded as the major P. 
falciparum virulence factor and therefore of utmost interest. 
While the process of PfEMP1 export is still not completely understood, it was shown to 
be dependent on the presence of the resident integral MC protein ‘membrane associated 
histidine rich protein 1’ (MAHRP1): in parasites in which the mahrp1 gene is deleted 
PfEMP1 accumulates within the confines of the plasma membrane / PVM interface and is 
not presented at the RBC surface anymore. This suggests that MAHRP1 could be 
involved in transport of PfEMP1 in a complex (9). After erythrocyte invasion the 
‘PEXEL-negative exported protein’ (PNEP) MAHRP1 is early expressed and exported 
into the RBC cytoplasm where it inserts into MC membranes. In addition to a single 
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central TM domain MAHRP1 contains a histidine rich C-terminal domain which in 3D7 
has a histidine content of nearly 30 % and contains six tandem repeats of the amino acid 
sequence DHGH. Because MAHRP1 is predicted to be a type I TM protein this histidine 
rich domain faces the erythrocyte cytoplasm where it is believed to protect the MCs and 
their associated proteins from deleterious effects of ferriprotoporphyrin (FP) by 
enhancing its degradation to H2O2 (10). Knock-out of MAHRP1 not only was shown to 
have an effect on PfEMP1 transport, its absence further resulted in morphologically 
different MCs suggesting a role of MAHRP1 as a structural component. (9). 
PfEMP1 is known to be the major virulence factor of P. falciparum. However, due to its 
variable nature it might not be suitable as a target for antimalarial interventions. 
Therefore single copy genes essential for PfEMP1 export like MAHRP1 come into focus. 
To bring new insight into the function of MAHRP1 and its role in PfEMP1 export we 
identified by co-immunoprecipitation (co-IP) two exported proteins, namely 
PF3D7_0501000 (PFE0050w) and ‘parasite-infected erythrocyte surface protein’ 
(PIESP2) (PF3D7_0501200 / PFE0060w) as potential MAHRP1 binding partners 
(Annette Gaida, unpublished). The aim of this study was to characterize PIESP2 and 
PF3D7_0501000 and to confirm their potential interaction with MAHRP1 by a mating-
based split-ubiquitin system (mbSUS) pairwise interaction assay using the recently 
established MAHRP1 bait (chapter 2). This yeast based in vitro interaction platform for 
membrane proteins consists of a split ubiquitin whose moieties are only able to 
reconstitute a functional protein if brought into proximity via the interaction of the 
respective proteins that are fused to them (11). Upon bait and prey protein interaction the 
functional ubiquitin is cleaved off by specific proteases which releases a transcription 
factor (TF) from yeast membranes. The TF then diffuses to the nucleus and starts 
transcription of the selection markers his3 and ade2 whose activation enables the yeast to 
grow on defined minimal medium lacking histidine and / or adenine (12). 
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Methods 
 
Generation of transfection constructs 
 
Full-length PIESP2 / PF3D7_0501000 was PCR amplified using primers summarized in 
table S1 and cloned 5’ to gfp into pARL1mGFPmT (13) via AflII and ClaI / ApaI 
restriction sites. 
 
P. falciparum transfection 
 
Ring stage 3D7 P. falciparum infected erythrocytes (parasitemia ~ 10 %) were 
transfected with 100 µg plasmid DNA as described (14) and cultured in the presence of 
2.5 mg/ml Blasticidin S. Drug resistant parasites were obtained approximately 4 weeks 
after transfection. 
 
Fluorescence microscopy 
 
Thin smears of parasite infected red blood cells were fixed on glass slides with methanol 
at -20°C for 2 min, air-dried and blocked with 3 % BSA in PBS. After incubation with 
mouse anti-GFP (Roche 1:500) and rabbit anti-MAHRP1 serum (1:500) (15) as primary 
antibodies, slides were washed and incubated with Alexa Fluor 594 (Invitrogen 1:200) 
conjugated goat anti-mouse and Alexa Fluor 488 (Invitrogen 1:200) conjugated goat anti-
rabbit antibodies. After washing, Vectashield Hard Set (Vector Laboratories) containing 
DAPI was added and covered by a glass coverslip. Images were obtained using a Leica 
DM 5000B fluorescence microscope. Images were analysed using Photoshop software. 
 
Triton X-114 solubility assay 
 
0.5 ml RBCs infected with 3D7 parasites episomally expressing PIESP2-GFP / 
PF3D7_0501000-GFP were lysed on ice in 0.15 % saponin. The pellet was resuspended 
in 200 µl 1 % Triton X-114 in PBS containing protease inhibitors (Roche) and incubated 
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on ice for 30 min. After centrifugation at 3000 g for 15 min, the supernatant was 
collected, incubated at 30 °C for 5 min and centrifuged at 20’000 g for 1 min. The 
supernatant was removed as the aqueous phase and the pellet was washed and 
resuspended with PBS as detergent phase. Equal amounts of both phases were analyzed 
by Western blotting (16). 
 
Western blot analysis 
 
Protein samples were resuspended in Laemmli sample buffer, separated on a 12.5 % 
acrylamide gel and blotted to nitrocellulose (Hybond-C extra; GE Healthcare) using a 
Trans-Blot semi-dry electroblotter (Bio-Rad). The membrane was blocked in 10 % skim 
milk + 0.1 % Tween in Tris-buffer. As primary antibodies mouse anti-GFP (Roche 
1:1000) or rabbit anti-MAHRP2 serum (1:2000) was used (15). The secondary antibodies 
used were horseradish peroxidase-conjugated goat anti-mouse (Pierce, 1:20 000) and goat 
anti-rabbit (Acris, 1:5000) IgG. 
 
Yeast medium 
 
NMY51 reporter strain (17) was cultured in Yeast Extract - Peptone - Dextrose plus 
Adenine medium (YPAD: 1 % yeast extract (Sigma), 2 % Bacto Peptone (BD), 210 µM 
adenine hemisulfate, 2 % glucose). NMY51 transfected with a bait vector was cultured in 
minimal medium lacking leucine (SD-leu: 38 mM ammonium sulphate, 0.17 % Difco 
yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-arginine, 
230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 108.6 µM adenine hemisulfate, 129 µM L-histidine, 100µM L-tryptophan, 2 % 
glucose). NMY51 co-transfected with bait and prey vectors was cultured in minimal 
medium lacking leucine and tryptophan (SD-trp-leu: 38 mM ammonium sulphate, 0.17 % 
Difco yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-
arginine, 230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
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valine, 108.6 µM adenine hemisulfate, 129 µM L-histidine, 2 % glucose). mbSUS 
functional assays and pairwise interaction assays were performed in minimal medium 
lacking leucine, tryptophan, histidine and adenine (SD-trp-leu-his-ade: 38 mM 
ammonium sulphate, 0.17 % Difco yeast nitrogen base w/o amino acids and ammonium 
sulphate (BD), 115 µM L-arginine, 230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM 
L-methionine, 300 µM L-phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 
µM L-uracil, 1.28 mM L-valine, 2 % glucose, 100 mM 3-aminotriazole). 
 
Bait vector construction 
 
Full-length mahrp1 was PCR amplified from cDNA using primers shown in table S1 and 
cloned into the bait vector pBT3-SUC (17) via SfiI restriction sites. To produce a read-
out in the nucleus, the bait-Cub fusion protein must be present in the cytoplasm. 
Therefore the topology of the investigated protein has to be considered. Because 
MAHRP1 is a type 1 transmembrane protein, it was ligated into the plasmid vector 5’ to 
the C-terminal half of ubiquitin (Cub) which itself is fused to a LexA-VP16 TF. This 
guarantees that the TF is exposed to the cytoplasm and able to diffuse into the yeast 
nucleus after ubiquitin-cleavage. pBT3-SUC contains the two selectable markers kanR 
and leu2 which allow selection of plasmid-bearing cells on medium containing 
kanamycin (bacteria) or lacking leucine (yeast). It further adds the S. cerevisiae signal 
sequence (SUC2) to the bait’s N-terminus, which ensures proper insertion into yeast 
membranes. 
 
Transformation of the bait vector into the NMY51 yeast reporter strain 
 
A single colony from a 3 day old NMY51 streak was inoculated into 20 ml of liquid 
YPAD medium (in a 100 ml Erlenmeyer flask) and incubated o/n on a shaker at 275 rpm 
and 30°C. The titer of the culture was determined using a Neubauer chamber and 2.5x108 
cells were added to 50 ml pre-warmed YPAD to give 5x106 cells / ml. Cells were 
incubated at 30°C and 275 rpm till the cell titer was 2x107 (~5 h). and subsequently 
centrifuged (3000 g, 5 min) and the supernatant removed. After washing in 25 ml ddH2O 
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(3000 g, 5 min) cells were resuspended in 1 ml dd H2O. Meanwhile the ss carrier DNA (2 
mg / ml) was boiled at 95°C for 5 min and chilled on ice. The cell suspension was 
centrifuged (11’000 rpm, 30 sec), the supernatant discarded, and the pellet was 
resuspended in ddH2O to a final volume of 1 ml and vortexed vigorously. 100 µl aliquots 
were distributed into new tubes, centrifuged (11’000 rpm, 30 sec) and the supernatant 
removed. 360 µl transformation mix (33 % PEG 3350, 100 mM LiOAc, 0.1 mg boiled ss 
carrier DNA, 2.5 µg bait vector) were added and resuspended by vigorously vortexing. 
After incubation at 42°C (water bath) for 40 min the cells were pelleted (11’000 rpm, 30 
sec) and the supernatant removed. The cells were resuspended in 200 µl ddH2O and 100 
µl were spread on pre-warmed (30°C) SD-Leu Agar plates. Plates were sealed with 
parafilm and incubated at 30°C for 3-5 days.  
 
Freezing of yeast strains (Glycerol stocks) 
 
20 ml liquid yeast medium (depending on the strain either YPAD, SD-Leu or SD-Trp) 
were inoculated from a single colony from a 3 day old streak (in a 100 ml Erlenmeyer 
flask) and incubated o/n on a shaker at 275 rpm and 30°C. After centrifugation (2600 g, 5 
min), the supernatant was removed and the pellet resuspended in 10 ml 2x YPAD 
containing 25 % Glycerol. 1 ml aliquots were distributed into screw cap cryotubes and 
frozen at -80°C. 
 
Prey vector construction   
 
Piesp2 / pf3d7_0501000 fragments (Fig. 2A) were PCR amplified from cDNA using 
primers shown in table S1 and cloned into the prey vector pPR3-N  (17) via SfiI 
restriction sites. pPR3-N adds the coding sequence of an N-terminal split-ubiquitin (Nub) 
5’ to the prey’s N-terminus and further contains the two resistance genes ampR and trp1 
which allow selection by growth on medium containing ampicilin (bacteria) or lacking 
tryptophan (yeast).  
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mbSUS pairwise interaction assay 
 
A single colony from a 3 day old NMY51 pBT3-SUC-MAHRP1 streak was inoculated 
into 20 ml of liquid YPAD medium (in a 100 ml Erlenmeyer flask) and incubated o/n on 
a shaker at 275 rpm and 30°C. The titer of the culture was determined and 2.5 x 108 cells 
were added to 50 ml pre-warmed YPAD to give 5 x 106 cells / ml. The cells were 
incubated at 30°C and 275 rpm till the cell titer was 2 x 107. The cells then were 
centrifuged (3000 g, 5 min) and the supernatant removed. The pellet was washed in 25 ml 
ddH2O (3000 g, 5 min) and resuspended in 1 ml dd H2O. Meanwhile the ss carrier DNA 
(2 mg / ml) was boiled at 95°C for 5 min and chilled on ice. The cell suspension was 
centrifuged (11’000 rpm, 30 sec) and the supernatant discarded. The pellet was 
resuspended in ddH2O to a final volume of 1 ml and vortexed vigorously. 200 µl aliquots 
were distributed into new tubes, centrifuged (11’000 rpm, 30 sec) and the supernatant 
removed. 360 µl transformation mix (33 % PEG 3350, 100 mM LiOAc, 0.2 mg boiled ss 
carrier DNA, 2.5 µg prey plasmid DNA) were added and resuspended by vigorously 
vortexing. After incubation at 42°C (water bath) for 40 min the cells were pelleted 
(11’000 rpm, 30 sec) and the supernatant removed. Each pellet was resuspended in 1 ml 
pre-warmed YPAD and incubated at 30°C for 90 min. After centrifugation (11’000 rpm, 
30 sec) the supernatant was removed, each pellet resuspended in 180 µl ddH2O (3 ml 
total) and 80 µl aliquots were spread on pre-warmed (30°C) SD-Trp-Leu-His-Ade Agar 
plates containing 100 mM 3-AT. Additionally a 1:1000 dilution of the transformation 
was plated on a SD-Trp-Leu plate to determine the transformation efficiency. Plates were 
sealed with parafilm and incubated at 30°C for 3 (SD-Trp-Leu) or 5 days (SD-Trp-Leu-
His-Ade) before number of colony forming units was determined. 
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Results 
 
PIESP2 and PF3D7_0501000 are exported proteins 
 
PIESP2 and PF3D7_0501000 are both located on chromosome 5, separated by only one 
single gene which is a heat shock protein 40 (HSP40). PIESP2 with 408 amino acids (aa) 
is considerably larger than PF3D7_0501000 with 260 aa but otherwise both proteins 
share a number of similarities. They are mainly expressed during the early trophozoite 
stage, have a PEXEL/VTS motif and a two exon structure with no syntenic genes in other 
Plasmodium species and no annotated functional domains except the transmembrane 
domains (TMs).  
Both proteins have a predicted TM at the N-terminus in PlasmoDB and PIESP2 has two 
additional TMs near the C-terminus (Fig. 1A). Further analysis with the TM domain 
prediction software TMHMM (18) showed a high probability of two additional TM 
domains at the C-terminus of PF3D7_0501000 (Fig. 1B). 
 
Subcelullar localization of PIESP2 and PF3D7_0501000 
 
We generated 3D7 transfectants expressing PIESP2 / PF3D7_0501000 C-terminally 
fused to GFP under the control of the PfCRT5’ promoter using the transfection vector 
pARL (13). When parasite-lysates were probed with antibodies against GFP, a protein of 
approximately 75 kDa and 50 kDa was observed in PIESP2-GFP or PF3D7_0501000-
GFP transfectants, respectively, and no signal was detected in uninfected erythrocytes 
(not shown). 
Subcellular localization of PIESP2-GFP and PF3D7_0501000-GFP was investigated by 
immunofluorescence assays (IFAs) and transfectants were co-labelled with antibodies 
against GFP and against MAHRP1 (10). Both, PIESP2-GFP and PF3D7_0501000-GFP 
co-localized to or close to the MCs with MAHRP1 (Fig. 1C). 
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Solubility of PIESP2 and PF3D7_0501000 
 
Episomally transfected PIESP2-GFP and PF3D7_0501000-GFP parasites were saponin-
lysed and used for a TritonX-114 solubility assay to isolate integral membrane proteins. 
The soluble and insoluble fractions were analyzed by Western blot using antibodies 
against GFP and MAHRP2, a PEXEL negative exported protein which behaves like a 
membrane associated protein despite the presence of a predicted TM domain (15). 
PIESP2 and PF3D7_0501000 were both detected in the insoluble membrane protein 
fraction but a substantial amount was also found in the soluble fraction. In contrast, as 
expected MAHRP2 was found mainly in the soluble protein fraction (Fig. 1D). 
 
mbSUS pairwise interaction assay of MAHRP1 with PIESP2 and PF3D7_0501000 
 
We investigated potential PIESP2 and PF3D7_0501000 binding to MAHRP1 using the 
mbSUS interaction screen in a pairwise manner. Therefore, we generated for each gene 
two different prey vectors, one included both predicted C-terminal TM domains whilst 
the other clone ended just before the TMs. Since PEXEL cleavage does not occur in yeast 
we generated both prey proteins to start with the cleaved PEXEL motif xE/D (Fig. 2A). 
After transformation of the prey vectors into the NMY51 reporter strain expressing the 
SUC-MAHRP1 bait described in chapter 2, cells were plated on SD-trp-leu-his-ade 
containing 100 mM 3-AT and grown for 6 days at 30°C. We also transfected both control 
plasmids pPR3-N (negative) and pOst1-NubI (positive) into the MAHRP1-bait strain. 
Any interaction between MAHRP1 and the two tested prey proteins would have 
maintained growth but neither PF3D7_0501000 nor PIESP2 could trigger growth of the 
reporter strain on selective medium (Fig. 2B). Hence, no interaction between MAHRP1 
and any of the candidate clones could be confirmed. 
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Discussion 
 
The MC-resident MAHRP1 was shown to be essential for the export of PfEMP1 to the 
erythrocyte membrane and is therefore of major interest. However, the specific function 
of MAHRP1 and its role in PfEMP1 export remain unclear. In an attempt to obtain new 
insight into the function of MAHRP1 we identified two exported proteins namely 
PF3D7_0501000 and PIESP2 as potential MAHRP1 binding partners by co-IP (Annette 
Gaida, unpublished). Both have predicted TM domains and were identified as possible 
erythrocyte surface proteins in a proteomic screen of tagged proteins (19).  
Fluorescence microscopy showed that both candidates, PIESP2 and PF3D7_0501000 at 
least partially co-localize with MAHRP1 at the MCs. This PIESP2 location confirms a 
study by Viscensini and colleagues who identified PIESP2 in a proteomic analysis as a 
MC protein and also showed this by immunofluorescence microscopy (20). In the same 
study they also obtained peptides of PF3D7_0501000 but did not further study its 
localization. Besides the confirmed location of PF3D7_0501000 at the MCs we were not 
able to detect any erythrocyte surface localization of PIESP2 or PF3D7_0501000 as has 
been reported by Florens and colleagues (19). However, it can not be excluded that weak 
signals at the surface were overshadowed by the strong MC signal of PIESP2 and 
PF3D7_0501000.  
Solubility assays further confirmed that both proteins were true transmembrane proteins 
which for PF3D7_0501000 is in contrast to the PlasmoDB annotation showing only a 
single TM that is cleaved off upon PEXEL cleavage. This solubility assay now confirms 
the TMHMM prediction of additional TM domains.  
Using the mbSUS (Chapter 2) we pairwise tested whether PIESP2 or PF3D7_0501000 
interacted with MAHRP1. Since the presence of two transmembrane domains potentially 
could generate difficulties to correctly insert the protein into the yeast membrane we 
tested two different prey clones for each protein, one clone including the two C-terminal 
TMs whilst the sequence of the other clone terminates before the TM domain. Neither of 
the two PIESP2 or two PF3D7_0501000 constructs could support growth, direct binding 
of MAHRP1 to either PIESP2 or PF3D7_0501000 could therefore not be confirmed. 
However, we cannot exclude that any of the three proteins might interact within a protein 
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complex but without direct binding. Since we were unable to prove that the prey proteins 
were correctly expressed it is possible that no interaction was detected  because of the 
inability to express PIESP2 or PF3D7_0501000 correctly. The high AT content (80 %) of 
P. falciparum genes (21) might hinder protein expression in such heterologous systems 
(22). In addition, screening with the MAHRP1 bait requires very stringent screening 
conditions to eliminate false positive clones and it could be possible that the interaction 
of MAHRP1 with any of the tested proteins might be too weak to sustain these stringent 
conditions.  
Although we were unable to confirm a direct binding of MAHRP1 to PIESP2 or 
PF3D7_0501000 we have shown that both proteins localize in a similar pattern and 
remain interesting candidates for further investigation of the interaction network of 
exported proteins. 
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Figure legends 
 
Figure 1 PF3D7_0501000 and PIESP2 are exported membrane proteins. A: 
schematic representation of the PF3D7_0501000 and PIESP2 proteins. Both proteins 
have a predicted transmembrane domain (TM) at the N-terminus and only PIESP2 has 
two additional TM domains predicted near the C-terminus by PlasmoDB. B: Additional 
analysis also showed a high probability for two C-terminal TM domains in 
PF3D7_0501000. C: Immunofluorescence assays of MeOH-fixed RBCs infected with 
3D7 episomally expressing PF3D7_0501000 or PIESP2 with a C-terminal GFP tag, co-
labelled with mouse α-GFP and rabbit α-MAHRP1 antibodies. D: Parasite pellet of 3D7 
episomally expressing PF3D7_0501000-GFP or PIESP2-GFP was generated by saponin 
lysis and partitioned into a soluble protein containing aqueous fraction (a) and a 
membrane protein fraction contained in the detergent pellet (d). Fractions were analyzed 
by immunoblot using mouse α-GFP and rabbit α-MAHRP2 antibodies. 
 
Figure 2 mbSUS pairwise interaction assay of MAHRP1 with PF3D7_0501000 & 
PIESP2. A: Schematic depiction of PF3D7_0501000 and PIESP2 fragments ligated into 
the prey vector pPR3-N. B: These prey plasmids and the two controls pPR3-N (negative 
control) & pOST1-NubI (positive control) were transfected into the pBT3-SUC-
MAHRP1 bearing yeast reporter NMY51. Transfected cells were spread onto selective 
medium (SD-trp-leu / SD-trp-leu-his-ade + 100 mM 3-AT) and after incubation for 6 
days at 30°C the number of CFUs was determined (B). 
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Figure 1 
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Figure 2 
  100 
Gene primer Sequence RS vector   
mahrp1 
F ATTAACAAGGCCATTACGGCCGCAGAGCAAGCAGCAGTACA SfiI pBT3-SUC / -STE 
bait F ATTAACAAGGCCATTACGGCCAAAAATGGCAGAGCAAGCAGCAGT SfiI pBT3-C 
R AACTGATTGGCCGAGGCGGCCCCATTATCTTTTTTTTCTTGTTCTAATTT SfiI pBT3-C / -SUC / -STE 
piesp2 
F ATTAACAAGGCCATTACGGCCGCAGATTTTAATGACATGTTTGC SfiI pPR3-N 
prey 
R+TMs AACTGATTGGCCGAGGCGGCCTTAAGTTAGTAATAAATTATGAAGAC SfiI pPR3-N 
R-TMs AACTGATTGGCCGAGGCGGCCTTAAAGTTTCATAACTTCATTAATATATTG SfiI pPR3-N 
pf3d7_0501000 
F ATTAACAAGGCCATTACGGCCGCAGAGCAAGAAGATCAATACA SfiI pPR3-N 
R+TMs AACTGATTGGCCGAGGCGGCCCTATTTATTTGATTCTTGTTCGTTA SfiI pPR3-N 
R-TMs AACTGATTGGCCGAGGCGGCCTTAGTTAATTCTTTTTAAACTACCAACA SfiI pPR3-N 
piesp2 
F ATTAACTTAAGATGTTACTCTTTTTTGCAAAAC AflII pARL1mGFPmT 
transfection 
R TAATTATCGATAGTTAGTAATAAATTATGAAGACC ClaI pARL1mGFPmT 
pf3d7_0501000 
F ATTAACTTAAGATGATGAATAAAAAATCAATG AflII pARL1mGFPmT 
R TAATTGGGCCCTTTATTTGATTCTTGTTCG ApaI pARL1mGFPmT 
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Summary 
 
Survival and virulence of the human malaria parasite Plasmodium falciparum during the 
blood stage of infection critically depend on extensive host cell refurbishments mediated 
through the export of numerous parasite proteins into the host cell. Parasite-derived 
membranous structures called Maurer’s clefts (MC) presumably play an important role in 
protein trafficking from the parasite to the red blood cell membrane. However, their 
specific function has yet to be determined. We identified and characterized a new MC 
membrane protein, termed small exported membrane protein 1 (SEMP1). Upon invasion 
it is exported into the RBC cytosol where it inserts into the MCs before it is at least partly 
translocated to the RBC membrane. Using conventional and conditional loss-of-function 
approaches we found that SEMP1 is not essential for parasite survival, 
gametocytogenesis, or PfEMP1 export under culture conditions. Co-IP experiments 
identified several potential interaction partners, including REX1 and other membrane-
associated proteins that were confirmed to co-localize with SEMP1 at the MCs. 
Transcriptome analysis further showed that expression of a number of exported parasite 
proteins was up-regulated in SEMP1-depleted parasites. By using Co-IP and 
transcriptome analysis for functional characterization of an exported parasite protein we 
provide a new starting point for further detailed dissection and characterisation of MC-
associated protein complexes. 
CHAPTER 4: SEMP1 IS A SMALL EXPORTED MEMBRANE PROTEIN 
 
 103 
Introduction 
 
The protozoan parasite Plasmodium falciparum is causing malaria tropica, the most 
severe form of human malaria responsible for nearly 700’000 annual deaths worldwide 
(1). Its pathology is associated with the asexual development of the unicellular parasite 
within the red blood cell (RBC). Because the human erythrocyte is a highly specialized 
cell which is devoid of all internal organelles, survival of P. falciparum critically depends 
on extensive host cell refurbishments mediated by the export of numerous parasite 
proteins into the erythrocyte cytoplasm. Some of these proteins like e.g. the major 
parasite virulence factor PfEMP1, insert into the host cell membrane where they mediate 
adhesion to endothelial receptors. Thereby the parasite not only prevents elimination of 
infected RBCs in the spleen, but as a side-effect also causes organ failure and cerebral 
malaria (2). 
Although protein export is the basis of P. falciparum pathology, it is still not completely 
understood. It was shown that many virulence proteins are exported via parasite derived 
membranous structures in the RBC cytoplasm termed Maurer’s clefts (MCs), which are 
believed to concentrate virulence proteins for delivery to the RBC membrane (3,4). 
However, while MCs were shown to play a major role in export of virulence proteins 
(3,4), their precise function remains elusive.  
Many exported P. falciparum proteins contain a signal peptide (SP) and a PEXEL/VTS 
export motif (5,6). However, some of the best characterized MC proteins (MAHRP1, 
SBP1, REX1 & REX2) are PEXEL-negative exported proteins which do not contain a 
conserved export signal (7–10). While lacking a conserved export motif, these proteins 
share some similarities among each other: they are expressed early after invasion and 
mostly possess a transmembrane (TM) domain (MAHRP1, SBP, REX2). Some PEXEL-
negative proteins (e.g. REX1, MAHRP2) were shown to be membrane-associated rather 
than integral membrane proteins but still possess a predicted hydrophobic domain. 
 
In our studies to elucidate the function and composition of MCs, we identified and 
characterized a new MC-resident protein termed ‘small exported membrane protein 1’ 
(SEMP1: PF3D7_0702400 / PF07_0007). SEMP1 is a small PEXEL-negative protein 
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which is expressed early during blood stage infection and exported to the MCs before 
being partly translocated further to the RBC membrane where it is suggested to be 
involved in membrane modification. 
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Methods 
 
Cell culture 
 
The P. falciparum 3D7 strain was cultured in vitro at 5 % haematocrit as described (11) 
using RPMI medium containing 0.5 % Albumax (12). Parasites were synchronized with 5 
% sorbitol as described (13).  
 
Plasmid constructs 
 
Full-length semp1 was PCR amplified using primers 5’-CAGTCTTAAGATGAGTCA-
ACCACAAAAACAAC-3’ and 5’-CAGTATCGATTTTTGCGTTCTGTAAACTGGCT-
3’ and cloned 5’ to gfp into pARL1mGFPmT (14) via AflII and ClaI restriction sites. 
PIESP2 was also cloned into pARL1mGFPmT via AflII and ClaI using primers 5’-
ATTAACTTAAGATGTTACTCTTTTTTGCAAAAC-3’ and 5’-TAATTAT-
CGATAGTTAGTAATAAATTATGAAGACC-3’. Truncated and mutated constructs for 
SEMP1 trafficking studies were generated similarly using primers summarized in table 
S1.  
Primers 5’-GATCGGATCCTGAAAATGAGTCAACCACAAAAAC-3’ and 5’-
GATCCCATGGTTTTGCGTTCTGTAAACTG-3’ were used to clone full-length 
SEMP1 5’ to 3xHA into pBcam-3xHA (15) via BamHI and NcoI restriction sites. 
Similarly PF3D7_0601900 was cloned into pBcam-3xHA via AflII and ClaI using 
primers 5’-CAGTCTTAAGATGACGGACCATTTATTGGATTT-3’ and 5’-
CAGTATCGATATTTTCTGCATTGGCTGAAGCA-3’ and PF3D7_0702500 via 
BamHI and NotI using promers 5’- ATATGGATCCATGGCTTATCCTCTTTTAG-
AAGATG-3’ and 5’- ATATGCGGCCGCTACATGAGCTTCATTAGTGTTTAAAC-3’. 
To disrupt the SEMP1 gene in 3D7 parasites, a DNA flank of approximately 500 bp 
starting 78 bp upstream of the SEMP1 start codon was inserted into the transfection 
vector pH-KO via PstI and EcoRI restriction sites using primers 5’- 
CAGTCTGCAGCTATTTTCCCTTTAACAATCTTTTT-3’ and 5’- CAGTGAATTCG-
ACTTCATGAATTAATTATGCAATA-3’.  
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To fuse a FKBP destabilization domain (DD) to the C-terminus of the endogenous 
SEMP1 in 3D7 wild type parasites, an approximately 500 bp DNA flank of the 3’ end of 
SEMP1 was cloned into the transfection vector pARL-DD via BglII and AvrII restriction 
sites using primers 5’- CAGTAGATCTCCCAAGAAAAGAAATTCAACCC-3’ and 5’- 
CAGTCCTAGGTTTTGCGTTCTGTAAACTGGCT-3’. 
 
P. falciparum transfection 
 
Ring stage 3D7 P. falciparum infected erythrocytes (parasitemia ~ 10 %) were 
transfected with 100 µg plasmid DNA as described (16) and cultured in the presence of 
either 10 nM WR99210 (pARL1mGFPmT / pH-KO / pARL-DD ) or 2.5 mg/ml 
Blasticidin S (pBcam-3xHA). Drug resistant parasites were obtained approximately 4 
weeks after transfection. 
To select for integration of the SEMP1 flank into the parasite genome (pH-KO & pARL-
DD) transfectants were cycled (3 weeks on / 3 weeks off drug) three times and tested for 
integration by Southern blot. After integration of the SEMP1 flank into the endogenous 
gene was observed, a single parasite was isolated by serial dilution. 
 
Triton X-114 solubility assay 
 
0.5 ml RBCs infected with 3D7 parasites episomally expressing SEMP1-3xHA were 
lysed on ice in 0.15 % saponin. The pellet was resuspended in 200 µl 1 % Triton X-114 
in PBS containing protease inhibitors (Roche) and incubated on ice for 30 min. After 
centrifugation at 3000 g for 15 min, the supernatant was collected, incubated at 30 °C for 
5 min and centrifuged at 20’000 g for 1 min. The supernatant was removed as the 
aqueous phase and the pellet was washed and resuspended with PBS to build the 
detergent phase. Equal amounts of both phases were analyzed by Western blotting (17). 
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Generation of SEMP1 mouse polyclonal antibodies 
 
Codon-optimized (for expression in E. coli) full-length SEMP1 (Eurofins) was cloned 5’ 
to a 6xHis-tag into the expression vector pSCherry2 (Eurogentec). The SEMP1-6xHis 
fusion protein was recombinantly expressed in E. coli using the CherryTMCodon kit 
(Eurgentec) and FPLC-purified with an anti-His column. Recombinant SEMP1 protein 
(0.2 mg/ml) in PBS was mixed with Sigma-Adjuvant-System (S6322, Sigma-Aldrich) 
according to the manufacturer`s protocol. 3 mice (female, balb/c, 16 weeks, Harlan 
Laboratories) were immunized intra-peritoneally with a 200 µl dose, 3 mice were 
immunized subcutaneously with a 100 µl dose in each of two sites. All mice were 
boosted on day 21 and bled on day 31. Blood was collected in heparinised tubes and 
centrifuged for 10 min at 2000 g. The plasma fraction was removed and stored at -20°C 
until further use.  
 
Fluorescence microscopy 
 
Thin smears of parasite infected red blood cells were fixed on glass slides with methanol 
at -20°C for 2 min, air-dried and blocked with 3 % BSA in PBS. After incubation with 
primary antibodies mouse anti-SEMP1 serum (1:100), mouse anti-GFP (Roche 1:500), 
rabbit anti-GFP (Abcam 1:200), rat anti-HA (Roche 1:100), rabbit anti-MAHRP1 serum 
(1:500) (18), rabbit anti-REX1 (1:500) (19), mouse anti-SBP1 (1:200) (20), mouse anti-
PfEMP1 (1:50) (21), mouse anti-Pf332 (1:200)  (22) and mouse anti-KAHRP (1:500), 
slides were washed and incubated with Alexa Fluor 488 / 594 (Invitrogen 1:200) 
conjugated goat anti-mouse antibodies, Alexa Fluor 488 (Invitrogen 1:200) conjugated 
goat anti-rabbit antibodies or Alexa Fluor 568 (Invitrogen 1:200) conjugated goat anti-rat 
antibodies. After washing, Vectashield Hard Set (Vector Laboratories) containing DAPI 
was added and covered by a glass coverslip. Images were obtained using a Leica DM 
5000B fluorescence microscope. Images were analysed using Photoshop software. 
Alternatively, SEMP1-3xHA infected red blood cells were fixed in 4 % formaldehyde + 
0.01 % glutaraldehyde in PBS. After washing in PBS the cells were permeabilized with 
0.1 % Triton X-100 in PBS and then blocked with 3 % BSA in PBS. After incubation 
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with primary antibodies rat anti-HA (Roche 1:100) and rabbit anti-MAHRP1 serum 
(1:500), cells were washed with PBS and incubated with Alexa Fluor 568 (Invitrogen 
1:200) conjugated goat anti-rat and Alexa Fluor 488 (Invitrogen 1:200) conjugated goat 
anti-rabbit antibodies. After washing cells were resuspended in  PBS, mixed with 0.4 
volumes Vectashield Hard Set (Vector Laboratories) containing DAPI and mounted on a 
glass slide with a cover slip. Images were obtained using a Zeiss confocal microscope 
LSM 700. 
 
Electron microscopy 
 
Immuno-electron microscopy of RBCs infected with 3D7 parasites episomally expressing 
SEMP1-GFP was performed according to Tokuyasu (23). Cells were chemically fixed in 
0.1 M phosphate buffer containing 2 % paraformaldehyde and 0.2 % glutaraldehyde, 
embedded in gelatin and cryo-preserved in 2.3 M sucrose. Gelatin blocks were frozen in 
liquid nitrogen and sectioned at -120 °C using an ultramicrotome (UC7, Leica) to 
generate 70 – 80 nm sections. Immunolabelling was done in 1 % BSA in PBS with rabbit 
anti-GFP primary antibodies (Abcam, 1:40) and 5 nm immunogold-coupled Protein A 
(CMC Utrecht, 1:70). After immunolabelling, the sections were stained at 4°C in a 1:9 
mixture of 4 % uranyl acetate and 2 % methylcellulose. Images were taken with a CM100 
at 80 kV. 
 
Western blot analysis 
 
0.5 ml infected red blood cells were lysed on ice in 0.15 % saponin in PBS. The resulting 
parasite pellet was resuspended in Laemmli sample buffer, separated on a 12.5 % 
acrylamide gel or a NuPAGE 4–12 % Bis-Tris gel (Novex) and blotted to nitrocellulose 
(Hybond-C extra; GE Healthcare) using a Trans-Blot semi-dry electroblotter (Bio-Rad). 
The membrane was blocked in 10 % skim milk + 0.1 % Tween in Tris-buffer. The used 
primary antibodies were mouse anti-SEMP1 serum (1:1000), mouse anti-HA (Roche 
1:5000), mouse anti-GAPDH (1:20’000) (24), mouse anti-GFP (Roche 1:1000) or rabbit 
anti-MAHRP2 serum (1:2000) (18). The used secondary antibodies were horseradish 
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peroxidase-conjugated goat anti-mouse (Pierce, 1:20 000) and goat anti-rabbit (Acris, 
1:5000) IgG. 
 
Southern blot analysis 
 
Genomic DNA was isolated by phenol/chloroform extraction of saponin lysed parasites 
as described (25). DNA was digested with either ClaI & XmaI (SEMP1-KO) or EcoRI 
(SEMP1-DD) restriction enzymes, separated on a 0.8 % agarose gel and transferred onto 
a Amersham Hybond-N+ membrane (GE Healthcare). Blots were probed with 32P-dATP-
labelled hdhfr PCR fragments.  
 
Co-Immunoprecipitation 
 
240 ml culture (5 % hematocrit ,8 % parasitemia) of 3D7 parasites episomally expressing 
SEMP1-3xHA was cross-linked in 1 % formaldehyde at 37°C. Reaction was stopped 
after 10 min by addition of 0.125 M glycine and transfer on ice. Cells were pelleted at 
700 g for 5 min, washed in ice cold PBS and red blood cells lysed on ice in 0.15 % 
saponin. After additional washing in PBS the pellet was resuspended in 1.5 ml sonication 
buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1 % SDS) containing complete protease 
inhibitor cocktail and sonicated with a Bioruptor UCD-300 for 10 min (30 sec on / 30 sec 
off). After centrifugation at 20’000 g for 10 min the supernatant was collected.  650 µl 
supernatant was mixed with 650 µl 2x binding buffer (50 mM Tris-HCl pH 7.4, 300 mM 
NaCl, 2 % NP40) and for the negative control additionally 150 µg HA peptide (Sigma) 
was added. Samples were mixed with 150 µl α-HA affinity matrix (Roche) and incubated 
at 4°C for 16 h at 25 rpm. The beads were pelleted at 300 g for 1 min and the supernatant 
removed and collected (supernatant). After washing for 4 x 5 min with 1 ml washing 
buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 % NP40) the final 
supernatant was collected (wash) and the beads mixed with 40 µl elution buffer (1x 
binding buffer containing 0.5 mg / ml HA peptide and protease inhibitors). After 
incubation at 25 rpm for 2 h the beads were pelleted at 300 g for 1 min and the 
supernatant collected (elution). The protein content of the elution was subsequently 
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analyzed by mass-spectrometry from either TCA precipitated pellets or from extracted 
gel bands after separation on a NuPage 4-12 % Bis-Tris gel (Novex) and Coomassie 
staining. 
 
Comparative transcriptome analysis by microarray 
 
After Sorbitol-synchronization to an 8 h window, a culture of SEMP1-DD parasites was 
split and cultured in the presence or absence of Shield. At four specific time points (6-14 
hpi, 16-24 hpi, 26-34 hpi & 36-44 hpi) parasite RNA was isolated from 30 ml culture (5 
% hematocrit, 5 % parasitemia) using RiboZol RNA extraction reagent (Amresco). RNA 
was transcribed into cRNA and Cyanine 5-labelled by incorporation of Cy5-CTP using 
the Quick Amp labelling kit (Agilent). 450 ng Cy5-labelled SEMP1-DD cRNA 
containing 5 pmol dye were mixed with an equal amount of Cy3-labelled 3D7 reference 
cRNA generated from mixed stages (equal amounts of ring-, trophozoite- and schizont-
stage RNA) and hybridized onto an Agilent P. falciparum microarray (AMADID 
#037237) as described (26). After washing, the slide was air-dried and scanned using a 
GenePix 4000B microarray scanner and GenePix Pro 7 software. Lowess normalization 
and background elimination was performed using Acuity 4.0 software (Molecular 
Devices). SEMP1-dependent transcriptional changes were identified by either 
Significance Analysis of Microarrays (SAM) (27) or by Student’s t-test. Heatmap of 
candidate genes was generated using Cluster and TreeView software (28). 
 
CD36 binding assay 
 
Recombinant human CD36 (125 μg/ml in PBS) or 1% BSA in PBS (control) was 
immobilized on a Petri dish as described (29). After incubation in a humid chamber over 
night at 4°C, unspecific binding was blocked with 1% BSA in PBS for 30 min at room 
temperature and washed with RPMI-Hepes. Infected erythrocytes in RPMI-Hepes and 
10% serum (5% hematocrit) were added and incubated for 30 min at 37°C. After gentle 
washing with RPMI-Hepes, bound cells were fixed with 2% glutaraldehyde in RPMI-
Hepes for 2 h and stained with 10% Giemsa for 10 min. Bound infected RBCs were 
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quantified in 8 or 10 different 0.2 mm2 areas. The mean value was calculated as infected 
RBCs per mm2 and normalized to a parasitemia of 1%. The experiment was performed 
three times. 
 
Induction of gametocytogenesis 
 
A 10 ml SEMP1-KO parasite culture (5 % hematocrit, 6 % parasitemia) was sorbitol-
synchronized and cultured for 24 h in 20 ml RPMI medium containing 1 % Albumax. 
After dilution to a parasitemia of ~ 2 % trophozoites, to prevent overgrowth, the 
committed parasites were cultured in 10 ml normal RPMI medium (0.5 % Albumax) for 
additional 24 h. Then parasites were cultured for 4 days in 10 ml medium containing 50 
mM N-Acetylglucosamine (GlcNac) (replaced daily). 
 
CHAPTER 4: SEMP1 IS A SMALL EXPORTED MEMBRANE PROTEIN 
 
 112 
Results 
 
Subcelullar localization of SEMP1 
 
SEMP1 (PF3D7_0702400) is located on chromosome 7, contains one intron and encodes 
a protein of 123 amino acids (aa). This small, early expressed ’Plasmodium protein with 
unknown function‘ (PlasmoDB) has no PEXEL motif, no classical signal peptide but a 
single predicted transmembrane domain  (TM) from aa 76 to 98 (Fig. 1A). Like many 
other PEXEL-negative exported proteins, no syntenic genes in other Plasmodium species 
exist but weak homologies to hypothetical proteins in P. vixax, P. cynomolgi, and P. 
knowlesi can be found. 
We generated 3D7 transfectants expressing SEMP1 with a C-terminal green fluorescent 
protein (GFP) under the control of the PfCRT5’ promoter using the transfection vector 
pARL (14). Additionally, we also used a parasite line expressing SEMP1 C-terminally 
fused to a triple Hemagglutinin tag (3xHA) (30). When parasite-lysates were probed with 
antibodies against 3xHA or GFP, a protein of approximately 20 kDa and 40 kDa in size 
was observed in SEMP1-3xHA and SEMP1-GFP transfectants (Fig 1B), respectively, 
and no signal was detected in uninfected erythrocytes. 
Live cell imaging of the SEMP1-GFP transfectants showed that the GFP-tagged protein 
was exported (Fig. 1C). There was also significant fluorescence observed within the 
parasite which might be due to protein overexpression. We further investigated the 
subcellular localization of SEMP1-3xHA by IFA using co-labelling with antibodies 
against the HA-tag and with either antibodies against MAHRP1 (31), REX1 (7) or 
KAHRP (32). SEMP1-3xHA colocalized with MAHRP1 and REX1 to the MCs (Fig. 1D 
+ 1E). This confirms a study by Heiber and colleagues, which bioinformatically 
identified new PEXEL-negative proteins and also localized GFP-tagged SEMP1 to the 
MCs in ring stages and trophozoites  (33). Electron microscopy using antibodies against 
GFP confirmed the localization of SEMP1-GFP at the MCs (Fig 1F). Interestingly, we 
found that SEMP1-3xHA is further transported to the RBC membrane and partially 
localizes with KAHRP in later stages (Fig. 2A).  
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The solubility of SEMP1 was determined in Triton X114-solubility assays where it was 
detected in the membrane protein fraction as an integral membrane protein but a 
substantial amount was also found in the soluble fraction. In contrast, MAHRP2, a 
PEXEL-negative protein shown to be membrane-associated (18), was found exclusively 
in the soluble protein fraction confirming that the membrane fraction was not 
contaminated with soluble proteins (Fig. 2B). 
To also analyse SEMP1 in wild type parasites, we generated affinity purified mouse 
antibodies raised against recombinant full-length SEMP1 protein. These antibodies 
recognized a protein of expected 15 kDa in 3D7 parasite lysates but not in uninfected 
erythrocytes (Fig. 3A). Double-labeling IFAs of sorbitol-synchronized parasites at 6-14 
hours post invasion (hpi), 16–24 hpi, 26–34 hpi and 36–44 hpi showed that SEMP1, 
similarly to MAHRP1, is exported early after invasion to MCs where it partially co-
localizes with MAHRP1 (Fig 3B). In younger stages SEMP1 is not found at all MCs 
whereas in later stages it is transported further to the RBC membrane. Western blots with 
parasite lysates taken at corresponding timepoints showed that endogenous SEMP1 is 
constantly expressed throughout the asexual intra-erythrocytic cycle (Fig 3C). 
 
Requirements for export of SEMP1 
 
To elucidate sequence requirements for SEMP1 export SEMP1-KO parasites (see below) 
were complemented with transfection constructs expressing full-length, truncated, or 
mutated versions of SEMP1 with a C-terminal GFP-tag (Fig. 4A). SEMP1-KO parasites 
were used to avoid interference with the endogenous protein. IFAs to localize these 
fusion proteins showed that deletion of the complete C-terminus of SEMP1 (SEMP11-97-
GFP) did not impair export and resulted in correct localisation whilst deletion of the first 
16 amino acids (SEMP117-123-GFP) of the N-terminus resulted in an impaired export from 
the parasite. The deletion of 71 amino acids (SEMP172-123-GFP) of the N-terminus 
prevented export and resulted in the concentration of SEMP1 in or at the endoplasmic 
reticulum (Fig. 8B). If the first 16 amino acids of SEMP1 were replaced by the 
corresponding amino acids of MAHRP2 (M21-16SEMP117-123-GFP) or the classical signal 
peptide of MSP1 (MSP11-16SEMP117-123-GFP) the fusion protein was exported in both 
CHAPTER 4: SEMP1 IS A SMALL EXPORTED MEMBRANE PROTEIN 
 
 114 
cases albeit with lower efficiency as indicated by the high amount of labelled protein 
within the parasite confines (Fig. 4B). 
 
Identification of potential SEMP1 interaction partners by Co-IP 
 
In order to reveal proteins interacting with SEMP1 we performed co-
immunoprecipitation (Co-IP) experiments followed by mass spectrometry-based protein 
identification. Protein extracts from formaldehyde-crosslinked trophozoite stage parasites 
expressing SEMP1-3xHA were incubated with anti-HA affinity matrix. Subsequently, 
bound SEMP1-3xHA and potential interacting proteins were eluted by competition with 
soluble HA peptides. As a negative control, an excess of HA peptides was added to the 
protein extracts during the binding step to prevent binding of SEMP1-3xHA to the 
affinity matrix. Western blot analysis confirmed that SEMP1-3xHA was successfully 
purified and eluted (Fig. 5A), and silver staining revealed that additional proteins were 
co-eluted with SEMP1-3xHA (Fig. 5B). Table 1 summarizes the identified parasite 
proteins for which ≥5 peptides were detected in LC-MS/MS analysis of either TCA 
precipitated elutions or from Coomassie-stained SDS-PAGE gel slices. 
To confirm potential interacting partners 3D7 parasites were transfected with constructs 
to express candidate proteins with either a C-terminal 3xHA tag (PF3D7_0702500 / 
PF3D7_0601900), or with a GFP tag (PIESP2). 
We determined the subcellular localization of these potential interaction partners by IFAs 
using mouse anti-SEMP1 antibodies combined with either rat anti-HA antibody for 
PF3D7_0702500-3xHA and PF3D7_0601900-3xHA or rabbit anti-GFP antibody for 
PIESP2-GFP. For Pf332 we used mouse anti-Pf332 antibody and rat anti-HA antibody in 
parasites expressing SEMP1_3xHA. REX1 co-localization was determined using rabbit 
anti-REX1 antibodies and mouse anti-SEMP1 antibodies. All potential interaction 
partners co-localized at least partially with SEMP1, but in particular with Pf332 or 
PIESP2 antibodies only a fraction of SEMP1 positive MCs were labelled with either 
antibody suggesting that distinct subpopulations of MCs exist (Fig. 6). 
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Knockout of SEMP1 
 
To investigate the function of SEMP1, the gene was knocked out in 3D7 wild type 
parasites by single crossover gene disruption. Integration of the human dihydrofolate 
reductase (hdhfr) cassette-containing plasmid pH-SEMP1-KO into the correct location of 
the parasite genome was confirmed by Southern blot (Fig. 7A) and a parasite clone was 
isolated by serial dilution. Western blot analysis using polyclonal antibodies against 
SEMP1 showed that the gene disruption was successful and SEMP1 was absent (Fig 7B). 
SEMP1-KO parasites were viable in absence of SEMP1 and also showed no adverse 
growth effects in culture. 
In order to test if transport of other proteins was disturbed we analyzed the SEMP1-KO 
parasite clone by IFA using antibodies against MAHRP1, SBP1, REX1 and PfEMP1. All 
four tested proteins were still exported in absence of SEMP1 (Fig. 7C). We further tested 
whether PfEMP1 was correctly exposed on the erythrocyte surface of KO parasites by 
testing binding of iRBCs to CD36 under static conditions but no differences were 
observed when compared to the parental parasites (Fig. 7D). Lastly, we tested whether 
gametocytogenesis could be induced in the SEMP1-KO strain and after five days type II 
gametocytes appeared and fully matured to stage V gametocytes similarly as in the wild 
type (Fig. 7E). 
To have the ability to to investigate the SEMP1 function under controlled conditions and 
between isogenic populations we also generated a conditional SEMP1 knockdown 
parasite in 3D7 by fusing a FKBP destabilization domain (DD) to the C-terminus of the 
endogenous SEMP1. DD confers instability to the fusion protein resulting in its targeted 
degradation if not stabilised by the small molecule Shield-1 (34,35). Integration of the DD 
and hdhfr cassette-containing plasmid pARL-SEMP1-DD at the correct locus was 
confirmed by Southern blot (Fig. 8A). Western blot analysis of synchronized SEMP1-DD 
parasites grown for 2 weeks with or without Shield showed significantly reduced 
amounts SEMP1 and only minute amounts of protein could be detected (Fig. 8B).  
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Transcriptional changes in absence of SEMP1 
  
To test if parasites responded to SEMP1 depletion with possible compensatory changes in 
gene expression we conducted comparative transcriptional profiling using genome-wide 
microarray technology. Parasite RNA was isolated at four specific time points (6-14 hpi, 
16-24 hpi, 26-34 hpi & 36-44 hpi) from synchronized SEMP1-DD parasites cultured with 
and without Shield. The Cy5-labelled SEMP1-DD cRNA was mixed with an equal 
amount of Cy3-labelled 3D7 reference cRNA (mixed stages) and hybridized onto an 
Agilent P. falciparum Microarray slide (AMADID #037237) containing oligonucleotides 
for all P. falciparum genes (26). We did not detect any significant transcriptional changes 
in SEMP1-depleted parasites using Significance Analysis for Microarrays (27). However, 
using the less stringent Student’s t-test, a total of 34 genes were significantly (p < 0.05) 
up-regulated over either two, three or four consecutive time points with a relative average 
fold change (RAFC) > 1.5. Down-regulation was observed for twelve parasite genes with 
a RAFC < 1.5 (p < 0.05). The highest fold change of 2.18 was seen for a var gene 
(PF3D7_0900100) between 6 & 14 hours post invasion (hpi). The most highly down-
regulated gene codes for a conserved protein with unknown function (PF3D7_1475200) 
with a 2-fold change between 6 & 14 hpi (Table 2).  
A total ten of the up-regulated genes, including the four most highly up-regulated genes, 
encode known exported proteins (Table 2), namely PfEMP1, HYP12, PHISTb and 
PfEMP3. In contrast, only one of the twelve down-regulated genes codes for a predicted 
exported protein with unknown function (PF3D7_0113400). Figure 9 shows that up-
regulation of the exported proteins did mostly not peak after invasion but during the 
tropozoite and schizont stage. 
Strikingly, two of the ten up-regulated exported proteins were also identified as potential 
interaction partners of SEMP1: HSP70-x (PF3D7_0831700) and a protein with unknown 
function (PF3D7_1353100). Although all other proteins identified as potential SEMP1  
interaction partners did not have a RAFC > 1.5, four of them were still significantely (p < 
0.05) up-regulated: REX1 (RAFC = 1.20), PF3D7_0702500 (RAFC = 1.33), 
PF3D7_0601900 (RAFC = 1.35) and GBP (RAFC = 1.44). 
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Discussion 
 
MCs have a crucial role in protein trafficking to the iRBC membrane and there is 
evidence that they act as secretory organelles concentrating virulence proteins destined 
for the host cell membrane (3,4), but further functions have yet to be determined. 
Similarly, the protein composition of MCs is not well established and there are steadily 
new proteins revealed, which are either resident or transiently located to the MCs 
indicating that the current MC proteome is far from complete. Since many of the MC 
proteins lack a signal peptide (SP) and a PEXEL/VTS motif it impossible to virtually 
establish a comprehensive MC proteome. 
Here we report the identification and characterization of a new MC protein that we 
termed SEMP1. It is a small protein with unknown function, has neither a PEXEL-motif 
nor a SP (PlasmoDB) and the SMART protein domain prediction tool (36) identified a 
single transmembrane (TM) domain from amino acid 76 to 98 (Fig. 1A). Similar to the 
MC resident proteins MAHRP1 and SBP1, it is expressed early and exported to the MCs 
where it integrates into the MC membrane. However, unlike MAHRP1 or SBP1, which 
persist as integral MC membrane proteins throughout the whole intraerythrocytic cycle 
(20,31), SEMP1 is translocated further to the RBC membrane in schizonts (Fig. 3B). 
 
Although a number of MC proteins have been identified and extensively studied, 
surprisingly little is known about their function. Analysis of REX1 null mutants showed 
that PfEMP1 is exported to the MCs but not efficiently presented at the RBC surface (37) 
whilst in MAHRP1 or SBP1 knock-out parasites PfEMP1 was not translocated to the 
RBC surface but was retained within the parasite confines or in the MCs (8,21,38). To 
study the role of SEMP1 in protein export we deleted the protein in two ways. First, we 
generated a SEMP1 knock-out parasite by single crossover gene disruption and secondly 
we generated a conditional SEMP1 knock down parasite by fusing the FKBP 
destabilization domain (DD) to the C-terminus of endogenous SEMP1. In neither parasite 
line we observed any obvious phenotypic change under in vitro culture conditions. All 
tested proteins (REX1, SBP1, MAHRP1, and PfEMP1) were trafficked to their correct 
destinations in SEMP1-KO parasites, there was no growth reduction, and gametocyte 
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production was similar to wild type parasites. This suggests that SEMP1 is neither 
essentially involved in PfEMP1 export nor in gametocytogenesis. This indicates 
redundancy of functional pathways in which other proteins might compensate for the loss 
of SEMP1, and that SEMP1 may have other functions during the intraerythrocytic cycle 
which escaped our observation such as fitness in natural human infections.   
 
To further elucidate its role we were interested in potential interaction partners of 
SEMP1. Using Co-IP 13 different P. falciparum proteins were identified in two 
independent experiments. Three proteins were identified in both experiments and hence 
were priority candidates, namely REX1, PF3D7_0702500, and PF3D7_0601900. While 
REX1 is a known MC resident protein, both other proteins were uncharacterized so far. 
Both, PF3D7_0702500 and PF3D7_0601900 have similarities to semp1 in that they have 
one intron, are non-syntenic to other Plasmodium species and code for small parasite 
proteins with unknown function (PlasmoDB). They also have a predicted single TM 
domain and no PEXEL/VTS motif or signal peptide. Their localization to the MCs was 
recently confirmed by a study that used a bioinformatics approach to identify new 
PEXEL-negative exported proteins (33), yet we cannot conclude that these proteins are 
true interaction partners since there is no functional prediction. However, since parasite 
proteins were extracted with 1 % sodium dodecyl sulphate (SDS), a detergent that breaks 
down membranes by emulsifying the lipids and proteins, it is conceivable these MC 
transmembrane proteins were co-precipitated as constituents of the same complex and not 
just as constituents of the same membrane fragment. None of the other identified 
exported proteins has been shown to be resident in the MCs. PfHsp70-x is an exported 
chaperone which in a complex with co-chaperones forms highly mobile structures in the 
RBC cytosol called J-dots (39,40). MAHRP2 has been described as a PEXEL-negative 
protein forming cylindrical structures called tethers which are believed to tether the MCs 
to the erythrocyte skeleton (18). Pf332 is a large P. falciparum protein exported into the 
RBC (41) where it is, similar to SEMP1, closely associated with the MCs (42,43) but also 
partly with the RBC membrane (43–45). The parasite-infected erythrocyte surface protein 
2 (PIESP2) has been identified as a TM protein in the MCs (46) but it also may partly be 
associated with the RBC membrane (47).  
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Our study represents one of the first using Co-IP and MS/MS to identify interaction 
partners of exported P. falciparum proteins. While the detected potential SEMP1 
interactions need further confirmation, the remarkable cleanliness achieved with HA 
peptide elution in combination with colocalization of SEMP1 with most identified 
candidates is very promising.   
 
Since no phenotype could be observed upon knocking out SEMP1, we speculated that the 
function of SEMP1 might have been compensated for by altered expression of other 
gene(s). We therefore conducted a comparative transcriptome analysis with SEMP1-DD 
parasites grown with or without Shield-1. Thus we were able to monitor the effect of loss 
of SEMP1 in genetically identical parasites at four consecutive time points spanning an 
entire IDC. In this analysis, 34 genes were identified to be significantly up-regulated over 
at least two consecutive time points, four of which with the highest RAFC were all 
exported proteins. Up-regulation of a var gene (PF3D7_0900100) is not really surprising 
since var genes regularly switch from expression of one var gene to another. In contrast, 
PF3D7_1301400 codes for an early expressed predicted exported protein containing a SP 
and PEXEL motif, which belongs to the hypothetical gene family hyp12. The three hyp12 
paralogs have no orthologs in any other organism and do not possess any annotated 
protein domains, making them elusive for functional predictions (48). However, other 
HYP proteins have been shown to be variantly expressed (49) and it could be conceivable 
that SEMP1 knockdown parasites switched to the expression of another HYP12. 
Similarly, PHIST proteins, of which PF3D7_0532300 is a member, also show variant 
transcriptional expression (49). The PHIST protein encoded by PF3D7_0532300 is 
expressed early during the IDC and its function is unknown. However, PHIST proteins 
have been shown to be involved in many functions such as modification of the infected 
host cell, alteration of membrane rigidity (50), and in the export process itself (50). Some 
PHIST proteins containing a DnaJ domain might be involved in stabilization of exported 
proteins (48), and they have been identified in J-dots (40), as constituents of knobs (51), 
and recently identified to be associated with exosomes (52). In light of these promiscuous 
functions and localisations of PHIST proteins an involvement in the structure and / or 
function of MCs is clearly conceivable. PfEMP3 (PF3D7_0201900) is a large PEXEL-
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containing protein that is expressed during the ring and trophozoite stage. It associates 
with MCs and is further transported to the cytoplasmic face of the iRBC where it 
localizes to knobs but can also be distributed more broadly (53). PfEMP3 seems to be 
involved in PfEMP1 trafficking (54) and by binding to actin and spectrin contributes to 
loss of mechanical stability of the erythrocyte membrane (55,56). Together, this gives 
circumstantial evidence that SEMP1 could potentially be involved similarly in these 
processes in concert with PfEMP3 and probably also with PHIST proteins. This would 
also support the identification of Pf332 in our Co-IPs because Pf332 has also been shown 
to modulate the erythrocyte membrane skeleton (57). Coincidentally, Pf332 expression 
was moderately up-regulated in SEMP1-depleted parasites but did not reach significance. 
SEMP1 belongs to the group of PEXEL-negative exported proteins, which also includes 
proteins such as MAHRP1 (31), SBP1 (38), REX1 (9) and REX2 (10). It is still under 
debate how these proteins find their destination and no consensus targeting sequence has 
been found to date. The most common feature is the necessity of most N-terminal region. 
Similar to REX2 (10) and MAHRP2 (18) deletion of the first 16 amino acids completely 
abolished export of SEMP1 leaving the protein distributed throughout the parasite. 
Further truncation of the N-terminal part of SEMP1 up to the TM domain (SEMP172-123-
GFP) leads to an arrest of the protein within the ER. Through this truncation, the TM 
becomes the N-terminus and might anchor the protein like a non-cleavable SP in the ER 
membrane. This has also been observed when the MAHRP1 TM domain was fused to 
GFP (58). As has been shown before with other exported proteins (10,58–60) the first 16 
amino acids of SEMP1 could be replaced either with the N-terminal SP of MSP1 or with 
the first 16 N-terminal residues of MAHRP2.  
 
In conclusion, we identified and characterized a new MC protein termed SEMP1. Upon 
invasion it is exported early into the iRBC cytosol where it inserts into the MCs before it 
is at least partly translocated to the RBC membrane. A parasite with knocked out SEMP1 
revealed that the protein is not essential for parasite survival, gametocytogenesis or 
PfEMP1 export under culture conditions. This lack of altered phenotypes after gene 
knock-out is not an exception but rather the rule. A large-scale study which previously 
produced knock-out parasites for 39 exported P. falciparum proteins only was able to 
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identify phenotypical changes for 15 clones (38.5 %) (50). By using Co-IP and 
transcriptome analysis for functional characterization we provide a new starting point for 
further detailed dissection and characterisation of MC-associated proteins that show no 
phenotypical changes in knock-out parasites.  
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Table 1 Identification of potential SEMP1 interaction partners by Co-IP 
 
Gene ID Gene product 
# of detected peptides Exported to 
RBC 
cytosol 
precipitation Gel 
extraction elution elution (c-) 
PF3D7_0702400  SEMP1 12 0 67 MC 
PF3D7_0935900 * REX1 5 0 29 MC 
PF3D7_0702500 * Plasmodium exported protein 6 0 19 MC 
PF3D7_0601900 * Conserved Plasmodium protein 5 0 13 MC 
PF3D7_0831700 PfHsp70-x 0 0 31 J-dots 
PF3D7_0818900 HSP70 0 0 15 no 
PF3D7_0708400 HSP90 0 0 15 no 
PF3D7_1353200 MAHRP2 0 0 12 tethers 
PF3D7_1149000 * Pf332 0 0 11 MC 
PF3D7_1016300 Glycophorin Binding Protein GBP 0 0 11 RBC 
PF3D7_0507100 60S ribosomal protein L4 0 0 9 no 
PF3D7_0517000 60S ribosomal protein L12 0 0 6 no 
PF3D7_0501200 * PIESP2 0 0 5 MC 
PF3D7_1462800 GAPDH 0 0 5 no 
 
Identified potential SEMP1 interaction partners with the number of detected peptides in 
each MS analysis and their localization during the asexual intraerythrocytic cycle (MC = 
Maurer’s clefts; RBC = soluble in the erythrocyte, no = not exported). Marked (*) 
candidates were investigated for colocalization with SEMP1 by Immunofluorescence 
assays. 
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Table 2 Microarray analysis: Transcriptional changes in absence of SEMP1 
GeneID FC 1 FC 2 FC 3 FC 4 RAFC Product Description 
PF3D7_0900100 2.18 1.26 1.08 2.00 2.09 PfEMP1 
PF3D7_1301400 0.79 1.77 1.84 2.02 1.93 P. exported protein (hyp12) 
PF3D7_0532300 0.74 2.15 1.56 1.59 1.77 P. exported protein (PHISTb) 
PF3D7_0201900 0.56 1.71 1.69 1.27 1.70 PfEMP3 
PF3D7_0618200 1.15 1.08 1.75 1.63 1.69 conserved Plasmodium protein 
PF3D7_0903700 0.95 0.70 1.62 1.72 1.67 alpha tubulin 1 
PF3D7_1468200 1.00 1.41 1.60 1.70 1.65 conserved protein,  
PF3D7_0831700 1.02 1.27 1.62 1.66 1.64 heat shock protein 70 (HSP70-x) 
PF3D7_0113000 0.71 1.60 1.65 1.62 1.64 glutamic acid-rich protein (GARP) 
PF3D7_0319900 1.63 1.38 1.16 1.61 1.62 conserved Plasmodium protein,  
PF3D7_0821700 1.15 1.47 1.47 1.91 1.61 60S ribosomal protein L22 
PF3D7_1226300 1.83 1.36 1.62 1.24 1.60 cof-like hydrolase 
PF3D7_1415700 1.21 1.62 1.53 1.42 1.57 serine C-palmitoyltransferase 
PF3D7_0804800 1.55 1.10 1.57 1.57 1.57 peptidyl-prolyl isomerase (CYP24) 
PF3D7_1200600 1.41 1.49 1.79 0.89 1.56 PfEMP1 (VAR2CSA) 
PF3D7_1242700 0.97 1.19 1.56 1.57 1.56 40S ribosomal protein S17 
PF3D7_0629100 1.56 0.74 1.25 1.56 1.56 phosphoribosyltransferase 
PF3D7_0936800 0.85 1.57 1.38 1.71 1.55 P. exported protein (PHISTc) 
PF3D7_0323000 1.52 0.87 1.39 1.59 1.55 conserved Plasmodium protein 
PF3D7_1317900 0.87 1.53 1.58 1.38 1.55 nuclear export protein 
PF3D7_1476200 1.22 1.42 1.84 1.38 1.55 P. exported protein (PHISTb) 
PF3D7_0210900 1.11 1.04 1.49 1.58 1.54 conserved Plasmodium protein 
PF3D7_0403700 1.23 1.11 1.52 1.55 1.53 CGI-201 protein, short form 
PF3D7_0218100 1.70 1.47 0.80 1.43 1.53 conserved P. membrane protein 
PF3D7_1138500 1.53 1.51 1.16 1.36 1.52 protein phosphatase 2c 
PF3D7_0402000 0.96 0.85 1.47 1.56 1.52 P. exported protein (PHISTa) 
PF3D7_1305400 1.53 1.38 1.65 1.16 1.52 conserved Plasmodium protein 
PF3D7_1474000 1.50 1.52 1.07 0.95 1.51 probable protein 
PF3D7_0708800 1.04 0.84 1.49 1.53 1.51 heat shock protein 70 (HSP70-z) 
PF3D7_1353100 1.07 1.45 1.50 1.51 1.51 Plasmodium exported protein,  
PF3D7_1426600 1.55 1.28 1.69 1.24 1.51 conserved Plasmodium protein 
PF3D7_1443900 1.09 0.77 1.49 1.52 1.51 heat shock protein 90 (HSP90) 
PF3D7_1011800 1.42 0.99 1.64 1.46 1.51 QF122 antigen 
PF3D7_1237900 1.24 1.51 1.50 0.50 1.50 conserved Plasmodium protein 
PF3D7_0113400 0.60 0.79 1.34 0.60 0.60 Plasmodium exported protein 
PF3D7_0930300 1.26 1.14 0.61 0.58 0.59 merozoite surface protein 1 
PF3D7_0503200 0.59 0.60 0.70 1.30 0.59 conserved Plasmodium protein 
PF3D7_0827600 0.60 0.56 1.08 1.55 0.58 conserved Plasmodium protein 
PF3D7_1231300 0.50 0.60 0.61 0.60 0.57 conserved Plasmodium protein 
PF3D7_1216500 0.58 0.55 0.84 1.08 0.56 male development gene 1 (MDV1) 
PF3D7_0302200 1.01 1.04 0.57 0.56 0.56 cytoadherence linked protein 3.2 
PF3D7_0728800 0.57 0.55 1.25 1.55 0.56 conserved Plasmodium protein 
PF3D7_0217500 0.79 1.12 0.56 0.54 0.55 calcium dependent protein kinase 1 
PF3D7_1307500 0.56 0.78 0.93 0.52 0.54 conserved Plasmodium protein 
PF3D7_1112200 0.54 0.53 0.88 1.34 0.54 coq4 homolog, putative 
PF3D7_1475200 0.50 0.54 0.83 1.28 0.52 conserved protein 
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Summary of all significantly (p<0.05) up- (red) and down-regulated (green) parasite 
genes with a respective average fold change (RAFC) > 1.5 or < 0.6. The RAFC is thereby 
the average FC over the significantly up- / down-regulated time points only. The time 
points were 6-14 hpi (FC1), 16-24 hpi (FC2), 26-34 hpi (FC3) and 36-44 hpi (FC4). 
Exported parasite proteins are highlighted in yellow. 
 
Figure legends 
 
 
Figure 1 A: schematic representation of the semp1 gene (top) and SEMP1 protein 
structure (bottom). TM, transmembrane protein. B: lysates of 3D7 parasites expressing 
SEMP1-3xHA or SEMP1-GFP. Detection was by mouse α-HA or mouse α-GFP 
antibodies. C: Live cell imaging of 3D7 parasites expressing SEMP1 with C-terminal 
tagged GFP. D: Immunofluorescence assays of MeOH-fixed RBCs infected with 3D7 
expressing SEMP1 with a C-terminal 3xHA tag, co-labelled with rat α-HA and either 
rabbit α-MAHRP1 or rabbit α-REX1 antibodies. E: Scatter plot of co-localization of 
SEMP1 and REX1 in SEMP1-3xHA parasites. F: Electron microscopy (EM) of RBCs 
infected with 3D7 expressing SEMP1 with a C-terminal GFP tag labelled with rabbit α-
GFP antibodies and decorated with 5 nm gold conjugated Protein A.  
 
Figure 2 A: Immunofluorescence assays of MeOH-fixed RBCs infected with 3D7 
expressing SEMP1 with a C-terminal 3xHA tag, co-labelled with rat α-HA and mouse α-
KAHRP antibodies. B: Parasite protein pellet of 3D7 expressing SEMP1-3xHA was 
fractionated using TritonX-114 into a soluble (aqueous phase) (a) and an insoluble 
(membrane) fraction (d). Proteins were visualized using mouse α-HA and rabbit α-
MAHRP2 antibodies. 
 
Figure 3 Localization and expression of endogenous SEMP1 in 3D7 wild-type 
parasites A: 3D7 wild-type parasite lysate (3D7) and uninfected red blood cells (RBC) 
were analyzed by immunoblotting and probed with mouse serum raised against 
recombinant full-length SEMP1. B: IFAs of MeOH-fixed RBCs infected with 3D7 wild-
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type parasites synchronized at timepoints 6-14 hours post invasion (hpi), 16-24 hpi, 26-34 
hpi and 36-44 hpi. Cells were co-labelled with mouse α-SEMP1 and rabbit α-MAHRP1 
serum. C: 3D7 parasite pellets were generated at the respective timepoints by saponin 
lysis and analyzed by immunoblot using mouse α-SEMP1 serum and mouse α-GAPDH 
(PF3D7_1462800) antibodies. 
 
Figure 4 Requirements for SEMP1 export into the RBC. A: Lysates of SEMP1-KO 
parasites expressing full-length and truncated or mutated forms of SEMP1 C-terminally 
fused to GFP were generated by saponin lysis and analyzed by immunoblotting using 
mouse α-GFP antibodies. Lane 1: SEMP11-123-GFP (full-length), lane 2: SEMP117-123-
GFP, lane3: SEMP172-123GFP, lane4: SEMP11-97-GFP, lane 5: MSP11-16SEMP117-123-
GFP, lane 6: MAHRP21-16SEMP117-123-GFP. B: Immunofluorescence assays of MeOH-
fixed RBCs infected with SEMP1-KO parasites expressing full-length and truncated or 
mutated forms of SEMP1 C-terminally fused to GFP. Expressed SEMP1 was labelled 
with rabbit α-GFP antibodies. The transmembrane domain is depicted in red (TM), a 
MSP1 signal peptide in brown (MSP1) and the MAHRP2 N-terminus in blue (M2). 
 
Figure 5 Identification of potential SEMP1 interaction partners by Co-IP. Co-IP was 
performed with 3D7 parasites expressing SEMP1 with a C-terminal 3xHA tag. Cultures 
were cross-linked with 1 % formaldehyde and parasites were released by saponin 
treatment, lysed in 1%SDS followed by sonication. Lysate (Input) was incubated with α-
HA affinity matrix. After centrifugation the matrix was washed three times with washing 
buffer (Wash) and proteins were eluted from by HA peptide elution. As a negative 
control, an excess of soluble HA peptides was added to the input to block the HA binding 
sites of the matrix (c-). Samples were analyzed by Western blot with α-HA antibodies (A) 
and by silver staining (B). Proteins co-eluted with SEMP1-3xHA were identified by MS 
analysis of both TCA precipitated total elution (precipitation) and Coomassie-stained gel 
slices (gel extraction). 
 
Figure 6 Localization of potential SEMP1 interacting proteins. Immunofluorescence 
assays of MeOH-fixed RBCs infected with 3D7 expressing SEMP1 / PF3D7_0702500 / 
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PF3D7_0601900 with a C-terminal 3xHA tag and 3D7 expressing PIESP2 with a C-
terminal GFP-tag, co-labelled with mouse α-SEMP1 and rat α-HA (PF3D7_0702500-
3xHA & PF3D7_0601900-3xHA) / α-GFP (PIESP2-GFP). For co-labelling of SEMP1-
3xHA with REX1 and Pf332, rat α-HA and rabbit α-REX1 / mouse α-Pf332 antibodies 
were used. 
 
Figure 7 Knockout of SEMP1 by gene disruption has no detectable phenotype. A: 
ClaI- and XmaI-digested gDNA isolated from a SEMP1-KO clone (KO) pH-KO plasmid 
(DP) were analyzed by Southern blot and probed with radioactively labelled hdhfr. In 
case of an integration of the KO plasmid into the parasite genome the expected fragment 
size is 3927 bp. B: lysates of 3D7 wild type and SEMP1-KO (KO) parasites were 
generated by saponin lysis and analyzed by Western blot with α-SEMP1 and α-GAPDH 
(loading control) antibodies. C: Immunofluorescence assays of fixed RBCs infected with 
SEMP1-KO parasites, probed with α-MAHRP1, α-SBP1, α-REX1 and α-PfEMP1 
antibodies. The parasite nuclei were stained with DAPI. D: Bar graph depicting 
differential binding to CD36 of RBCs infected with wild-type 3D7 and SEMP1-KO 
parasites. CD36 (or BSA as control) was immobilized on Petri dishes and bound infected 
RBCs (iRBCs) were calculated as iRBCs per mm2 for 1 % parasitemia. E: Upon 
gametocytogenesis induction of SEMP1-KO parasites by anoxic stress the parasites were 
followed for 8 days to test for gametocyte formation.  
 
Figure 8 Conditional Knockdown of SEMP1. A: EcoRI-digested gDNA isolated from 
SEMP1-DD parasites (DD) was analyzed by Southern blot and probed with radioactively 
labelled hdhfr B: A culture of 3D7 parasites expressing SEMP1-DD was split and 
cultured for 2 weeks in presence (Shld +) or absence (Shld -) of the small molecule 
Shield-1. Whole parasite-lysates were generated after saponin lysis and analyzed by 
Western blot using α-SEMP1. As a loading control the blot was additionally probed with 
antibodies against the housekeeping protein GAPDH. 
 
Figure 9 Transcriptional changes in absence of SEMP1 identified by microarray 
analysis. Summary of all significantly (p<0.05) up- and down-regulated parasite genes 
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with a respective average fold change (RAFC) > 1.5 or < 0.6. The RAFC is thereby the 
average FC over the significanty up- / down-regulated time points (TPs) only. A graphic 
depiction of their FCs throughout the four time points (TPs) is shown in form of a heat 
map. Up-regulation (FC > 1) is indicated in red, down-regulation (FC < 1) in green. The 
time points were 6-14 hpi (TP1), 16-24 hpi (TP2), 26-34 hpi (TP3) and 36-44 hpi (TP4). 
Exported proteins are highlighted in yellow. 
 
 
Supplementary Material 
 
Construct Primer 
name 
Primer sequence RS 
SEMP117-123-GFP 
    
17-123-F CAGTCTTAAGATGGCCAATACCCAAGAAAAGAAATT AflII 
17-123-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
SEMP172-123-GFP 
             
72-123-F CAGTCTTAAGATGGAGTTGGTTGAATTTGGTTTAAAC AflII 
72-123-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
SEMP11-97-GFP 
 
1-97-F CAGTCTTAAGATGAGTCAACCACAAAAACAAC AflII 
1-97-R CAGTATCGATTACGTAATCATATATTTGTAAGGC ClaI 
 
MSP1-16SEMP117-123-
GFP 
 
MSP1-F 
CAGTCTTAAGATGAAGATCATATTCTTTTTATGTTC 
ATTTCTTTTTTTTATTATAAATACACAATGTGTAG 
CCAATACCCAAGAAAAGAAATT AflII 
MSP1-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
 
M21-16SEMP117-123-
GFP 
 
M2-F 
CAGTCTTAAGATGCAGCCTTGTCCATATGATGTATA 
CAATCAAATAAACCATGTAGGAACTCATTGGGCTGC 
CAATACCCAAGAAAAGAAATT AflII 
M2-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
 
Table S1. Primers used to generate truncated and mutated constructs for SEMP1 
trafficking studies. AflII and ClaI restriction sites (RS) thereby allowed directional 
cloning into the pARL1mGFPmT transfection vector. 
 
Codon-optimized SEMP1 sequence 
 
ATGAGTCAACCGCAGAAACAGCAGAATGAAGAAGGGGCTGCTACTGCGGCA
AACACCCAGGAGAAGAAATTCAATCCGACACGCAATCCTTCGCAATCTGGTC
CCTATCGTCACCATGGACCACAGGGTCGTACCCCGTATATGCAACTGCACAA
GAATCAGAACAACAACATGGTCAACAAAATCAGCAACTATCTCGGCATTGAG
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AACAAAGAACTGGTGGAATTTGGCCTGAATCTGTTTACGTACATCATTGCCAT
TTTCTTAGCCCTGCAAATCTACGACTATGTAACCCATCGCAAATGCGGCTATT
ACAAAGATATGCTGGCGAAAATTGTTCGCTTTCAGGCATCACTTCAGAATGC
GAAA 
 
Supplementary Figure legends 
 
Figure S1. A: Lysates of 3D7 parasites expressing PF3D7_0702500-3xHA (0702500-
3xHA), PF3D7_0601900-3xHA (0601900-3xHA) and PIESP2-GFP generated by 
saponin lysis and analyzed by Western blot using rat α-HA / mouse α-GFP antibodies. 
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Figure 2 
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Figure 3 
 
CHAPTER 4: SEMP1 IS A SMALL EXPORTED MEMBRANE PROTEIN 
 
 138 
 
 
Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 3 
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Figure 9 
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Supplementary Material 
 
Construct Primer 
name 
Primer sequence RS 
SEMP117-123-GFP 
    
17-123-F CAGTCTTAAGATGGCCAATACCCAAGAAAAGAAATT AflII 
17-123-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
SEMP172-123-GFP 
             
72-123-F CAGTCTTAAGATGGAGTTGGTTGAATTTGGTTTAAAC AflII 
72-123-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
SEMP11-97-GFP 
 
1-97-F CAGTCTTAAGATGAGTCAACCACAAAAACAAC AflII 
1-97-R CAGTATCGATTACGTAATCATATATTTGTAAGGC ClaI 
 
MSP1-16SEMP117-123-
GFP 
 
MSP1-F 
CAGTCTTAAGATGAAGATCATATTCTTTTTATGTTC 
ATTTCTTTTTTTTATTATAAATACACAATGTGTAG 
CCAATACCCAAGAAAAGAAATT AflII 
MSP1-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
 
M21-16SEMP117-123-
GFP 
 
M2-F 
CAGTCTTAAGATGCAGCCTTGTCCATATGATGTATA 
CAATCAAATAAACCATGTAGGAACTCATTGGGCTGC 
CAATACCCAAGAAAAGAAATT AflII 
M2-R CAGTATCGATTTTTGCGTTCTGTAAACTGGCT ClaI 
 
Table S1. Primers used to generate truncated and mutated constructs for SEMP1 
trafficking studies. AflII and ClaI restriction sites (RS) thereby allowed directional 
cloning into the pARL1mGFPmT transfection vector. 
 
Codon-optimized SEMP1 sequence 
 
ATGAGTCAACCGCAGAAACAGCAGAATGAAGAAGGGGCTGCTACTGCGGCA
AACACCCAGGAGAAGAAATTCAATCCGACACGCAATCCTTCGCAATCTGGTC
CCTATCGTCACCATGGACCACAGGGTCGTACCCCGTATATGCAACTGCACAA
GAATCAGAACAACAACATGGTCAACAAAATCAGCAACTATCTCGGCATTGAG
AACAAAGAACTGGTGGAATTTGGCCTGAATCTGTTTACGTACATCATTGCCAT
TTTCTTAGCCCTGCAAATCTACGACTATGTAACCCATCGCAAATGCGGCTATT
ACAAAGATATGCTGGCGAAAATTGTTCGCTTTCAGGCATCACTTCAGAATGC
GAAA 
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Supplementary Figure legends 
 
Figure S1. Lysates of 3D7 parasites expressing PF3D7_0702500-3xHA (0702500-
3xHA), PF3D7_0601900-3xHA (0601900-3xHA) and PIESP2-GFP generated by 
saponin lysis and analyzed by Western blot using rat α-HA / mouse α-GFP antibodies. 
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Introduction 
 
The apicomplexan parasite Plasmodium falciparum is the pathogenic agent causing the 
most severe form of human malaria called malaria tropica, which is responsible for 
almost 700’000 deaths annually worldwide (1). Once in the blood stream the protozoan 
parasite undergoes an asexual developmental cycle consisting of repeated erythrocyte 
invasion, multiplication and release by cell rupture. The disease symptoms are strongly 
associated with this development within the human red blood cells. Since human 
erythrocytes are devoid of internal organelles and any protein trafficking machinery, 
parasite survival and virulence depend on substantial host cell modifications. These are 
mediated by exporting a large number of parasite proteins into the RBC cytosol and to 
the RBC membrane. The latter were shown to be transported via parasite derived 
membranous structures in the RBC cytosol called Maurer’s clefts (MCs) which are 
thought to function as a form of a surrogate Golgi which concentrates virulence proteins 
for delivery to the RBC surface (2,3). However, their specific function has yet to be 
determined. 
 
In an attempt to bring new insight into the function and composition of MCs we 
identified and characterized the MC resident small exported membrane protein 1 
(SEMP1, accession number). Although lacking a classical signal peptide (SP) and a 
PEXEL motif, SEMP1 is exported into the host cell (4) early after erythrocyte invasion. 
There it inserts into the MCs as a transmembrane (TM) protein before it appears to be 
partly further exported to the RBC membrane. Knock out studies revealed that SEMP1 is 
not essential for parasite survival, PfEMP1 export, or gametocytogenesis under culture 
conditions. Transcriptomic analysis revealed that in absence of SEMP1 transcription of a 
number of exported parasite proteins is up-regulated, including PfEMP3. Since PfEMP3 
was shown to be involved in determining the rigidity of the host cell membrane by 
binding to actin and spectrin (5,6) its upregulation in a SEMP1 knock out could indicate 
that PfEMP3 might compensate for the loss of SEMP1. In orther to further investigate the 
function of SEMP1 we performed co-immunoprecipitation (co-IP) and identified several 
potential interaction partners, including the two previously uncharacterized MC proteins 
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PF3D7_0702500 (PF07_0008) and PF0601900 (PFF0090w). The aim of this study was 
to investigate the potential binding of SEMP1 to PF3D7_0702500 and PF3D7_0601900 
by the maiting-based split-ubiquitin system (mbSUS) (7) in a pairwise interaction assay. 
This yeast based in vitro interaction platform for membrane proteins consists of a split 
ubiquitin whose moieties are only able to reconstitute a functional protein if brought into 
proximity via the interaction of the respective proteins that are fused to them (8). Upon 
bait and prey protein interaction the functional ubiquitin is cleaved off by specific 
proteases which releases a transcription factor (TF) from yeast membranes. The TF then 
diffuses to the nucleus and starts transcription of the selection markers his3 and ade2 
whose activation enables the yeast to grow on defined minimal medium lacking histidine 
and / or adenine (7). 
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Methods 
 
Yeast medium 
 
NMY51 reporter strain (9) was cultured in Yeast Extract - Peptone - Dextrose plus 
Adenine medium (YPAD: 1 % yeast extract (Sigma), 2 % Bacto Peptone (BD), 210 µM 
adenine hemisulfate, 2 % glucose). NMY51 transfected with a bait vector was cultured in 
minimal medium lacking leucine (SD-leu: 38 mM ammonium sulphate, 0.17 % Difco 
yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-arginine, 
230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 108.6 µM adenine hemisulfate, 129 µM L-histidine, 100µM L-tryptophan, 2 % 
glucose). NMY51 co-transfected with bait and prey vectors was cultured in minimal 
medium lacking leucine and tryptophan (SD-trp-leu: 38 mM ammonium sulphate, 0.17 % 
Difco yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-
arginine, 230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 108.6 µM adenine hemisulfate, 129 µM L-histidine, 2 % glucose). mbSUS library 
screenings and functional assays were performed in minimal medium lacking leucine, 
tryptophan and histidine (SD-trp-leu-his: 38 mM ammonium sulphate, 0.17 % Difco 
yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-arginine, 
230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 108.6 µM adenine hemisulfate, 2 % glucose) or minimal medium lacking leucine, 
tryptophan, histidine and adenine (SD-trp-leu-his-ade: 38 mM ammonium sulphate, 0.17 
% Difco yeast nitrogen base w/o amino acids and ammonium sulphate (BD), 115 µM L-
arginine, 230 µM L-isoleucine, 164 µM L-lysine-HCl, 135 µM L-methionine, 300 µM L-
phenylalanine, 1.68 mM L-threonine, 166 µM L-tyrosine, 178 µM L-uracil, 1.28 mM L-
valine, 2 % glucose). 
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Bait vector construction 
 
Since the prediction programs MEMSAT2 (10) and TMHMM (11) made conflicting 
predictions of the membrane orientation of SEMP1 (Fig 1A), two prey vectors were 
generated to facilitate both orientations (Fig. 1B). Therefore full-length semp1 was PCR 
amplified from cDNA using primers summarized in table S1 and cloned into the bait 
vectors pBT3-SUC and  pBT3-N (9) via SfiI restriction sites. pBT3-N adds the C-
terminal half of ubiquitin (Cub) which itself is fused to a LexA-VP16 TF 5’ to semp1, 
pBT3-SUC adds it 3’ to semp1. Both bait vectors contain the two selectable markers kanR 
and leu2 which allow selection of plasmid-bearing cells on medium containing 
kanamycin (bacteria) or lacking leucine (yeast). pBT3-SUC additionally adds the S. 
cerevisiae signal sequence (SUC2) to the bait’s N-terminus, which ensures proper 
insertion into yeast membranes. 
 
Transformation of the bait vector into the NMY51 yeast reporter strain 
 
A single colony from a 3 day old NMY51 streak was inoculated in 20 ml of liquid YPAD 
medium (in a 100 ml Erlenmeyer flask) and incubated o/n on a shaker at 275 rpm and 
30°C. The titer of the culture was determined using a Neubauer chamber and 2.5x108 
cells were added to 50 ml pre-warmed YPAD to give 5x106 cells / ml. The cells were 
incubated at 30°C and 275 rpm till the cell titer was 2x107 (~5 h). Then the cells were 
centrifuged (3000 g, 5 min) and the supernatant removed. After the cells were washed in 
25 ml ddH2O (3000 g, 5 min) they were resuspended in 1 ml dd H2O. Meanwhile single 
stranded (ss) carrier DNA (2 mg / ml) was boiled at 95°C for 5 min and chilled on ice. 
The cell suspension was centrifuged (11’000 rpm, 30 sec) and the supernatant discarded. 
The pellet was resuspended in ddH2O to a final volume of 1 ml and vortexed vigorously. 
100 µl aliquots were distributed into new tubes, centrifuged (11’000 rpm, 30 sec) and the 
supernatant removed. 360 µl transformation mix (33 % PEG 3350, 100 mM LiOAc, 0.1 
mg boiled ss carrier DNA, 2.5 µg bait vector) were added and resuspended by vigorously 
vortexing. After incubation at 42°C (water bath) for 40 min the cells were pelleted 
(11’000 rpm, 30 sec) and the supernatant removed. The cells were resuspended in 200 µl 
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ddH2O and 100 µl were spread on pre-warmed (30°C) SD-Leu Agar plates. Plates were 
sealed with parafilm and incubated at 30°C for 3-5 days.  
 
Freezing of yeast strains (Glycerol stocks) 
 
20 ml liquid yeast medium (depending on the strain either YPAD, SD-Leu or SD-Trp) 
were inoculated from a single colony of a 3 day old streak (in a 100 ml Erlenmeyer flask) 
and incubated o/n on a shaker at 275 rpm and 30°C. After centrifugation (2600 g, 5 min), 
the supernatant was removed and the pellet resuspended in 10 ml 2x YPAD containing 25 
% Glycerol. 1 ml aliquots were distributed into screw cap cryotubes and frozen at -80°C. 
 
Prey vector construction   
 
Full-length pf3d7_0702500 and pf3d7_0601900 were PCR amplified from cDNA using 
primers summarized in table S1 and cloned into the prey vectors pPR3-N and pPR3-SUC 
(9) via SfiI restriction sites. pPR3-N adds the coding sequence of an N-terminal split-
ubiquitin (Nub) 5’ to the prey’s N-terminus, pPR3-SUC to the C-terminus. Both prey 
vectors contain the two resistance genes ampR and trp1 which allow selection by growth 
on medium containing ampicilin (bacteria) or lacking tryptophan (yeast). pPR3-SUC 
additionally adds the S. cerevisiae signal sequence (SUC2) to the prey’s N-terminus, 
which ensures proper insertion into yeast membranes. 
 
mbSUS functional assay and pairwise interaction assay 
 
To test if SEMP1 inserted correctly into the yeast membrane and was functional in the 
mbSUS assay, pBT3-SUC-SEMP1 and pBT3-N-SEMP1 were both co-transformed into 
the NMY51 yeast reporter strain with either of the two control plasmids pOst1-NubI 
(positive control) and pPR3-N (negative control) to perform a functional assay. A single 
colony from a 3 day old NMY51 pBT3-SUC-SEMP1 or pBT3-N-SEMP1 streak was 
inoculated in 20 ml of liquid YPAD medium (in a 100 ml Erlenmeyer flask) and 
incubated o/n on a shaker at 275 rpm and 30°C. The titer of the culture was determined 
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and 2.5 x 108 cells were added to 50 ml pre-warmed YPAD to give 5 x 106 cells / ml. The 
cells were incubated at 30°C and 275 rpm till the cell titer was 2 x 107. The cells then 
were centrifuged (3000 g, 5 min) and the supernatant removed. The pellet was washed in 
25 ml ddH2O (3000 g, 5 min) and resuspended in 1 ml dd H2O. Meanwhile the ss carrier 
DNA (2 mg / ml) was boiled at 95°C for 5 min and chilled on ice. The cell suspension 
was centrifuged (11’000 rpm, 30 sec) and the supernatant discarded. The pellet was 
resuspended in ddH2O to a final volume of 1 ml and vortexed vigorously. 200 µl aliquots 
were distributed into new tubes, centrifuged (11’000 rpm, 30 sec) and the supernatant 
removed. 360 µl transformation mix (33 % PEG 3350, 100 mM LiOAc, 0.2 mg boiled ss 
carrier DNA, 2.5 µg of either pPR3-N (empty prey vector: negative control) or pOst1-
NubI (wild type Nub with strong affinity for Cub: positive control) or prey plasmid 
DNA) were added and resuspended by vigorously vortexing. After incubation at 42°C 
(water bath) for 40 min the cells were pelleted (11’000 rpm, 30 sec) and the supernatant 
removed. Each pellet was resuspended in 1 ml pre-warmed YPAD and incubated at 30°C 
for 90 min. After centrifugation (11’000 rpm, 30 sec) the supernatant was removed, each 
pellet resuspended in 180 µl ddH2O (3 ml total) and 80 µl aliquots were spread on pre-
warmed (30°C) SD-Trp-Leu-His / SD-Trp-Leu-His-Ade Agar plates containing 100 mM 
3-AT. Additionally a 1:1000 dilution of the transformation was plated on a SD-Trp-Leu 
plate to determine the transformation efficiency. Plates were sealed with parafilm and 
incubated at 30°C for 3 (SD-Trp-Leu) or 5 days (SD-Trp-Leu-His / SD-Trp-Leu-His-
Ade) before number of colony forming units was determined. Significance of difference 
in cell growth on selective medium compared to the negative control pPR3-N was 
determined by Fisher’s exact tests. 
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Results 
 
Functional assay of pBT3-SUC-SEMP1 and pBT3-N-SEMP1 
 
To test if SEMP1 inserted correctly into the yeast membrane and was functional in the 
mbSUS assay, pBT3-SUC-SEMP1 and pBT3-N-SEMP1 were both co-transformed into 
the NMY51 yeast reporter strain with either of the two control plasmids pOst1-NubI 
(positive control) and pPR3-N (negative control). The transformed cells were plated onto 
selective medium (SD-trp-leu, SD-trp-leu-his and SD-trp-leu-his-ade) and after 
incubation at 30°C for 5 days the number of grown colonies was determined. Figure 1C 
shows that 9 % of the yeast cells co-transformed with pBT3-SUC-SEMP1 and pOST1-
NubI (positive control) grew on minimal medium lacking histidine (SD-trp-leu-his). In 
contrast no colony was obtained with the empty prey vector pPR3-N (negative control) 
under the same conditions. While the pBT3-SUC-SEMP1 bait seems to be correctly 
expressed and functional to a certain degree, the ratio of pOst1-NubI bearing cells which 
grow on selective medium is with ~ 9 %, respectively 0.5 % under more stringent 
conditions (SD-trp-leu-his-ade) quite low. The pBT3-N-SEMP1 bait seems to be not 
functional in this assay. This would suggest that SEMP1 is a type I transmembrane 
protein. 
 
mbSUS pairwise interaction assay of SEMP1 with PF3D7_0702500 or 
PPF3D7_0601900 
 
Both TM domain-bearing PEXEL-negative exported proteins (PNEPs) PF3D7_0702500 
and PPF3D7_0601900 were identified by Co-IP as potential interaction partners of the 
integral MC protein SEMP1. To investigate potential binding of SEMP1 with either of 
the two candidates, a mbSUS pairwise interaction assay was performed. Since the 
different TM prediction tools gave conflicting results about membrane orientation of 
PF3D7_0702500 and PPF3D7_0601900 (either type I or type II TM proteins), two prey 
vectors were generated for each gene facilitating either direction and tested for potential 
interaction (Fig. 2A). After transformation of the pPR3-N-PF3D7_0702500 or 
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PPF3D7_0601900 and pPR3-SUC-PF3D7_0702500 or PPF3D7_0601900 prey vectors 
into the pBT3-SUC-SEMP1 bearing NMY51 yeast reporter strain cells were plated onto 
SD-trp-leu-his. After incubation at 30°C for 5 days the number of grown colonies was 
determined for each combination. Although only few colonies were obtained in all four 
screens the number of colonies obtained with pPR3-N-PPF3D7_0601900 bearing cells 
were significantly higher (p<0.001) than with pPR3-N containing cells (negative control) 
when grown on selective medium (SD-trp-leu-his) (Figure 2B). This could indicate that 
direct binding between SEMP1 and PF3D7_0601900 occurred and would also suggest 
that PF3D7_0601900 is a type II transmembrane protein.  
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Discussion 
 
Parasite derived membranous structures called Maurer’s clefts are important for protein 
trafficking from the parasite to the RBC membrane, probably by acting as secretory 
organelles that concentrate virulence proteins for further export. However, their specific 
function in the export process has yet to be determined (2,3). The same applies to their 
protein composition: while previous studies successfully identified numerous MC 
resident proteins (12–14), the fact that ongoing research steadily reveals new candidates 
(15) indicates that the current MC proteome is far from complete. Since many of these 
newly identified MC proteins are so called PEXEL-negative exported proteins (PNEPs) 
which lack a SP and a PEXEL/VTS motif, it is impossible to estimate how many 
additional MC proteins have yet to be identified. 
In an attempt to bring new insight into the function and composition of the MCs we have 
characterized the new MC protein SEMP1 and thereby identified two potential 
interaction partners namely PF3D7_0702500 and PF3D7_0601900 by Co-IP 
experiments. Both have similarities to SEMP1 in that they co-localize at the MCs, all 
have a two exon structure, they are non syntenic to other Plasmodium species, they code 
for small parasite proteins with unknown function (PlasmoDB), and all three proteins 
have a predicted single TM domain and neither a PEXEL/VTS motif nor a SP. 
To investigate PF3D7_0702500 and PF3D7_0601900 for interaction with SEMP1 a 
mbSUS pairwise interaction assay was performed. The basic requirement of the mbSUS 
is exposure of the split ubiquitin into the cytoplasm (7) which makes bait protein 
orientation within the yeast membrane a crucial selection criteria for the bait vector that 
determines to which end the Cub is added. Since it was unclear in which orientation 
SEMP1 would integrate into the membrane two different baits were generated to cover 
both possibilities. Because SEMP1 lacks a classical SP, the S. cerevisae signal sequence 
SUC2 was added to the N-terminus of the SEMP1 bait clone which had the Cub fragment 
fused to its C-terminus to ensure membrane insertion. Functional assays revealed that 
both baits seemed to be correctly expressed but only the one with the C-terminal Cub was 
functional. From this we concluded that SEMP1 is a type I TM protein similar to e.g. 
MAHRP1 (12).  
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The functional pBT3-SUC-SEMP1 bait clones were used in a mbSUS pairwise 
interaction assay to test binding to PF3D7_0702500 or PF3D7_0601900. Since 
membrane orientation of these proteins was also unclear, prey vectors were generated to 
facilitate both orientations and used in the screen. No binding could be detected between 
SEMP1 and PF3D7_0702500 (p = 0.549) whilst pRR3-N-PF3D7_0601900 bearing cells 
together with SEMP1 produced significantly (p < 0.001) more colonies on selective 
medium than the negative control. Although these results suggested specific binding 
between SEMP1 and PF3D7_0601900, the small number of colonies is of concern. It 
could indicate that the interaction of both proteins is weak, the bait is inefficiently 
expressed, or the Cub fragment is poorly accessible. The latter two reasons are likely 
since even under non-stringent screening conditions the SEMP1 bait only achieved a 
growth ratio of 9 % in the functional assay and it is possible that the bait-prey interaction 
hinders reconstitution of a functional ubiquitin. With the available control it was not 
possible to confirm the correct expression of the prey protein and the high AT content of 
80 % of P. falciparum genes (16) could have  hindered protein expression in yeast (17) 
leading to an inefficient prey expression. However, the significant number of colonies 
with PF3D7_0601900 gives strong evidence for a direct interaction but the lack of 
growth does not exclude such interaction between SEMP1 and PF3D7_0702500. Further 
examination is therefore needed, e.g. by pull-down assays or Far-western-blot 
experiments. For quantification of the detected interactions more complex analyses 
should be considered: Surface Plasmon Resonance (SPR) studies (18) woluld allow 
investigation of very small protein amounts without labelling and thereby not only 
determine association but also dissociation rates. The disadvantage of SRP is that 
immobilized proteins may be inactivated. Isothermal Titration Calorimetry (ITC) is the 
most quantitative technique available for measuring the thermodynamic properties of 
protein–protein interactions and would allow investigation of proteins in solution. 
However, application for membrane proteins was shown to be difficult (19). 
Spectroscopy study by NMR would also allow investigation of proteins in solution and in 
addition was already successfully used to verify interactions of exported P. falciparum 
proteins (20). 
CHAPTER 5: SEMP1 DIRECTLY INTERACTS WITH PF3D7_0601900 
 158 
The preceding co-IPs and Immunofluorescence assays (chapter 4) indicate that SEMP1, 
PF3D7_0601900, PF3D7_0702500 and ‘ring exported protein 1’ (REX1) might all be 
part of the same protein complex. mbSUS analysis should therefore be expanded to test 
direct binding between all these proteins. Furhter, substantiation of the correctness of the 
co-IP results by this mbSUS study gives reason to characterize PF3D7_0601900 and 
PF3D7_0702500 in more detail. Generation of specific antibodies would allow 
localization of the endogenous protein instead of an episomally overexpressed one  
(chapter 4) and knockout studies might enable functional characterization. Finally co-IP 
experiments would expand our knowledge of the interaction network centred around 
SEMP1. 
 
In conclusion, the results from the pairwise interaction assay with SEMP1 and 
PF3D7_0601900 using the mbSUS need to be confirmed again but showed the 
applicability of this system to investigate membrane protein interactions in P. falciparum. 
The results from the co-IP presented in chapter 4 also add strong evidence for this 
interaction and support the notion that the mbSUS pairwise interaction assays could 
become a powerful tool for the confirmation of membrane protein interactions. However, 
the performed experiments made it also apparent that probably not all P. falciparum 
membrane proteins are suited for investigation by mbSUS. Since the investigated SEMP1 
bait protein appeared to be suboptimal for investigation by mbSUS, either because of 
ineffective expression or hindered accessibility of the split ubiquitin, it has to be assumed 
that several P. falciparum membrane proteins are completely inapplicable for this 
promising system. However, in the absence of flawless alternatives mbSUS remains an 
intriguing strategy for verification of P. falciparum membrane protein interactions. 
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Figure legends 
 
Figure 1 Orientation of SEMP1 in the yeast membrane. A. Different prediction 
program gave contrasting results for the orientation of SEMP1. MEMSAT (left) predicted 
SEMP1 as a type I TM protein, while TMHMM (right) predicted SEMP1 to be a type II 
TM protein. B. Two SEMP1-bait vectors were generated to facilitate both orientations: 
pBT3-SUC-SEMP1 to facilitate a type I TM protein, pBT3-N-SEMP1 to facilitate a type 
II TM protein. Cub = C-terminal split ubiquitin, NubI = wild type N-terminal ubiquitin, N 
= nucleus, RG = reporter gene, TF = transcription factor. C. Both baits were co-
transformed into the yeast reporter strain NMY51 with either the empty library plasmid 
pPR3-N (negative control) or the control plasmid pOst1-NubI which contains a wild-type 
N-terminal ubiquitin (NubI) which has a strong Cub-affinity (positive control). The 
transformed cells were spread on selective medium (SD-trp-leu / SD-trp-leu-his / SD-trp-
leu-his-ade) and the number of colony forming units was determined after incubation at 
30°C for 4 days. The number in brackets indicates the ratio of grown cells compared to 
distributed cells (SD-trp-leu). 
 
Figure 2 mbSUS pairwise interaction assay of SEMP1 with either PF3D7_0702500 
or PF3D7_0601900. A. For both PF3D7_0702500 and PF3D7_0601900 two prey 
vectors were generated to also facilitate the unknown transmembrane orientation: pBT3-
SUC-PF3D7_0702500 and PF3D7_0601900 to facilitate a type I TM protein, pBT3-N-
PF3D7_0702500 and PF3D7_0601900 to facilitate a type II TM protein. Cub = C-
terminal split ubiquitin, Nub = N-terminal ubiquitin with point mutation, N = nucleus, 
RG = reporter gene, TF = transcription factor. B: These prey vectors and the empty 
pPR3-N plasmid (negative control) were transformed into the pBT3-SUC-SEMP1 
bearing yeast reporter NMY51. Transformed cells were spread onto selective medium 
(SD-trp-leu / SD-trp-leu-his) and after incubation for 5 days at 30°C the number of CFUs 
was determined. Significance of difference in cell growth compared to the negative 
control pPR3-N was determined by Fisher’s exact test and p-values are shown in 
brackets. 
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Figure 1 
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Supplementary table 1. Primers used for mbSUS bait and prey vector generation 
 
 
 
Gene Primer Sequence RS vector   
SEMP1 
F ATTAACAAGGCCATTACGGCCAGTCAACCACAAAAACAACAAAAC SfiI pBT3-SUC 
bait 
R AACTGATTGGCCGAGGCGGCCCCTTTTGCGTTCTGTAAACTGGCTT SfiI pBT3-SUC 
F ATTAACAAGGCCATTACGGCCATGAGTCAACCACAAAAACAACA SfiI pBT3-N 
R AACTGATTGGCCGAGGCGGCCTTATTTTGCGTTCTGTAAACTGG SfiI pBT3-N 
PF3D7_0702500 
F ATTAACAAGGCCATTACGGCCATGGCTTATCCTCTTTTAGAAGA SfiI pPR3-N 
prey 
R AACTGATTGGCCGAGGCGGCCTTATACATGAGCTTCATTAGTGTT SfiI pPR3-N 
F ATTAACAAGGCCATTACGGCCGCTTATCCTCTTTTAGAAGATGA SfiI pPR3-SUC 
R AACTGATTGGCCGAGGCGGCCCCTACATGAGCTTCATTAGTGTTTAA SfiI pPR3-SUC 
PF3D7_0601900 
F ATTAACAAGGCCATTACGGCCATGACGGACCATTTATTGGATTT SfiI pPR3-N 
R AACTGATTGGCCGAGGCGGCCTTAATTTTCTGCATTGGCTGAAG SfiI pPR3-N 
F ATTAACAAGGCCATTACGGCCACGGACCATTTATTGGATTTTAAT SfiI pPR3-SUC 
R AACTGATTGGCCGAGGCGGCCCCATTTTCTGCATTGGCTGAAGCA SfiI pPR3-SUC 
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General Discussion 
 
Despite enormous control efforts Malaria remains one of the world’s most devastating 
human infectious diseases. The causative agent of the most deadly form called malaria 
tropica is the apicomplexan parasite Plasmodium falciparum. Most of the parasite’s 
pathology is associated with its asexual development within the red blood cell. Because 
the human erythrocyte is a highly specialized cell which is devoid of all internal 
organelles, survival of P. falciparum critically depends on extensive host cell 
refurbishments. These are mediated by the export of numerous parasite proteins into the 
erythrocyte cytoplasm, including parasite derived membranous structures termed 
Maurer’s clefts (MCs) which are believed to function as a surrogate Golgi by 
concentrating virulence proteins for delivery to the RBC membrane (1,2). One of these 
virulence proteins is the variable surface antigen ‘P. falciparum erythrocyte membrane 
protein 1’ (PfEMP1), which after insertion into the erythrocyte membrane mediates 
adhesion to endothelial receptors. Thereby it not only prevents elimination of infected 
RBCs in the spleen, but as a side-effect also causes organ failure and cerebral malaria (3). 
Because this transport of parasite proteins into the host cell is the source of severe P. 
falciparum pathology, identification and characterization of the components of the 
transport system is of major interest. Although MCs were shown to play a major role in 
export of virulence proteins (1,2), their precise function remains elusive. In an attempt to 
bring new insight into the function and composition of these important structures, we 
identified and characterized the new integral MC protein ‘small exported membrane 
protein 1’ (SEMP1) by immunofluorescence assays, knockout studies, co-
immunoprecipitation (co-IP) and transcriptional analysis (chapter 4).  
Studies on model organisms revealed that protein-protein interactions (PPIs) play a major 
role in eukaryotic protein secretion which is so important that for their identification 
James Rothman, Randy Schekman and Thomas Südhof were honoured with the Nobel 
Prize in Physiology or Medicine in 2013 (4,5). Despite their prime importance, still very 
little is known about PPIs of secreted P. falciparum proteins. The reasons for that are 
manifold. Because of the parasite’s large evolutionary distance to eukaryotic model 
organisms, about 60 % of its genes lack similarity to functionally annotated genes (6). 
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Interaction partners of their proteins can therefore only be experimentally identified, 
which is additionally hindered by the complexity of the parasite’s intracellular life cycle. 
To overcome the described difficulties, high throughput yeast-two-hybrid (Y2H) 
screenings were undertaken to generate a first P. falciparum PPI network (7). However, 
due to the hydrophobic nature, membrane proteins are not suitable for investigation by 
Y2H since they insert into the yeast membranes. P. falciparum membrane protein 
interactions have therefore so far been largely ignored. Since the many exported parasite 
proteins were shown to be membrane proteins, like the ‘membrane associated histidine-
rich protein 1’ (MAHRP1) (8), an alternative approach is needed in order to generate an 
extensive interaction network of exported P. falciparum proteins. With this study we 
aimed at bringing new insight into interactions of exported P. falciparum proteins and 
thereby establishing a basis for the generation of the interactome of the parasite’s 
exportome. Therefore we not only performed interaction studies using classical 
approaches like co-IP, but also tried to establish the mating-based split-ubiquitin system 
(mbSUS) (9) as a new in vitro interaction platform for P. falciparum membrane proteins 
on the basis of the integral Maurer’s cleft protein MAHRP1. 
 
Generation of a new interaction network of exported P. falciparum proteins 
 
In order to expand our knowledge on interactions of exported P. falciparum proteins and 
to create a starting point for generation of a new protein-protein interaction network (Fig. 
1), we performed two independent co-IP experiments with the integral MC resident 
SEMP1. Thereby peptides of three different parasite proteins, namely the ‘ring exported 
protein 1’ (REX1), PF3D7_0702500 and PF3D7_0601900 could be detected in both 
experiments. While REX1 is a well characterized MC protein which was shown to be 
essential for PfEMP1 export to the RBC membrane (10), the other two proteins were 
previously uncharacterized. All three candidates were PEXEL-negative exported proteins 
(PNEPs) which co-localized with SEMP1 at the MCs and had a predicted single 
transmembrane (TM) domain. Additionally to these three top candidates, peptides of four 
other exported proteins could be detected in either one of the two experiments: the 
parasite-infected erythrocyte surface protein (PIESP2), the P. falciparum antigen 332 
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(Pf332), the membrane associated histidine rich protein 2 (MAHRP2) and the heat shock 
protein 70-x (HSP70-x). Like SEMP1 the two exported proteins PIESP2 and Pf332 are 
mainly associated with MCs, but also with the erythrocyte membrane. Although these 
proteins could only be detected in the second co-IP experiment which was more sensitive, 
their co-localization with SEMP1 (chapter 4) makes them interesting candidates. Due to 
their localization to different compartments of the infected erythrocyte, an interaction of 
SEMP1 with MAHRP2 found at tethers, or HSP70-x found in J-dots seems less likely.  
PIESP2 as a potential SEMP1 interactor was previously also co-precipitated in two 
independent experiments with the integral MC protein MAHRP1 (Annette Gaida, 
unpublished). MAHRP1 was not co-precipitated with SEMP1 but it appears that these 
two proteins could be indirectly connected via the common interactor PIESP2. MAHRP1 
co-IP experiments also identified PF3D7_0501000 as a potential MAHRP1 interactor 
which was supported by the finding presented in chapter 3 where both PIESP2 and 
PF3D7_0501000 were shown to be membrane proteins co-localizeing with MAHRP1 at 
the MCs. Although this is circumstantial evidence it could suggest a MAHRP1-PIESP2 / 
PF3D7_0501000 interaction. 
Co-IP experiments with membrane proteins always bear the risk that identified proteins 
are not real interactors but co-precipitated as constituents of the same membrane 
fragment. To counteract this problem we extracted parasite proteins with 1 % sodium 
dodecyl sulphate (SDS), a detergent that breaks down membranes by emulsifying the 
lipids and proteins. However, although extraction with SDS reduced the described risk 
significantly, the identified interactions should be further analyzed to resolve all doubt. 
To investigate if some of the potential PPIs identified by co-IP were binding directly, 
pairwise interaction assays using the mbSUS were performed. While neither the 
MAHRP1 – PIESP2 or PF3D7_0501000 nor the SEMP1 – PF3D7_0702500 interaction 
could be confirmed, the mbSUS assays showed a weak but significant interaction of 
SEMP1 with another MC protein (PF3D7_0601900). This was in agreement with the 
previously described co-IP results which together strongly suggested an interaction 
between SEMP1 and PF3D7_0601900. Possible follow-up experiments for further 
verification are  pull-down assays or NMR spectroscopy studies which would even allow 
quantification of the detected interactions. 
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The comparison of our data on this small preliminary PPI network of exported P. 
falciparum proteins to the large-scale Y2H data of LaCount et al (7) showed three new 
potential interaction partners for Pf332 which were all uncharacterized. These were the 
PHIST protein PF3D7_0936800, the exported protein with unknown function 
PF3D7_0730800.1, and the conserved Plasmodium protein with unknown function 
PF3D7_1325800. LaCount et al. (7) predicted in addition an interaction between 
MAHRP2 and the putative CCR4-NOT transcription complex subunit 4 
PF3D7_1235300. For all other members which we had identified in this PPI network they 
either found no interactions or they were observed once and therefore not reliable. In 
particular, none of the potential interaction partners we had identified by co-IP was 
detected in the Y2H study proving again the non-suitability of the Y2H for the 
investigation of exported parasite proteins. 
In summary, we have potentially generated a small PPI network of exported parasite 
proteins centred around the two integral MC proteins SEMP1 and MAHRP1 by 
combining co-IPs, mbSUS assays and the results from a previous large-scale- Y2H study 
(Fig.1). While most of the identified potential interactions still need further confirmation, 
e.g. by pull down assays, Far Western blotting, fluorescence resonance energy transfer 
(FRET), NMR spectroscopy studies, Isothermal Titration Calorimetry (ITC) or Surface 
Plasmon Resonance (SPR) studies, this could be the basis for numerous follow-up studies 
which in the end will result in a comprehensive PPI network of exported P. falciparum 
proteins. 
 
Functional characterization of SEMP1 
 
Since disruption of the semp1 gene did not result in any obvious phenotypic changes 
under culture conditions we decided to investigate the function of SEMP1 by interaction 
studies. By two independent co-IP experiments we identified several potential SEMP1 
interaction partners: the five Maurer’s clefts proteins REX1, Pf332, PIESP2, 
PF3D7_0702500 and PF3D7_0601900, as well as the tether protein MAHRP2 and the J-
dot protein HSP70-x. Additional co-IPs further revealed a potential indirect interaction 
between SEMP1 and the integral MC protein MAHRP1 via the common interactor 
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PIESP2. While for some of these identified potential interacting proteins the function is 
unknown, others have been extensively studied and functionally characterized. Both MC 
proteins REX1 and MAHRP1 were shown to be essential for PfEMP1 trafficking and 
maintaining the MC ultrastructure. In REX1 knockout parasites PfEMP1 was still 
exported to the MCs but not efficiently presented at the erythrocyte membrane (1), while 
MAHRP1 deletion abolished PfEMP1 export to the MCs (2). Pf332 is a large peripheral 
MC protein which also associates with the RBC membrane similar to SEMP1. Knock-out 
studies showed that it also disrupted PfEMP1 transport and the structure of the MCs, but 
additionally modulated the erythrocyte membrane rigidity (3,4). The exported chaperone 
HSP70-x has been shown to be a component of highly mobile structures in the 
erythrocyte cytoplasm called J-dots and could probably also be involved in PfEMP1 
transport (5,6). It is important to note that the four potential SEMP1 interactors REX1, 
MAHRP1, Pf322, and HSP70-x are all involved in PfEMP1 export, and in determing MC 
ultrastructure or modulating erythrocyte membrane rigidity. Whether this suggests any 
indirect involvement of SEMP1 in PfEMP1 trafficking remains to be elucidated but 
seems unlikely since knock-out of SEMP1 had no effect on PfEMP1 export to the RBC 
surface and binding of infected erythrocytes to CD36 under static conditions. 
Nevertheless, it might be possible that SEMP1 is involved in determining MC structure 
or modulation of erythrocyte membrane rigidity. For the latter there is some evidence 
from the transcriptional analysis which revealed up-regulation of PfEMP3 in absence of 
SEMP1. Similar to SEMP1 the exported parasite protein PfEMP3 first associates with 
MCs but is later transported further to the cytoplasmic face of the RBC membrane (7). 
PfEMP3 seems to be involved in PfEMP1 trafficking (8) but was also shown to mediate 
loss of mechanical stability of the RBC membrane by binding to actin and spectrin (9,10). 
In the absence of SEMP1 not only PfEMP3 potentially involved in modulation of the 
RBC membrane rigidity was transcriptionally up-regulated but also a Plasmodium helical 
interspersed subtelomeric (PHIST) protein (PF3D7_0532300) which has not been 
characterized but some other members of the PHIST family have been shown to be 
involved in alteration of the RBC membrane (11). If we speculate that pfemp3 and phist 
transcription were altered by the parasite to compensate for the loss of SEMP1, this 
would indicate an involvement of SEMP1 in similar functions.  
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Taking together co-IP results and the transcriptome analysis, there is some evidence that 
SEMP1 might be indirectly involved in PfEMP1 trafficking and/or modulation of RBC 
membrane rigidity and determination of MC structure. However, knock out studies 
proved that SEMP1 is not essential for PfEMP1 export and insertion into the RBC 
membrane. Its involvement in altering RBC membrane rigidity or MC structure remains 
to be determined. Further investigation into these two possibilities is needed e.g. by 
deformability testing with atomic force microscopy (AFM), an artificial spleen system 
(12), a laser-assisted optical rotational cell analyzer (LORCA) (13) or electron 
microscopy (EM).  
  
Combination of co-IP and mbSUS: a new strategy for identification and verification 
of direct P. falciparum membrane protein interactions? 
 
 Because we could not prove the functionality of our P. falciparum blood stage cDNA 
library (chapter 2) the mbSUS can yet not be used to identify new interaction partners. 
However, if it would be functional in pairwise interaction assays, as suggested by the 
significant increase in growth of yeast cells co-expressing SEMP1 and PF3D7_0601900 
(chapter 5), it would provide a new tool to verify potential direct binding of two 
implicated interacting proteins. Those candidates for pairwise mbSUS testing could be 
identified using the optimized co-IP protocol described in chapter 4 which showed a 
remarkable specific elution due to usage of HA peptides and anti-HA matrix. Such 
combination of co-IP and mbSUS could represent a new strategy for identification and 
confirmation of direct P. falciparum membrane protein interactions. 
However, it became apparent that not all P. falciparum membrane proteins seemed to be 
suited for the mbSUS. While the MAHRP1 bait was able to trigger growth in 30 % yeast 
cells containing the positive control under stringent screening conditions, SEMP1 yielded 
only 0.5 % under the same conditions. While this could be improved to 9 % by reducing 
stringency, the observation that of two investigated bait proteins only one is functional 
under stringent conditions indicates that several P. falciparum membrane proteins might 
be inapplicable for this promising system. The mbSUS might therefore only be used to 
confirm but not refute direct binding between two potential interactors. However, the 
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proposed combination of co-IP and mbSUS remains an intriguing strategy for 
identification and verification of P. falciparum membrane protein interactions. 
  
Functional characterization of exported P. falciparum proteins by comparative 
transcriptome analysis 
 
With SEMP1 we identified a non-essential exported P. falciparum protein for which no 
phenotypical changes could be observed in knock-out parasites. Disruption of the semp1 
gene was shown to neither have an effect on export of the major parasite virulence factor 
PfEMP1 nor on gametocyte formation. The lack of altered phenotypes after gene knock-
out is not an exception but rather the rule. A large-scale study which previously produced 
knock-out parasites for 39 exported P. falciparum proteins only was able to identify 
phenotypical changes for 15 clones (38.5 %) (20). In our lab we have made similar 
experience with a number of knock out clones as with SEMP1. At first glance these 
observations might suggest that many exported parasite proteins are redundant but  the 
expression and export of proteins is associated with high energy costs for the parasite, 
and makes this rather unlikely. One possible explanation would be that these proteins are 
involved in processes others than observed under culture conditions. The in vitro 
cultivation of P. falciparum used for studying the intraerythrocytic cycle of the parasite 
(22) does not reflect the conditions found in the human body. All nutrients abound and 
interactions with the immune system are completely missing, hence it is possible that 
these proteins are involved in processes such as signal transduction or other immune 
evasion mechanisms which are difficult to be investigated under culture conditions. It 
becomes very difficult to investigate these processes and one possibility to overcome 
these problems would be to do in vivo studies in monkeys (23). However, such 
experiments are too difficult, ethically problematic, and expensive to be performed on a 
routine basis.  
The lack of phenotypical changes in parasites with various genes knocked-out could also 
be due to compensatory mechanisms by up-regulating transcription of other genes with 
similar function. This could be examined by comparative transcriptome analysis and by 
using this approach we showed that in absence of SEMP1 the transcription of several 
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parasite genes is slightly up-regulated, including PfEMP3 which contributes to a loss of 
mechanical stability of the RBC membrane via binding to spectrin and actin (18,19). This 
gives circumstantial evidence that SEMP1 potentially could be involved in modifying 
RBC membrane rigidity in concert with PfEMP3.  
However, since the conditional SEMP1 knock-out parasite grew normally after 
withdrawal of shield, the transcriptional changes cannot have been resulted by selection 
but would require feedback-driven transcriptional regulation of exported P. falciparum 
proteins. This increased PfEMP3 transcription needs to be confirmed e.g. by qPCR to 
speculate on such feedback regulation. 
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Figure 1 Interaction network of exported P. falciparum proteins. By combining co-
immunoprecipitation (co-IP) and mating-based split ubiquitin system (mbSUS) results a 
small network of potential protein-protein (PPI) interactions was generated. The arrows 
thereby indicate the likelihood of the respective interaction: dashed arrows represent 
interactions only detected once by co-IP, fine solid arrows stand for interactions either 
observed twice by co-IP or at least five times in a large-scale yeast-two-hybrid study by 
LaCount et al. (7), and the thick arrow indicates an interaction detected twice by co-IP 
and significant (p < 0.001) in an mbSUS pairwise interaction assay. The colours indicate 
the subcellular localization of the respective protein. 
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Outlook 
 
The aim of this thesis was to increase our understanding of the mechanisms involved in 
erythrocyte modification by the malaria parasite Plasmodium falciparum. In order to 
verify our hypotheses and to bring new insight into the interactions and functions of 
exported parasite proteins I suggest the following experiments: 
 
 All three previously isolated SEMP1-KO parasite clones contain a subtelomeric 
chromosome 2 truncation which among others leads to a loss of the kahrp gene. 
These parasites are therefore unqualified to investigate potential deleterious effects 
of SEMP1 disruption on Knob formation. Hence a kahrp containing parasite clone 
needs to be isolated from a non-clonal culture. This SEMP1-KO clone then should 
be analyzed for: 
 
-  involvement of SEMP1 in knob formation and Maurer’s clefts ultrastructure 
determination by electron microscopy. 
 
-  involvement of SEMP1 in modification of erythrocyte membrane rigidity by 
deformability testing with a laser-assisted optical rotational cell analyzer 
(LORCA). 
 
-  involvement of SEMP1 in stress response by nutrient starvation. 
 
 In order to confirm the by microarray detected transcriptional up- or down-
regulation of several P. falciparum genes including PfEMP3, qPCR should be 
performed from the corresponding timepoints. 
 
 The in chapter 3 and 5 described mbSUS pairwise interaction assays need to be 
repeated in order to confirm the supposed binding between SEMP1 and 
PF3D7_0601900.  
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 Before further mbSUS library screenings make sense the quality and functionality 
of the generated P. falciparum blood stage cDNA library needs to be further 
evaluated. I therefore propose to PCR screen it for presence of rhoptry neck protein 
2 (RON2) fragments. If the library contains such fragments, an apical membrane 
antigen (AMA1) bait should be generated and used for a library screen. The thereby 
generated yeast clones can be analyzed for true positives by PCR srceens using 
RON2 primers. Alternatively the newly identified SEMP1 – PF3D7_0601900 
interaction can be used as a positive control if it can be confirmed by a repeated 
mbSUS pairwise interaction assay. 
 
 The potential interactions between SEMP1 and REX1 / PF3D7_0702500 / 
PF3D7_0601900 / PIESP2 / Pf332 / Hsp70-x / MAHRP2 need to be further 
investigated by either by pull-down or NMR experiments. 
 
 In order to expand the generated small potential interaction network of exported P. 
falciparum proteins, co-IP experiments with the already available PF3D7_0601900-
3xHA and PF3D7_0702500-3xHA parasites should be performed. 
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Appendix 
 
 
Cell biological characterization of the malaria vaccine 
candidate trophozoite exported protein 1 
 
 
 
During the course of this thesis contributions to a research manuscript published in ‘PLoS 
One’ were made. It characterizes the malaria vaccine candidate ‘trophozoite exported 
protein 1’ (Tex1) which was localized at the Maurer’s clefts. 
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